{"meta":{"query_hash":"fbf7c1d7d8b0","filters":{"venue":"Annals of Hematology"},"cohort_total":159,"direct_labels_cover":0,"predictions_cover":159,"exported":159,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fbf7c1d7d8b0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Annals+of+Hematology"},"results":[{"id":"W1049067418","doi":"10.1007/s00277-015-2467-z","title":"Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia; American Society of Hematology","keywords":"Medicine; Refractory (planetary science); Internal medicine; CHOP; Diffuse large B-cell lymphoma; Lymphoma; Hematology; Surgery; Gastroenterology","score_opus":0.03958313229841773,"score_gpt":0.3005493670425425,"score_spread":0.2609662347441247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1049067418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797124,0.0005879896,0.000054534463,0.000089063586,0.000017252858,0.0000070424094,0.00012789125,0.000004188916,0.0011409172],"genre_scores_gemma":[0.9992786,0.00012808677,0.000012488246,0.000055380253,0.00003309212,0.0000040859977,0.00029349903,0.0000017489493,0.00019301608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997545,0.00004960228,0.000021381395,0.000032921962,0.000028378663,0.00011324876],"domain_scores_gemma":[0.9993901,0.00014575443,0.00014493024,0.000027346305,0.00005000341,0.00024178607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025931123,0.00022182526,0.00053815177,0.00031041098,0.00052182924,0.000723204,0.0002529583,0.00048226345,0.001377957],"category_scores_gemma":[0.001309446,0.000102921185,0.0006465815,0.00040842118,0.00034199955,0.00041322314,0.00044310399,0.0005282276,0.0003867504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007868616,0.00044807646,0.9517128,0.00007957227,0.00026605287,0.016089946,0.00039615002,0.0010991791,0.002395034,0.00014757292,0.0009894075,0.018507516],"study_design_scores_gemma":[0.00017885792,0.0032257047,0.97948796,0.0000301137,0.00022807416,0.014265218,0.00042459817,0.0007605479,0.0002988564,0.00020576351,0.0008685601,0.000025725554],"about_ca_topic_score_codex":0.0011521676,"about_ca_topic_score_gemma":0.0011771921,"teacher_disagreement_score":0.001377957,"about_ca_system_score_codex":0.0006085688,"about_ca_system_score_gemma":0.00027537992,"threshold_uncertainty_score":0.0046097636},"labels":[],"label_agreement":null},{"id":"W1751016438","doi":"10.1007/s00277-015-2478-9","title":"Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; H. Lundbeck A/S; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Internal medicine; Mantle cell lymphoma; Neutropenia; Tolerability; Gastroenterology; Rituximab; Nausea; Adverse effect; Progressive disease; Salvage therapy; Phases of clinical research; Surgery; Febrile neutropenia; Lymphoma; Chemotherapy","score_opus":0.047856919404286505,"score_gpt":0.32922497514834703,"score_spread":0.28136805574406054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1751016438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951963,0.0016536226,0.00051317323,0.0002196623,0.00007097493,0.0006897188,0.00057533797,0.00006606354,0.001015217],"genre_scores_gemma":[0.99475926,0.0010924197,0.0009222682,0.00031897353,0.00013165001,0.0005671903,0.0011072776,0.000027749724,0.0010732175],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994351,0.00029163083,0.00002573855,0.00009546994,0.000047545123,0.00010451697],"domain_scores_gemma":[0.99925476,0.0001408417,0.0001325145,0.00009274111,0.000039423652,0.00033980174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014295386,0.0017081172,0.002436698,0.00058631925,0.00039370972,0.001043726,0.0011749773,0.0011848458,0.002710281],"category_scores_gemma":[0.0008461464,0.0007533747,0.0014991587,0.0004895082,0.0012724786,0.0010723681,0.0003482666,0.0032164415,0.000833724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7865293,0.06875254,0.004082398,0.00050184096,0.0021964323,0.00038614654,0.0002709321,0.002538774,0.08273364,0.00023217883,0.0016659439,0.050109837],"study_design_scores_gemma":[0.53380346,0.44790545,0.008011079,0.000026764532,0.00073199056,0.0003608252,0.00006597239,0.0010766011,0.006265004,0.0001303482,0.0015883365,0.000034171364],"about_ca_topic_score_codex":0.0013439237,"about_ca_topic_score_gemma":0.0025662319,"teacher_disagreement_score":0.002710281,"about_ca_system_score_codex":0.0009872816,"about_ca_system_score_gemma":0.0012516148,"threshold_uncertainty_score":0.00906682},"labels":[],"label_agreement":null},{"id":"W1818977891","doi":"10.1007/s00277-015-2487-8","title":"Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia","year":2015,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Ibrutinib; Autoimmune hemolytic anemia; Medicine; Chronic lymphocytic leukemia; Hematology; Internal medicine; Leukemia; Anemia; Hemolytic anemia; Immunology","score_opus":0.07872316819994295,"score_gpt":0.3517327384379987,"score_spread":0.2730095702380557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1818977891","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31749424,0.04570887,0.0029514357,0.5514929,0.0083857365,0.00008293302,0.00040243875,0.00036510246,0.07311624],"genre_scores_gemma":[0.8436926,0.006634539,0.0012032395,0.12710054,0.01708048,0.000054545137,0.00025272314,0.00006563211,0.0039156005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99943644,0.00019142886,0.00008648872,0.00005246046,0.00010206452,0.00013102133],"domain_scores_gemma":[0.99855,0.00067739165,0.00018036451,0.00006394815,0.00013576417,0.00039249015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004589265,0.00023731783,0.00062987354,0.00038060953,0.00094604975,0.0011282461,0.0005185147,0.0036541894,0.002511632],"category_scores_gemma":[0.0048314226,0.00014917877,0.0005717452,0.00048826326,0.00049688894,0.0007133891,0.00034675654,0.0033914011,0.00087377056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046631414,0.0009281656,0.19290803,0.00041001276,0.00035997364,0.20217314,0.00070292945,0.0014942251,0.0073558125,0.0068088463,0.25223753,0.32995814],"study_design_scores_gemma":[0.002590526,0.0039460817,0.15647827,0.0017599278,0.0010098323,0.40686935,0.002299329,0.006762823,0.0068426454,0.031315356,0.37992764,0.00019820254],"about_ca_topic_score_codex":0.0012678939,"about_ca_topic_score_gemma":0.0027786621,"teacher_disagreement_score":0.0036541894,"about_ca_system_score_codex":0.0014574717,"about_ca_system_score_gemma":0.0016135866,"threshold_uncertainty_score":0.010574698},"labels":[],"label_agreement":null},{"id":"W1886638497","doi":"10.1007/s00277-015-2519-4","title":"Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; International Prognostic Scoring System; Myelodysplastic syndromes; Internal medicine; Ferritin; Erythropoiesis; Gastroenterology; Hemoglobin; Hematology; Anemia; Bone marrow","score_opus":0.08651732193006928,"score_gpt":0.3571977235027097,"score_spread":0.2706804015726404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886638497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8238859,0.097987145,0.000982712,0.058325972,0.0020014793,0.00016249758,0.00063760596,0.00013913783,0.01587742],"genre_scores_gemma":[0.96989495,0.017363744,0.0015436434,0.007879543,0.0015666406,0.00009068295,0.000388299,0.000011841861,0.0012605898],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973553,0.00010713766,0.000036755275,0.000026122168,0.00005442936,0.000040056682],"domain_scores_gemma":[0.9993389,0.0002569878,0.00015442747,0.00002430499,0.00009457128,0.00013073035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004624953,0.00039067215,0.0012716934,0.00031679883,0.0003206582,0.0005686038,0.00040211057,0.000974261,0.0017172121],"category_scores_gemma":[0.004129683,0.00012116742,0.00064396084,0.00035539118,0.00024902873,0.000578611,0.00024697842,0.0012247931,0.00033905523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025609726,0.0046896725,0.39602727,0.0018898975,0.002174658,0.0020312995,0.00029147303,0.0012052222,0.0047947085,0.001777268,0.026835268,0.53267354],"study_design_scores_gemma":[0.010376908,0.012753873,0.91059434,0.0021874066,0.0051302887,0.0038528314,0.0009838329,0.002605174,0.0026793566,0.008140432,0.040591095,0.00010440422],"about_ca_topic_score_codex":0.0018870375,"about_ca_topic_score_gemma":0.0031130856,"teacher_disagreement_score":0.0018870375,"about_ca_system_score_codex":0.0003573612,"about_ca_system_score_gemma":0.0006319613,"threshold_uncertainty_score":0.005744636},"labels":[],"label_agreement":null},{"id":"W1960760923","doi":"10.1007/s00277-015-2540-7","title":"Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"CEBPA; NPM1; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Oncology; Medicine; Chemotherapy; Hematology; Induction chemotherapy; Transplantation; Leukemia; Melphalan; Immunology; Cancer research; Biology; Karyotype; Mutation; Genetics; Gene","score_opus":0.04535198571691033,"score_gpt":0.29059420863287017,"score_spread":0.24524222291595985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960760923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974432,0.00045654227,0.00013262856,0.000174209,0.00003304243,0.000006898048,0.00013514167,0.0000075782564,0.0016108218],"genre_scores_gemma":[0.99917454,0.00014317507,0.00006996507,0.000058184913,0.000039645794,0.0000036399051,0.00020637532,0.000002058544,0.0003024664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993634,0.000008663416,0.000004950918,0.000011444612,0.000010510362,0.000028098233],"domain_scores_gemma":[0.9997831,0.00004586796,0.000059783175,0.000014358665,0.000012341709,0.00008447148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008296989,0.00020865058,0.00031333254,0.00023764548,0.00024364553,0.00030811035,0.00010989302,0.0002549267,0.0025522718],"category_scores_gemma":[0.0004307745,0.000069344256,0.0001557517,0.00024836976,0.00022895157,0.00024921732,0.00019331399,0.00028664467,0.00035239258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058668675,0.00022989698,0.8841438,0.000050285114,0.00017820703,0.010287941,0.00008667864,0.00057429436,0.04354953,0.0010536263,0.001933437,0.05204551],"study_design_scores_gemma":[0.00028665503,0.0013302523,0.9510337,0.000017656575,0.0002162975,0.03487352,0.00023847065,0.00093752873,0.0032286409,0.0020764016,0.0057386127,0.000022177142],"about_ca_topic_score_codex":0.00024301959,"about_ca_topic_score_gemma":0.0004250187,"teacher_disagreement_score":0.0025522718,"about_ca_system_score_codex":0.0001502367,"about_ca_system_score_gemma":0.0001839413,"threshold_uncertainty_score":0.008538187},"labels":[],"label_agreement":null},{"id":"W1968124066","doi":"10.1007/s00277-012-1475-5","title":"Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL)","year":2012,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Erythropoiesis; Anemia; Medicine; Leukemia; Bone marrow; Disease; Ineffective erythropoiesis; Hematology; Immunology; Bioinformatics; Cancer research; Internal medicine; Biology","score_opus":0.07454213810316791,"score_gpt":0.38083549500626207,"score_spread":0.30629335690309417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968124066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118301155,0.9993407,0.0000505871,0.00016380737,0.000057086585,0.0000020490102,0.000009254767,0.0000027023964,0.00025543303],"genre_scores_gemma":[0.0006996971,0.9988877,0.00009553456,0.00009614383,0.00008139607,0.0000028667869,0.000017045671,2.679876e-7,0.000119349206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998603,0.000021506758,0.000027999266,0.000023478971,0.000051849802,0.000014820236],"domain_scores_gemma":[0.99980134,0.000086437816,0.000049950384,0.000004655992,0.00004215838,0.000015452553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165349,0.00062719913,0.0012477582,0.0015940488,0.00022554577,0.00080373697,0.0007583007,0.000781382,0.0014747075],"category_scores_gemma":[0.00056116894,0.00023878133,0.00043042883,0.0015998252,0.00036102498,0.0008081456,0.0005633678,0.0010134957,0.0006031929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001113254,0.000077099096,0.00082577486,0.015392692,0.0001471627,0.00040140084,0.00004913104,0.00028121617,0.0014722012,0.0027229297,0.02008885,0.95843023],"study_design_scores_gemma":[0.00009654676,0.00020330686,0.004576137,0.0065660817,0.00075184816,0.0054948376,0.00016019402,0.00019151386,0.0012307927,0.003388223,0.97729945,0.00004104196],"about_ca_topic_score_codex":0.0010282804,"about_ca_topic_score_gemma":0.0018293913,"teacher_disagreement_score":0.0015940488,"about_ca_system_score_codex":0.0004364192,"about_ca_system_score_gemma":0.0010612493,"threshold_uncertainty_score":0.004933417},"labels":[],"label_agreement":null},{"id":"W1969284011","doi":"10.1007/s00277-013-1959-y","title":"A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma","year":2013,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Lymphoplasmacytic Lymphoma; Hematology; Multiple myeloma; PAX5; Lymphoma; Medicine; Pathology; Waldenstrom macroglobulinemia; Cancer research; Internal medicine; Immunology; B cell; Antibody","score_opus":0.056094194248893364,"score_gpt":0.3149534791100926,"score_spread":0.25885928486119925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969284011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7142086,0.018566692,0.013639064,0.09197454,0.008199678,0.0007204753,0.0010529965,0.0015139957,0.15012392],"genre_scores_gemma":[0.9675697,0.0026380536,0.0044264016,0.01013791,0.010441005,0.00007014269,0.0002284026,0.00010522117,0.00438312],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99861217,0.00023728175,0.00014261686,0.00027476906,0.0002613011,0.00047187446],"domain_scores_gemma":[0.9971173,0.0012529445,0.00045100844,0.00033756864,0.0002978395,0.0005433693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069447194,0.0020703627,0.0014989703,0.0024935661,0.00232282,0.0026329597,0.0019123208,0.01031189,0.0044698566],"category_scores_gemma":[0.0070761503,0.0011824883,0.0015502742,0.0016856029,0.0018451554,0.0029867468,0.001961012,0.0055839587,0.0017384777],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047952788,0.000012019473,0.0013899499,0.00003672403,0.000007346901,0.99460816,0.000042102263,0.00007421275,0.00067840575,0.00044294327,0.0013081002,0.0013521083],"study_design_scores_gemma":[0.000028047327,0.000032871114,0.0013595877,0.000021794382,0.000025934887,0.9947513,0.00007637925,0.0006972732,0.0005044876,0.0007068521,0.0017870804,0.000008399902],"about_ca_topic_score_codex":0.0014443252,"about_ca_topic_score_gemma":0.0015611189,"teacher_disagreement_score":0.01031189,"about_ca_system_score_codex":0.0024855803,"about_ca_system_score_gemma":0.000836423,"threshold_uncertainty_score":0.01803416},"labels":[],"label_agreement":null},{"id":"W1969934340","doi":"10.1007/s00277-004-0944-x","title":"IgD multiple myeloma?a clinical profile and outcome with chemotherapy and autologous stem cell transplantation","year":2004,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Autologous stem-cell transplantation; Chemotherapy; Internal medicine; Hematology; Transplantation; Oncology; Bone marrow; Hematopoietic stem cell transplantation; Gastroenterology; Surgery","score_opus":0.08139372406923957,"score_gpt":0.38818219888648675,"score_spread":0.3067884748172472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969934340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939434,0.0013926693,0.00010910981,0.00045969198,0.000030957697,0.000019376785,0.00019773708,0.000007683069,0.0038393068],"genre_scores_gemma":[0.9989606,0.0002501259,0.000050852515,0.0001457418,0.00009328302,0.000007706315,0.00022068544,0.0000033283468,0.00026773114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949837,0.00014253608,0.000052194475,0.0000716273,0.00008362301,0.0001516554],"domain_scores_gemma":[0.9984819,0.00044400903,0.0004099076,0.00007447344,0.00014356707,0.00044607258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006301371,0.00030306814,0.00081983086,0.00071621465,0.0007374564,0.0010029596,0.00040750805,0.0009657743,0.0021244546],"category_scores_gemma":[0.002464099,0.00016494918,0.00059682544,0.0013131447,0.00047544218,0.00095099676,0.00035201386,0.000644612,0.0005576278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002435426,0.00017305391,0.9824386,0.000011175667,0.000072811854,0.0043740286,0.00009102948,0.00020278743,0.0011657531,0.000104987834,0.00030613915,0.008624155],"study_design_scores_gemma":[0.00007447964,0.0012149266,0.98376274,0.000015608864,0.00013506715,0.012356988,0.0003506469,0.0005231707,0.00026950275,0.0004751599,0.00080045755,0.00002113884],"about_ca_topic_score_codex":0.001330972,"about_ca_topic_score_gemma":0.0016070304,"teacher_disagreement_score":0.0021244546,"about_ca_system_score_codex":0.0004617806,"about_ca_system_score_gemma":0.00057218166,"threshold_uncertainty_score":0.0071070194},"labels":[],"label_agreement":null},{"id":"W1975254425","doi":"10.1007/s00277-012-1449-7","title":"Transient appearance of GPI-deficient population in a patient with azathioprine-associated bone marrow aplasia","year":2012,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver General Hospital","funders":"","keywords":"Bone Marrow Aplasia; Medicine; Hematology; Azathioprine; Bone marrow; Aplasia; Population; Internal medicine; Transient (computer programming); Bone marrow failure; Gastroenterology; Haematopoiesis; Disease; Biology","score_opus":0.027198305009713236,"score_gpt":0.26471028273755975,"score_spread":0.23751197772784652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975254425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91357446,0.0053424235,0.0037411328,0.04102476,0.0034408264,0.00021085507,0.00039758594,0.0006126891,0.03165536],"genre_scores_gemma":[0.9873677,0.0010504836,0.0009385753,0.00533748,0.0035253668,0.000025731535,0.00010177796,0.00004608382,0.0016067671],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99938583,0.00012459268,0.00008386651,0.00013050814,0.000104645456,0.00017051367],"domain_scores_gemma":[0.99791175,0.0011427841,0.00019856688,0.00017446179,0.00013329713,0.0004390436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000499762,0.0015582896,0.0012262955,0.0014882456,0.0016443869,0.0012734369,0.0014747193,0.0082043875,0.0021037792],"category_scores_gemma":[0.0057578497,0.0007044667,0.001035472,0.000809798,0.0012351589,0.0012525539,0.0006833209,0.004324429,0.00085885107],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013184863,0.000026861626,0.0043026153,0.000028243758,0.0000082243105,0.9926353,0.00007398182,0.00004091872,0.00070297904,0.00015901431,0.00093158823,0.00095841585],"study_design_scores_gemma":[0.0000567343,0.00017137994,0.008349836,0.000022652948,0.000035199824,0.98809195,0.00009010562,0.00070467126,0.000816831,0.00035946697,0.0012878921,0.000013179645],"about_ca_topic_score_codex":0.0010751095,"about_ca_topic_score_gemma":0.0009491009,"teacher_disagreement_score":0.0082043875,"about_ca_system_score_codex":0.0010397458,"about_ca_system_score_gemma":0.0004346454,"threshold_uncertainty_score":0.0075439215},"labels":[],"label_agreement":null},{"id":"W1978618037","doi":"10.1007/s00277-013-1991-y","title":"Survival of patients with transformed lymphoma in the rituximab era","year":2014,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Medicine; Vincristine; Internal medicine; CHOP; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Cyclophosphamide; Prednisone; Chemotherapy; Oncology; Hematology; Gastroenterology","score_opus":0.023990251094445778,"score_gpt":0.2864974165225775,"score_spread":0.2625071654281317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978618037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961772,0.0016390228,0.00005630773,0.00023570571,0.00001943586,0.0000017330973,0.00023229011,0.0000063584303,0.0016319696],"genre_scores_gemma":[0.9992424,0.0002302949,0.000008321632,0.000069938076,0.00002200061,0.0000013685442,0.00021236754,0.00000136779,0.00021190687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975044,0.000047223235,0.0000133235335,0.000045084882,0.000027764603,0.00011618638],"domain_scores_gemma":[0.9994855,0.00011165057,0.00015602533,0.000029513865,0.00004953141,0.00016763565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023361914,0.00012747929,0.00030903408,0.0002947564,0.00029212303,0.0006447171,0.00018362114,0.00039265724,0.0017271725],"category_scores_gemma":[0.0013632774,0.00008804622,0.00027364652,0.00036299558,0.00018385643,0.00064093183,0.00032628488,0.00052387954,0.00026814337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033091165,0.00010762161,0.9714518,0.000023517518,0.00018020478,0.0009084372,0.00017204577,0.00054156693,0.0018021939,0.00025945282,0.0011618867,0.020082094],"study_design_scores_gemma":[0.00007277343,0.00076538185,0.9935725,0.000018935732,0.00019025887,0.0023332934,0.0002867573,0.00057555095,0.00025200736,0.00032921063,0.0015911837,0.000012246576],"about_ca_topic_score_codex":0.0014670484,"about_ca_topic_score_gemma":0.0013568947,"teacher_disagreement_score":0.0017271725,"about_ca_system_score_codex":0.00036473083,"about_ca_system_score_gemma":0.00025245087,"threshold_uncertainty_score":0.005777955},"labels":[],"label_agreement":null},{"id":"W1979271531","doi":"10.1007/s00277-013-1993-9","title":"Smouldering systemic mastocytosis with lymph node involvement mimicking malignant lymphoma","year":2013,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Systemic mastocytosis; Hematology; Medicine; Lymphoma; Internal medicine; Lymph node; Malignant lymphoma; Oncology; Pathology; Bone marrow","score_opus":0.03287375450675482,"score_gpt":0.24208107410860752,"score_spread":0.2092073196018527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979271531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6111012,0.029506708,0.008425478,0.10945372,0.013788538,0.0010074301,0.0010133678,0.0013503422,0.22435318],"genre_scores_gemma":[0.9541379,0.0036538795,0.0025276276,0.01155166,0.02104781,0.00006682575,0.0002324465,0.00008143959,0.0067003225],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990252,0.00020211774,0.0001014055,0.00019166313,0.0001573161,0.00032228508],"domain_scores_gemma":[0.9981919,0.0007653011,0.0002894184,0.00020303443,0.00013717035,0.00041317273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006909098,0.00213464,0.001374061,0.001633879,0.0016279225,0.0019388961,0.0020666155,0.01111069,0.005108247],"category_scores_gemma":[0.004977792,0.0011546105,0.001229057,0.0011700233,0.0017509044,0.002650028,0.0012312945,0.0060180626,0.0021079988],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067273715,0.000023220613,0.0018987003,0.000045313467,0.0000067116493,0.9931544,0.00004316207,0.00006175285,0.0005382162,0.00038573865,0.0025741,0.0012013649],"study_design_scores_gemma":[0.00007561574,0.00009858465,0.005120786,0.000048379534,0.000035384794,0.98840547,0.00012559483,0.0009348181,0.000451006,0.0010680653,0.0036238919,0.000012483066],"about_ca_topic_score_codex":0.0012066392,"about_ca_topic_score_gemma":0.001843668,"teacher_disagreement_score":0.01111069,"about_ca_system_score_codex":0.002060443,"about_ca_system_score_gemma":0.0007548533,"threshold_uncertainty_score":0.01708877},"labels":[],"label_agreement":null},{"id":"W1979675406","doi":"10.1007/s00277-011-1267-3","title":"Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules","year":2011,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia","funders":"","keywords":"Medicine; Major bleeding; Clinical prediction rule; Oral anticoagulant; Warfarin; Risk assessment; Atrial fibrillation; Meta-analysis; Intensive care medicine; Internal medicine","score_opus":0.2717546878085731,"score_gpt":0.46800784014528746,"score_spread":0.19625315233671436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979675406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008810816,0.9886425,0.0006376909,0.0003017509,0.00014965271,0.0001568667,0.0010029416,0.000023798755,0.00027403916],"genre_scores_gemma":[0.16937533,0.8220331,0.0052468106,0.00078568974,0.00028770106,0.00028937325,0.0018020173,0.000026282774,0.00015360555],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9898246,0.0037589602,0.0035274082,0.0010171124,0.001724005,0.00014793065],"domain_scores_gemma":[0.9271313,0.05781386,0.009815546,0.0011284595,0.0037624608,0.00034842716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0142051205,0.0015458754,0.011334367,0.004110638,0.00033814769,0.0018213581,0.0022340328,0.0013253235,0.0018087563],"category_scores_gemma":[0.06372316,0.0011106647,0.0147655485,0.0054884,0.0005301716,0.0018177036,0.0010464491,0.0017383306,0.00021586461],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031542748,0.00008771764,0.025928356,0.47682035,0.3748959,0.0002538848,0.00028403095,0.0011182359,0.00022888114,0.00032089176,0.004179612,0.1127279],"study_design_scores_gemma":[0.0022005278,0.0004291138,0.02244092,0.058720615,0.9080551,0.000601222,0.00012402268,0.0008921836,0.00019056852,0.0005265018,0.0057116034,0.00010757894],"about_ca_topic_score_codex":0.0063839243,"about_ca_topic_score_gemma":0.017200828,"teacher_disagreement_score":0.0142051205,"about_ca_system_score_codex":0.0013772578,"about_ca_system_score_gemma":0.0039389976,"threshold_uncertainty_score":0.07512474},"labels":[],"label_agreement":null},{"id":"W1980214740","doi":"10.1007/s00277-010-1050-x","title":"Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin","year":2010,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hepcidin; Internal medicine; Transferrin saturation; Medicine; Ferritin; Creatinine; Endocrinology; Gastroenterology; Urine; Transferrin; Anemia; Serum ferritin","score_opus":0.018372844450804202,"score_gpt":0.27747755565803806,"score_spread":0.25910471120723383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980214740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969674,0.0004898248,0.00030308,0.00018141972,0.000024865418,0.000011155173,0.00008882528,0.000031123804,0.0019022671],"genre_scores_gemma":[0.9990701,0.0001623783,0.00030812752,0.000050684215,0.000057376576,0.000005188074,0.00011606203,0.000005346506,0.00022475814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997421,0.000059564012,0.000039823455,0.00005062079,0.000060831677,0.000047104997],"domain_scores_gemma":[0.9990465,0.00021993121,0.00038626452,0.000055841036,0.00005275893,0.0002387046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027388797,0.0007880128,0.000440257,0.0015672678,0.00042196648,0.00049179053,0.0004303794,0.0007374254,0.0020564103],"category_scores_gemma":[0.0014210863,0.0003775706,0.00021414467,0.0011093941,0.00064132805,0.00031661373,0.00032166185,0.0005275644,0.00032812252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048150294,0.00029777444,0.80081505,0.00016038437,0.00016651687,0.13661872,0.0001927272,0.0002485039,0.040958714,0.00052877155,0.0012132991,0.013984587],"study_design_scores_gemma":[0.00008240741,0.000494832,0.7335909,0.0000314269,0.00010585873,0.25901994,0.00015617954,0.0012729467,0.0037219124,0.00067560637,0.0008211523,0.000026836076],"about_ca_topic_score_codex":0.0009158371,"about_ca_topic_score_gemma":0.00096061965,"teacher_disagreement_score":0.0020564103,"about_ca_system_score_codex":0.0002460939,"about_ca_system_score_gemma":0.0002675805,"threshold_uncertainty_score":0.0068793893},"labels":[],"label_agreement":null},{"id":"W1981438192","doi":"10.1007/s00277-010-0981-6","title":"Health-related quality of life outcomes for patients with immune thrombocytopenic purpura","year":2010,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Children's Hospital of Eastern Ontario","funders":"","keywords":"Thrombocytopenic purpura; Hematology; Medicine; Immune thrombocytopenia; Immune system; Quality of life (healthcare); Internal medicine; Thrombotic thrombocytopenic purpura; Purpura (gastropod); Pediatrics; Intensive care medicine; Immunology; Platelet; Biology; Nursing","score_opus":0.12534010969330137,"score_gpt":0.42933767430413705,"score_spread":0.3039975646108357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981438192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012848862,0.9982139,0.000046437497,0.000109787274,0.000048368333,0.0000036966837,0.000045952107,0.0000026369144,0.00024432517],"genre_scores_gemma":[0.01795083,0.9811763,0.00024637565,0.00022395073,0.000111109315,0.000012434027,0.00013363123,0.0000011314115,0.00014432688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997502,0.000056756242,0.000049163424,0.000039431652,0.00008257473,0.000021822461],"domain_scores_gemma":[0.9994282,0.00033463576,0.00013897801,0.0000068313807,0.00006590626,0.000025442903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006349479,0.0005866513,0.0023500547,0.0012529889,0.00014164779,0.00048585256,0.00056780066,0.00054291775,0.001390748],"category_scores_gemma":[0.0012110162,0.00015054471,0.0013318387,0.0017464277,0.00019930376,0.00045751888,0.00035589212,0.00096589205,0.00018209746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051932666,0.00015477894,0.005853272,0.036833454,0.0033728143,0.00015785516,0.000047163874,0.00037298916,0.00033773543,0.0003996868,0.010755799,0.9411952],"study_design_scores_gemma":[0.0023888564,0.0034658338,0.28181922,0.12634408,0.053720254,0.011207291,0.0010755949,0.0029306966,0.0018642165,0.0058886535,0.50895613,0.00033917476],"about_ca_topic_score_codex":0.0016336186,"about_ca_topic_score_gemma":0.004202972,"teacher_disagreement_score":0.0023500547,"about_ca_system_score_codex":0.0003935315,"about_ca_system_score_gemma":0.0005047228,"threshold_uncertainty_score":0.0046525598},"labels":[],"label_agreement":null},{"id":"W1982502351","doi":"10.1007/s00277-012-1665-1","title":"Is activity restriction appropriate for patients with hereditary spherocytosis? A population-based analysis","year":2013,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre; SickKids Foundation; Toronto General Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Population; Medicine; Demography; Mortality rate; Hereditary spherocytosis; Pediatrics; Internal medicine; Environmental health","score_opus":0.03435184894348327,"score_gpt":0.2995183769609304,"score_spread":0.26516652801744717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982502351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986482,0.00022655337,0.0002224144,0.00012031872,0.000007798092,0.000008901489,0.000105447674,0.0000052268456,0.00065507146],"genre_scores_gemma":[0.9996661,0.00006632603,0.000061361796,0.000040915707,0.000010977731,0.0000046180367,0.000095363226,0.000002895331,0.000051476305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873775,0.0004869536,0.00014594097,0.00028544877,0.00017976915,0.00016415126],"domain_scores_gemma":[0.9975624,0.0010248974,0.0007783799,0.00020340995,0.00022993314,0.00020102058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011198432,0.0005325906,0.0009331542,0.0012971997,0.00074919435,0.0009781548,0.0006037384,0.0012131279,0.002524549],"category_scores_gemma":[0.005036969,0.00032067072,0.0010346186,0.0016265955,0.00084095984,0.0010843617,0.0006045812,0.000956509,0.0003641347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028882653,0.000052726486,0.99711907,0.000005062498,0.00012060503,0.00031168747,0.00009405638,0.000048170543,0.00025901577,0.000041900938,0.000086024425,0.0015727709],"study_design_scores_gemma":[0.000030207082,0.00047283334,0.9952016,0.000009874693,0.00021454324,0.0023523134,0.0006317213,0.00054759264,0.0000999593,0.0001597822,0.00026631547,0.0000131967245],"about_ca_topic_score_codex":0.0017569412,"about_ca_topic_score_gemma":0.0013931108,"teacher_disagreement_score":0.002524549,"about_ca_system_score_codex":0.00029528493,"about_ca_system_score_gemma":0.00027370238,"threshold_uncertainty_score":0.008445501},"labels":[],"label_agreement":null},{"id":"W1984475717","doi":"10.1007/s00277-014-2292-9","title":"Refractory mixed autoimmune hemolysis, thrombocytopenia, and thrombosis: a diagnostic puzzle","year":2015,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hematology; Medicine; Hemolysis; Thrombosis; Internal medicine; Refractory (planetary science); Immune thrombocytopenia; Immunology; Platelet; Biology","score_opus":0.06735854467497986,"score_gpt":0.3362607032645585,"score_spread":0.2689021585895786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984475717","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02269083,0.029188905,0.0022699698,0.9179923,0.0085637225,0.00006322898,0.000131652,0.00010590619,0.018993504],"genre_scores_gemma":[0.34262154,0.02968946,0.0070408857,0.3848669,0.22948633,0.00012523207,0.0002891907,0.00007370303,0.005806801],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9975654,0.000909438,0.00043413948,0.00028814017,0.0005257925,0.000277107],"domain_scores_gemma":[0.9938374,0.003815718,0.00061237556,0.00025830767,0.00068347174,0.00079267315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019493131,0.0009694116,0.0017712294,0.0013524875,0.0021614393,0.0028276825,0.0019219767,0.017832804,0.003662029],"category_scores_gemma":[0.01683293,0.000749765,0.0010119905,0.0008387371,0.0020097778,0.0044733994,0.0011723952,0.014644651,0.0017279711],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005333583,0.00044740734,0.041186843,0.00057459576,0.00014459773,0.5583424,0.0005838503,0.0010174862,0.0013913583,0.020585129,0.30683357,0.068359315],"study_design_scores_gemma":[0.00067381974,0.00027266663,0.009198297,0.001572496,0.00020285332,0.8189102,0.0015819467,0.0055335606,0.00094786903,0.04578412,0.11520592,0.00011628717],"about_ca_topic_score_codex":0.0013988974,"about_ca_topic_score_gemma":0.0018857052,"teacher_disagreement_score":0.017832804,"about_ca_system_score_codex":0.0025513323,"about_ca_system_score_gemma":0.0016620125,"threshold_uncertainty_score":0.018511295},"labels":[],"label_agreement":null},{"id":"W1985399823","doi":"10.1007/s00277-002-0459-2","title":"Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transplantation","year":2002,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Hematology; Progenitor cell; Transplantation; Breast cancer; Internal medicine; Immunology; Recombinant DNA; Oncology; Cancer; Stem cell; Biology","score_opus":0.03876146293694321,"score_gpt":0.3111377077438331,"score_spread":0.2723762448068899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985399823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81197876,0.01182256,0.0018570863,0.1348598,0.006622126,0.00024941293,0.0004205599,0.00037499957,0.03181463],"genre_scores_gemma":[0.9402488,0.0024411243,0.0008630132,0.041830912,0.0052148905,0.00011680487,0.00026308434,0.000028283957,0.008993041],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979407,0.00008063535,0.000021113088,0.000014149077,0.000049663646,0.000040338615],"domain_scores_gemma":[0.99937856,0.00040641963,0.000052020216,0.00002376334,0.00004222193,0.000096991935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032521287,0.000299899,0.0008463653,0.00020052369,0.0003882119,0.00044317727,0.00032537474,0.0020760954,0.0018470929],"category_scores_gemma":[0.0024192205,0.00015156277,0.00034229836,0.00020793662,0.00020503721,0.00028191257,0.00011683676,0.0018044834,0.0004921451],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042966247,0.003884459,0.08192536,0.00043696034,0.00054783333,0.09392428,0.0006321461,0.0022276787,0.03489887,0.0017583509,0.22439669,0.5124011],"study_design_scores_gemma":[0.03340428,0.057806317,0.35232723,0.0004264751,0.0023595616,0.19504699,0.0011095515,0.018574968,0.04432297,0.0072651342,0.28716224,0.00019439678],"about_ca_topic_score_codex":0.00075123046,"about_ca_topic_score_gemma":0.0016390246,"teacher_disagreement_score":0.0020760954,"about_ca_system_score_codex":0.00051959476,"about_ca_system_score_gemma":0.00035485678,"threshold_uncertainty_score":0.006179154},"labels":[],"label_agreement":null},{"id":"W1988958071","doi":"10.1007/s00277-004-0900-9","title":"Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature","year":2004,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Hematology; Medicine; Factor IX; Myocardial infarction; Internal medicine; Cardiology","score_opus":0.07000332884452573,"score_gpt":0.4035350907244387,"score_spread":0.33353176187991296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988958071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036193992,0.9942767,0.00022217057,0.00047558662,0.0002730481,0.0000114755,0.000037131398,0.000016535501,0.0010679789],"genre_scores_gemma":[0.013646523,0.98411167,0.00035728392,0.00047181206,0.00092694856,0.000010105874,0.00007649444,0.0000031053044,0.00039613483],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99963284,0.000055437835,0.00010801042,0.0000734935,0.00009316552,0.000037088947],"domain_scores_gemma":[0.99928445,0.0003239151,0.00022128751,0.000020628515,0.00008398494,0.0000656827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003581651,0.0010650504,0.0022542817,0.0029466473,0.0003979497,0.001257277,0.0017796516,0.002223221,0.001958187],"category_scores_gemma":[0.0010379119,0.00040083224,0.00077818497,0.0033604424,0.0006391202,0.0020246732,0.0005511028,0.0009690593,0.0012675076],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035449237,0.00023852015,0.010121871,0.028376447,0.0006366512,0.27872348,0.00039499666,0.0004929183,0.0036961364,0.0005917175,0.03657984,0.63979286],"study_design_scores_gemma":[0.00013728632,0.00034925737,0.021073105,0.008321418,0.0014819301,0.7995685,0.0010535506,0.00036784945,0.0009479407,0.0011077371,0.16547538,0.000116033334],"about_ca_topic_score_codex":0.0008589817,"about_ca_topic_score_gemma":0.0015219012,"teacher_disagreement_score":0.0029466473,"about_ca_system_score_codex":0.0003885429,"about_ca_system_score_gemma":0.00086153415,"threshold_uncertainty_score":0.006550789},"labels":[],"label_agreement":null},{"id":"W1990645045","doi":"10.1007/s00277-012-1593-0","title":"Cytarabine toxicity of the corneal endothelium","year":2012,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Toxicity; Medicine; Corneal endothelium; Hematology; Cytarabine; Internal medicine; Endothelium; Ophthalmology; Oncology; Chemotherapy","score_opus":0.06884489757890278,"score_gpt":0.32220331673464303,"score_spread":0.25335841915574026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990645045","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11253287,0.019930728,0.0016339057,0.75687563,0.016908934,0.00011060805,0.00016066311,0.00021112867,0.091635525],"genre_scores_gemma":[0.632129,0.011554863,0.0019519344,0.26218575,0.0608087,0.00006159048,0.00009007613,0.00005607876,0.031162048],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994772,0.00019125018,0.000060607123,0.0000489105,0.00011406115,0.000107944594],"domain_scores_gemma":[0.9988167,0.0006726605,0.00013981448,0.00007926119,0.00012597718,0.00016563179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004337826,0.000487603,0.0006402075,0.0005029785,0.0015757957,0.0015415304,0.0006519644,0.010916487,0.0028353704],"category_scores_gemma":[0.0040754587,0.00038644802,0.0008450385,0.00045555944,0.0008558432,0.001214044,0.0004475692,0.007305177,0.0010089312],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037853557,0.00017097012,0.007764517,0.00023241028,0.00008048907,0.84793824,0.00024197748,0.000462313,0.0023251292,0.0050693764,0.10795267,0.02738349],"study_design_scores_gemma":[0.00041425953,0.0005275677,0.014104761,0.00035577387,0.00017225917,0.747217,0.0006325839,0.004436092,0.0043281657,0.0103557035,0.21738742,0.000068305584],"about_ca_topic_score_codex":0.002234422,"about_ca_topic_score_gemma":0.0050297356,"teacher_disagreement_score":0.010916487,"about_ca_system_score_codex":0.0024795837,"about_ca_system_score_gemma":0.0007206371,"threshold_uncertainty_score":0.017990708},"labels":[],"label_agreement":null},{"id":"W1990697314","doi":"10.1007/s00277-009-0828-1","title":"Compound heterozygosity of Hb Hamilton and de novo mutated HbM Saskatoon","year":2009,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Loss of heterozygosity; Hematology; Genetics; Internal medicine; Biology; Medicine; Gene; Allele","score_opus":0.052763407974169785,"score_gpt":0.32809401413470934,"score_spread":0.27533060616053956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990697314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7459235,0.0018570361,0.0015406247,0.13069469,0.0050419313,0.00012210174,0.0013444393,0.00016310217,0.11331262],"genre_scores_gemma":[0.96972185,0.00075946073,0.00062382146,0.010834609,0.001148508,0.000016749334,0.00016794898,0.00003167131,0.01669542],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99978095,0.0000527811,0.000026703556,0.000032655968,0.000027428263,0.000079462036],"domain_scores_gemma":[0.9994394,0.00018003122,0.00006145557,0.00002988939,0.000072684474,0.00021652071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021989214,0.0005597963,0.00028773,0.0005568919,0.00085673045,0.0006978236,0.00057091453,0.0026938347,0.0076676956],"category_scores_gemma":[0.0016159158,0.00028313033,0.0002735831,0.0005127936,0.00084330305,0.00054989755,0.00036906573,0.0023735487,0.0011313112],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017610678,0.000059537506,0.03901552,0.00003091712,0.000039704428,0.9386686,0.00019325284,0.000286404,0.0023854144,0.0017262804,0.013350066,0.0040682578],"study_design_scores_gemma":[0.00034498554,0.00019998112,0.11749687,0.00013425048,0.0001232062,0.82887954,0.0022693616,0.004144895,0.0019841,0.003817575,0.040530868,0.00007444269],"about_ca_topic_score_codex":0.050949547,"about_ca_topic_score_gemma":0.10504057,"teacher_disagreement_score":0.050949547,"about_ca_system_score_codex":0.0019165175,"about_ca_system_score_gemma":0.0020289228,"threshold_uncertainty_score":0.10130596},"labels":[],"label_agreement":null},{"id":"W1994880815","doi":"10.1007/s00277-015-2376-1","title":"Leishmaniasis involving the bone marrow of a patient with multiple myeloma","year":2015,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Multiple myeloma; Hematology; Medicine; Bone marrow; Internal medicine; Leishmaniasis; Oncology; Pathology","score_opus":0.0692648904479944,"score_gpt":0.3200012882003456,"score_spread":0.25073639775235124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994880815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77732605,0.012625382,0.0025287706,0.15007056,0.0059603797,0.0005541321,0.00062427524,0.00026355498,0.050046965],"genre_scores_gemma":[0.9608507,0.00397783,0.001176495,0.023613524,0.006974851,0.00003697487,0.00012878094,0.000032719836,0.003208145],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99928755,0.00016544142,0.00008742279,0.00012703428,0.0001273742,0.00020519343],"domain_scores_gemma":[0.99825937,0.000662715,0.00021333821,0.00009693081,0.00016246174,0.00060520665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057835877,0.0016299054,0.0011968578,0.0015209225,0.0032543421,0.001741486,0.0014187456,0.009889054,0.0025073993],"category_scores_gemma":[0.005683667,0.0010641088,0.0013436672,0.000985926,0.0012949167,0.0017394521,0.0012783166,0.0063547995,0.00088972214],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073665244,0.000051374616,0.0053335708,0.000050370272,0.000013092176,0.9900613,0.00022491808,0.00007979375,0.00052755966,0.00036080173,0.0022566956,0.00096692576],"study_design_scores_gemma":[0.00007163667,0.0002525984,0.009693482,0.00010211915,0.00007111573,0.9829775,0.0006381711,0.0007481963,0.0006341554,0.0010393945,0.0037493752,0.000022183393],"about_ca_topic_score_codex":0.004671679,"about_ca_topic_score_gemma":0.005560127,"teacher_disagreement_score":0.009889054,"about_ca_system_score_codex":0.0027958173,"about_ca_system_score_gemma":0.001196122,"threshold_uncertainty_score":0.02028513},"labels":[],"label_agreement":null},{"id":"W1997059013","doi":"10.1007/s00277-006-0202-5","title":"Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology","year":2006,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Pure red cell aplasia; Medicine; Rituximab; Neutropenia; Autoimmune hemolytic anemia; Immunology; Internal medicine; Exacerbation; Pathophysiology; Hematology; CD20; Pneumonia; Gastroenterology; Antibody; Anemia; Chemotherapy","score_opus":0.05902395893990869,"score_gpt":0.3666930499787996,"score_spread":0.3076690910388909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997059013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8317989,0.12552044,0.0037686224,0.0063847853,0.0007982584,0.00032532183,0.00036933506,0.0001438153,0.030890496],"genre_scores_gemma":[0.99246514,0.004147938,0.00084196875,0.0012372216,0.000561339,0.000048599322,0.00014645037,0.000014832365,0.0005365872],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985153,0.0007464641,0.00024911354,0.00009681466,0.00029048097,0.00010189415],"domain_scores_gemma":[0.9862476,0.010137511,0.0007197118,0.0009688745,0.0011418723,0.00078442885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006782151,0.00020045642,0.000990606,0.00044098528,0.0002621091,0.0006457271,0.00057018443,0.000864287,0.0018160545],"category_scores_gemma":[0.008190954,0.00011125306,0.00042292697,0.00036155662,0.00068874424,0.0006887981,0.00015378762,0.0012461743,0.0005000486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019997662,0.0021574255,0.056526083,0.0015883126,0.0010077046,0.0023069077,0.00030159665,0.0007909971,0.05261151,0.006046597,0.0049302853,0.85173494],"study_design_scores_gemma":[0.013822651,0.10323744,0.6516892,0.00093979307,0.0027588937,0.048632115,0.0005751945,0.0040195873,0.06740114,0.0089682015,0.097833775,0.000122033896],"about_ca_topic_score_codex":0.00021454116,"about_ca_topic_score_gemma":0.00048063227,"teacher_disagreement_score":0.006782151,"about_ca_system_score_codex":0.00063107203,"about_ca_system_score_gemma":0.00073511177,"threshold_uncertainty_score":0.03586781},"labels":[],"label_agreement":null},{"id":"W1999629406","doi":"10.1007/s00277-003-0789-8","title":"Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients","year":2004,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Medicine; Systemic inflammation; Inflammation; Internal medicine; C-reactive protein; Platelet; Peripheral arterial occlusive disease; Gastroenterology; Hematology; Cardiology; Peripheral","score_opus":0.02176479117290755,"score_gpt":0.2983012745881261,"score_spread":0.2765364834152186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999629406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981869,0.00059792324,0.000048455116,0.00008498843,0.00001353576,0.000005243173,0.000051901923,0.0000023360533,0.0010087498],"genre_scores_gemma":[0.9994949,0.00014515001,0.000055644214,0.000043301345,0.000038248596,0.0000035817693,0.000067022826,0.0000015070316,0.00015061222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995802,0.00016498326,0.000061921906,0.000046478934,0.00006624966,0.00008012709],"domain_scores_gemma":[0.9979882,0.0009459982,0.000449664,0.00007412005,0.0001228051,0.00041920724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046070386,0.00018006319,0.0005987153,0.00026558278,0.00027820596,0.0005706237,0.00010140351,0.0003373694,0.001755611],"category_scores_gemma":[0.003445708,0.00011047331,0.0004452473,0.00035274166,0.00018048775,0.00029275648,0.00016631385,0.0006065938,0.00018731834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011428026,0.0004891404,0.9699969,0.00004881168,0.00029614152,0.0008311699,0.00013774946,0.00014938737,0.0028655499,0.00007218737,0.00016556094,0.013519368],"study_design_scores_gemma":[0.00015278418,0.0032940353,0.9941024,0.000012337416,0.00029350864,0.0008935707,0.00012573894,0.000347134,0.0004421836,0.000053815358,0.00027386882,0.000008629643],"about_ca_topic_score_codex":0.0006462134,"about_ca_topic_score_gemma":0.0010071353,"teacher_disagreement_score":0.001755611,"about_ca_system_score_codex":0.00024094891,"about_ca_system_score_gemma":0.0003256652,"threshold_uncertainty_score":0.0058731437},"labels":[],"label_agreement":null},{"id":"W2000535196","doi":"10.1007/s00277-015-2304-4","title":"The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments","year":2015,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre; Capital District Health Authority; University Health Network; McMaster University","funders":"","keywords":"Medicine; Harm; Family medicine; Hematology; Intensive care medicine; Internal medicine","score_opus":0.7554721244055912,"score_gpt":0.6114322750263892,"score_spread":0.144039849379202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000535196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047511572,0.9621376,0.00007480289,0.030596575,0.0019806642,0.000038723676,0.00044851098,0.000026936232,0.004220998],"genre_scores_gemma":[0.008260537,0.97040176,0.0007033046,0.017404573,0.001163378,0.000039880233,0.00039621975,0.000009430257,0.0016208844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973097,0.00030980018,0.00019913602,0.00010628025,0.0016998937,0.00037523004],"domain_scores_gemma":[0.9914535,0.0019150153,0.0007186782,0.00007466316,0.0043119146,0.0015260874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047368794,0.0008044135,0.0019746209,0.0044162497,0.0015501338,0.0024341398,0.0018700064,0.0027188552,0.0078059556],"category_scores_gemma":[0.010708872,0.00031308946,0.0016085253,0.0063246195,0.0010134252,0.0012075072,0.0012317853,0.0042690453,0.0007158397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015254504,0.00008885527,0.0020266566,0.01448945,0.00043070782,0.00006836897,0.00011550426,0.00013049785,0.00008803626,0.0028344248,0.3757966,0.6037784],"study_design_scores_gemma":[0.00034723792,0.00009621753,0.021558054,0.047864806,0.0015108249,0.00022162864,0.0005101982,0.00017090939,0.00013616773,0.0015308602,0.925964,0.00008921125],"about_ca_topic_score_codex":0.665603,"about_ca_topic_score_gemma":0.8517334,"teacher_disagreement_score":0.9775202,"about_ca_system_score_codex":0.02247978,"about_ca_system_score_gemma":0.07732539,"threshold_uncertainty_score":0.6727327},"labels":[],"label_agreement":null},{"id":"W2001743614","doi":"10.1007/s00277-015-2350-y","title":"Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Immunophenotyping; Hematology; Medicine; Lymphocyte; Internal medicine; Immunology; Pathology; Flow cytometry","score_opus":0.027206065578226937,"score_gpt":0.2666363919037655,"score_spread":0.23943032632553854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001743614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990693,0.00030494758,0.00005057515,0.000021772314,0.0000037086513,0.0000024384894,0.000062203515,0.000002963895,0.00048209602],"genre_scores_gemma":[0.9996861,0.00010049394,0.000040889845,0.000012851611,0.000011576222,0.0000026581495,0.00007333463,8.403352e-7,0.000071437855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983513,0.000033729033,0.000031395564,0.000026892052,0.000029631377,0.000043135937],"domain_scores_gemma":[0.9994948,0.00017151739,0.00017522949,0.000025375777,0.000050436836,0.00008259907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002096021,0.00024433437,0.000237051,0.0008016163,0.00029742942,0.0004473022,0.00018192027,0.00032382493,0.0010406079],"category_scores_gemma":[0.001254288,0.00015268606,0.0001304098,0.00079859176,0.000284378,0.00049046683,0.0002445089,0.00035693252,0.00020710361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000311284,0.00002242395,0.9947918,0.000007862619,0.000010680054,0.001032033,0.000062526815,0.00004050119,0.0011271219,0.000023752451,0.000055153523,0.0025149456],"study_design_scores_gemma":[0.000009520969,0.00015254428,0.9920626,0.0000069924668,0.0000279815,0.006422575,0.00030683156,0.0002742178,0.00039464436,0.000080104866,0.00025748464,0.000004585653],"about_ca_topic_score_codex":0.00039547659,"about_ca_topic_score_gemma":0.00051317987,"teacher_disagreement_score":0.0010406079,"about_ca_system_score_codex":0.00011977353,"about_ca_system_score_gemma":0.00014614142,"threshold_uncertainty_score":0.0034812093},"labels":[],"label_agreement":null},{"id":"W2004739140","doi":"10.1007/s00277-012-1580-5","title":"KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement","year":2012,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mutation; Internal medicine; Idarubicin; Cytarabine; Myeloid leukemia; Core binding factor; Leukemia; Oncology; Hematology; Gene mutation; Cancer research; Biology; Genetics; Gene","score_opus":0.06405843739247338,"score_gpt":0.35387222646365485,"score_spread":0.2898137890711815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004739140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989428,0.00015655093,0.000094421535,0.00006921704,0.000008813111,0.000002898403,0.00012515289,0.0000058510336,0.0005943724],"genre_scores_gemma":[0.99953306,0.000054668802,0.000048082034,0.000019340237,0.00001843337,0.0000019549436,0.00015739817,0.0000029608993,0.00016422529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996197,0.000072706185,0.00004838456,0.000088750094,0.00008337825,0.00008695005],"domain_scores_gemma":[0.99876606,0.000209928,0.00060221745,0.00007366574,0.00006730016,0.00028093264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000261216,0.00033457062,0.0004292545,0.00080225716,0.0004949364,0.0005264299,0.00032431618,0.0005068789,0.0029207713],"category_scores_gemma":[0.0016031554,0.00020781095,0.00039743318,0.0009148665,0.00036975334,0.00038673545,0.0003250845,0.0005483943,0.00041627858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049383804,0.00003445072,0.9905552,0.0000069841126,0.00006236239,0.0010368401,0.00003596473,0.00010502593,0.0046523493,0.00005769503,0.00024928834,0.0027099245],"study_design_scores_gemma":[0.000015138534,0.0001235454,0.99302214,0.0000045361626,0.00008714243,0.0048712823,0.00012747954,0.00040217792,0.00071361207,0.0002562624,0.0003688444,0.000007904082],"about_ca_topic_score_codex":0.0011237004,"about_ca_topic_score_gemma":0.0015114292,"teacher_disagreement_score":0.0029207713,"about_ca_system_score_codex":0.00018969155,"about_ca_system_score_gemma":0.00024864342,"threshold_uncertainty_score":0.009770989},"labels":[],"label_agreement":null},{"id":"W2009551866","doi":"10.1007/s00277-008-0624-3","title":"Mutations in the paralogous human α-globin genes yielding identical hemoglobin variants","year":2008,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; South Health Campus; University of Calgary","funders":"","keywords":"Gene; Genetics; Biology; Globin; Mutation; Hemoglobin variants; Hemoglobin; Phenotype; Biochemistry","score_opus":0.06979908055389106,"score_gpt":0.3455387691862649,"score_spread":0.27573968863237386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009551866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872595,0.00026514436,0.000622672,0.000014570956,0.0000069507355,0.000016172075,0.00009644965,0.000008800298,0.00024337607],"genre_scores_gemma":[0.9986809,0.00014930507,0.00074013043,0.000030832183,0.000017181324,0.000010622079,0.00015989157,0.000005410749,0.00020573761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952126,0.000105083294,0.00007368003,0.00017981138,0.00007822857,0.000041897427],"domain_scores_gemma":[0.9994873,0.00018993866,0.00017630197,0.000064449814,0.000034863628,0.00004703617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003106197,0.0003672654,0.0003129874,0.0009667593,0.00036294872,0.00027680583,0.00026031895,0.00030351605,0.0013592545],"category_scores_gemma":[0.0012037543,0.00012403622,0.00025756916,0.0006565396,0.00046586938,0.00016242017,0.00037632385,0.0002571513,0.000224935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014932617,0.0002808813,0.59019506,0.00017124697,0.00040256206,0.024383508,0.0016559255,0.00045157425,0.32112104,0.0014178343,0.00048160204,0.05794556],"study_design_scores_gemma":[0.0001666582,0.0011980031,0.84476,0.000038952283,0.00031173223,0.093969375,0.0005354612,0.0011072145,0.051870562,0.00075517053,0.005247585,0.000039320024],"about_ca_topic_score_codex":0.00041606178,"about_ca_topic_score_gemma":0.0004923886,"teacher_disagreement_score":0.0013592545,"about_ca_system_score_codex":0.00015485888,"about_ca_system_score_gemma":0.00013096335,"threshold_uncertainty_score":0.0045471787},"labels":[],"label_agreement":null},{"id":"W2011170513","doi":"10.1007/s00277-014-2169-y","title":"The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey","year":2014,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; St. Michael's Hospital","funders":"","keywords":"Medicine; Tranexamic acid; Retrospective cohort study; Internal medicine; Telangiectasia; Thrombosis; Hematology; Surgery; Blood loss","score_opus":0.0808105954227732,"score_gpt":0.3118973847442949,"score_spread":0.2310867893215217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011170513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981376,0.0006197505,0.00008498164,0.000039451184,0.000005575212,0.0000064088226,0.00041093671,0.0000024371168,0.00069289457],"genre_scores_gemma":[0.9988537,0.0004520326,0.000059787206,0.00005666675,0.000013833607,0.000006846454,0.0004298007,0.0000017086811,0.0001256605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993747,0.0001230096,0.00014253816,0.00010892061,0.00013585712,0.000115165596],"domain_scores_gemma":[0.9981823,0.00039556655,0.00094050897,0.000094473355,0.00015341795,0.0002338033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038755243,0.00019270447,0.00043428986,0.0014188085,0.00042617394,0.0006916767,0.00020483494,0.00048322452,0.0019437474],"category_scores_gemma":[0.0014726255,0.000292213,0.0006447284,0.0020772328,0.00034446386,0.00069880055,0.0003804131,0.0005407015,0.0003624275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048348742,0.000024513893,0.99910164,0.0000074941395,0.00002990871,0.0001365068,0.000042274853,0.000010279316,0.00008254052,0.000010367647,0.000027101923,0.0004790405],"study_design_scores_gemma":[0.0000059887743,0.0001638524,0.99658656,0.000012378038,0.000048118196,0.001984325,0.00065712066,0.00007412686,0.000069792506,0.000020139345,0.0003710438,0.00000654545],"about_ca_topic_score_codex":0.0028102014,"about_ca_topic_score_gemma":0.0019367565,"teacher_disagreement_score":0.0028102014,"about_ca_system_score_codex":0.00028093538,"about_ca_system_score_gemma":0.00042387846,"threshold_uncertainty_score":0.0065024495},"labels":[],"label_agreement":null},{"id":"W2013888579","doi":"10.1007/s00277-008-0525-5","title":"The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review","year":2008,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Cancer Care Ontario; McMaster University; Queen's University; McMaster University Medical Centre; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Anemia; Hematology; Randomized controlled trial; Internal medicine; Cochrane Library; Erythropoietin; Clinical trial; Erythropoiesis; MEDLINE; Intensive care medicine; Myelodysplastic syndromes; Oncology; Bone marrow","score_opus":0.14890032219820742,"score_gpt":0.37569589704559453,"score_spread":0.2267955748473871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013888579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012322173,0.9980805,0.00007453508,0.00009946937,0.00006821002,0.00007936291,0.00018617188,0.000004512224,0.00017499189],"genre_scores_gemma":[0.01780951,0.98111206,0.00040380404,0.0003238162,0.000054865177,0.000083489875,0.000120977835,0.0000027734177,0.00008871607],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.998198,0.00051770435,0.0007315309,0.00018066443,0.0003084113,0.00006364434],"domain_scores_gemma":[0.99155605,0.0057236603,0.0020090663,0.00008242841,0.0004896336,0.00013915174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024630926,0.0008540965,0.006348636,0.0032015746,0.00029518697,0.001075737,0.0013081004,0.0012426855,0.0035463753],"category_scores_gemma":[0.010654602,0.00069892337,0.004969985,0.005010548,0.0005099856,0.0010752406,0.00073143124,0.0009697723,0.00021342695],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080975157,0.000039952447,0.0017949188,0.9085349,0.026152465,0.00017417327,0.000110694054,0.00015507624,0.0002691083,0.00013064659,0.0026023304,0.05922607],"study_design_scores_gemma":[0.0025899408,0.0010501446,0.018424293,0.50139874,0.42734843,0.0013281408,0.00036062626,0.00025656482,0.0005752125,0.0004003708,0.046167493,0.000099982404],"about_ca_topic_score_codex":0.0055184416,"about_ca_topic_score_gemma":0.019735426,"teacher_disagreement_score":0.006348636,"about_ca_system_score_codex":0.0012159542,"about_ca_system_score_gemma":0.0033210642,"threshold_uncertainty_score":0.013026178},"labels":[],"label_agreement":null},{"id":"W2020002107","doi":"10.1007/s00277-010-0916-2","title":"Mechanisms of platelet recovery in ITP associated with therapy","year":2010,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"","keywords":"Medicine; Splenectomy; Platelet; Immunosuppression; Immunology; Immune thrombocytopenia; Autoimmune disease; Hematology; Autoimmune thrombocytopenia; Spleen; Antibody; Immune system; Internal medicine","score_opus":0.08322795438328669,"score_gpt":0.36659128362005516,"score_spread":0.2833633292367685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020002107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011949605,0.99904233,0.00011075433,0.00015534784,0.00010477263,0.0000039979823,0.000008436797,0.0000042007687,0.0004504919],"genre_scores_gemma":[0.0009390053,0.9981192,0.00019823348,0.00014596747,0.00025361197,0.000008510006,0.000020868543,7.914678e-7,0.0003137501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998142,0.000036327427,0.000037854392,0.000029320508,0.000065843924,0.000016424116],"domain_scores_gemma":[0.9997458,0.00013845402,0.000054254753,0.0000073517895,0.000039679926,0.000014434024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053155754,0.0009997474,0.0017474273,0.0018043864,0.00022297629,0.0010408369,0.0009054556,0.0010910342,0.001970133],"category_scores_gemma":[0.00075083395,0.00030697943,0.0005799538,0.0015274944,0.0005437207,0.0010992714,0.00059847,0.0018183577,0.0012477296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020338356,0.0001051261,0.00042188214,0.012348261,0.00015395199,0.0006091236,0.000042252097,0.00036531617,0.0013809311,0.0025854865,0.019177139,0.9626072],"study_design_scores_gemma":[0.00016121697,0.00034467393,0.0039963126,0.0072458624,0.0007421556,0.008398789,0.0001265747,0.0004420272,0.0014229391,0.0051851496,0.97187966,0.000054653676],"about_ca_topic_score_codex":0.0006243111,"about_ca_topic_score_gemma":0.001156878,"teacher_disagreement_score":0.001970133,"about_ca_system_score_codex":0.00045964794,"about_ca_system_score_gemma":0.00081582915,"threshold_uncertainty_score":0.0065907836},"labels":[],"label_agreement":null},{"id":"W2022249597","doi":"10.1007/s00277-006-0149-6","title":"Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa; St. Paul's Hospital","funders":"","keywords":"Follicular lymphoma; Hematology; Lymphoma; Medicine; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Internal medicine; Haematopoiesis; Oncology; Hematopoietic cell; Autologous stem-cell transplantation; Follicular phase; Biology","score_opus":0.014911367398650708,"score_gpt":0.2537675452173268,"score_spread":0.2388561778186761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022249597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757464,0.0029469347,0.00044697768,0.0009890896,0.00012159148,0.00007707229,0.00016264472,0.000104746265,0.007576265],"genre_scores_gemma":[0.9958145,0.0012279205,0.0005923514,0.0004826862,0.00045847488,0.00004588294,0.00031327174,0.000024792647,0.0010401224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999105,0.000021687629,0.000007681855,0.000011388312,0.000013753468,0.000035093053],"domain_scores_gemma":[0.99970347,0.00006055359,0.000042521762,0.000011247273,0.000012406359,0.00016970967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015281496,0.0003515661,0.00063735823,0.00045075774,0.0007338522,0.00048688502,0.0003074803,0.00051296246,0.0050794175],"category_scores_gemma":[0.0006013087,0.00015907336,0.00035443399,0.000332003,0.00024982708,0.0003434188,0.00033806934,0.0008282358,0.00052306947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015555056,0.0043967688,0.5973103,0.00044274935,0.00019899121,0.095494695,0.00085279165,0.0014302165,0.024823634,0.00058481353,0.02154514,0.23736484],"study_design_scores_gemma":[0.0035636716,0.014983085,0.7999649,0.00022292072,0.00046906676,0.15451923,0.0013709343,0.00448939,0.0045472383,0.0014412974,0.014378323,0.000049864728],"about_ca_topic_score_codex":0.0011222712,"about_ca_topic_score_gemma":0.0031379396,"teacher_disagreement_score":0.0050794175,"about_ca_system_score_codex":0.00037544468,"about_ca_system_score_gemma":0.00060035265,"threshold_uncertainty_score":0.01699233},"labels":[],"label_agreement":null},{"id":"W2023807902","doi":"10.1007/s00277-014-2198-6","title":"Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study","year":2014,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Hospital Edmonton; University of Alberta Hospital; Vancouver Coastal Health; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Concomitant; Retrospective cohort study; Antithrombotic; Cohort; Cancer; Internal medicine; Hematology; Cohort study; Venous thromboembolism; Surgery; Pediatrics; Thrombosis","score_opus":0.014396711993972772,"score_gpt":0.29934686312463954,"score_spread":0.2849501511306668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023807902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999201,0.0002379734,0.00005435644,0.000021714424,0.0000053815183,0.0000071293744,0.00026174705,0.0000017411071,0.00020890398],"genre_scores_gemma":[0.9994042,0.00010840558,0.00004218108,0.000016333393,0.000010411228,0.000006401735,0.00035490622,0.0000016648816,0.000055528635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991381,0.00016902127,0.00015285038,0.00024612414,0.00012500556,0.00016885242],"domain_scores_gemma":[0.9981268,0.00022549875,0.00090073526,0.00022426558,0.00020458618,0.00031814224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056653895,0.0003655161,0.00059485994,0.0011181319,0.00077609404,0.0010911948,0.00056555594,0.0007201047,0.0016165768],"category_scores_gemma":[0.0024512794,0.00057840894,0.0010065492,0.0019862622,0.00041923267,0.0010435907,0.00068628165,0.000817072,0.0002827923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097086806,0.000028113784,0.999273,0.000003684952,0.00006960963,0.00013365757,0.000035102803,0.000014580815,0.00007682118,0.0000112765765,0.000033601103,0.00022348553],"study_design_scores_gemma":[0.00001540402,0.00016167149,0.99758935,0.000006107513,0.0000790039,0.0014068631,0.00037479657,0.00015383639,0.00004150096,0.0000254681,0.00013758829,0.00000832052],"about_ca_topic_score_codex":0.004973465,"about_ca_topic_score_gemma":0.0043901308,"teacher_disagreement_score":0.004973465,"about_ca_system_score_codex":0.000552212,"about_ca_system_score_gemma":0.00061865913,"threshold_uncertainty_score":0.009889066},"labels":[],"label_agreement":null},{"id":"W2025250975","doi":"10.1007/s00277-008-0559-8","title":"Hepatotoxicity as a rare but serious side effect of Thalidomide","year":2008,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Thalidomide; Hematology; Medicine; Internal medicine; Intensive care medicine; Pharmacology; Multiple myeloma","score_opus":0.05088394232195603,"score_gpt":0.3612637248419146,"score_spread":0.31037978251995857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025250975","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59854347,0.026180862,0.0067269667,0.25054875,0.010320414,0.00025244826,0.0003729604,0.00076144055,0.106292665],"genre_scores_gemma":[0.92344016,0.0046497514,0.0016576606,0.045657136,0.015655324,0.000050218914,0.00011590465,0.000060943115,0.00871288],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990969,0.00039553005,0.00011774605,0.000087310465,0.00014931796,0.00015321973],"domain_scores_gemma":[0.996974,0.00178949,0.00046426835,0.000210827,0.00023041613,0.0003309883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007690254,0.0008106364,0.0011629825,0.0007322259,0.001066131,0.0012378442,0.0009079212,0.010505172,0.0021252362],"category_scores_gemma":[0.0067546437,0.00062541227,0.0010784838,0.00066494494,0.00094755855,0.0013535125,0.0005016945,0.0052317567,0.0010580074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003693211,0.0000720632,0.009831216,0.0000822968,0.000047760048,0.96913975,0.000113260576,0.00027089153,0.0012962815,0.0008900151,0.010926319,0.006960943],"study_design_scores_gemma":[0.00027048588,0.0005639642,0.019647632,0.000094399074,0.000120537276,0.95640093,0.00021121366,0.0020749646,0.0012905729,0.002352665,0.016932921,0.000039722938],"about_ca_topic_score_codex":0.0012010479,"about_ca_topic_score_gemma":0.0025671988,"teacher_disagreement_score":0.010505172,"about_ca_system_score_codex":0.0016900292,"about_ca_system_score_gemma":0.00059064256,"threshold_uncertainty_score":0.012262106},"labels":[],"label_agreement":null},{"id":"W2026255716","doi":"10.1007/s00277-010-1059-1","title":"Aggressive LGL leukaemia presentation in old age","year":2010,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Hematology; Presentation (obstetrics); Medicine; Pediatrics; Internal medicine; Medical emergency; Emergency medicine; Surgery","score_opus":0.05435863746157886,"score_gpt":0.3956210204230223,"score_spread":0.3412623829614434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026255716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93553174,0.0068674088,0.0012945208,0.004029456,0.00054790464,0.00009728508,0.0004522781,0.00014204498,0.05103732],"genre_scores_gemma":[0.98944736,0.0028408193,0.0004246859,0.0011017316,0.0021194245,0.000020231753,0.00017213842,0.000019200965,0.003854282],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99981064,0.000023501418,0.00002135543,0.000021944286,0.00002612174,0.000096553485],"domain_scores_gemma":[0.9995141,0.00009081499,0.000120474855,0.000015693722,0.00004481243,0.0002141436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024593697,0.0006200274,0.000760742,0.0012752406,0.0007517099,0.00085994345,0.00028909856,0.0014194206,0.0062116827],"category_scores_gemma":[0.0015368616,0.00020306536,0.00026241288,0.00073363684,0.00040907017,0.0011611521,0.00056208274,0.00087845285,0.001629997],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003229337,0.00012618804,0.26959398,0.00008445268,0.000016181284,0.70895547,0.0004288992,0.00011720789,0.0033412932,0.00043482077,0.0045642415,0.012014359],"study_design_scores_gemma":[0.000028234283,0.00030742068,0.18624811,0.000084681255,0.000049359718,0.80364,0.0012085228,0.0002908769,0.00045323,0.00060198084,0.007065674,0.000021950875],"about_ca_topic_score_codex":0.0006206645,"about_ca_topic_score_gemma":0.000981005,"teacher_disagreement_score":0.0062116827,"about_ca_system_score_codex":0.0002820986,"about_ca_system_score_gemma":0.00026969763,"threshold_uncertainty_score":0.020780087},"labels":[],"label_agreement":null},{"id":"W2042913617","doi":"10.1007/s00277-013-1856-4","title":"Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)","year":2013,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Stage (stratigraphy); Nasal cavity; Internal medicine; Paranasal sinuses; Oncology; Hematology; Radiation therapy; Pathology; Surgery; Biology","score_opus":0.04692309188358019,"score_gpt":0.30938030324569665,"score_spread":0.26245721136211647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042913617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992016,0.00008616455,0.000037724552,0.000007810453,0.0000015807061,0.0000085776055,0.00046601935,0.0000020383043,0.00018855822],"genre_scores_gemma":[0.9977812,0.000106788306,0.00004658798,0.000020027019,0.000008888945,0.000022598193,0.0017192324,0.000003940813,0.0002906641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962676,0.000080605256,0.000027279522,0.00011663659,0.000055289973,0.0000933674],"domain_scores_gemma":[0.9995289,0.00007289564,0.00012750804,0.00008843956,0.000064479544,0.0001178346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044738452,0.0005365893,0.0007229538,0.0006354616,0.0005609572,0.00072814163,0.0005314456,0.00053684815,0.0014706377],"category_scores_gemma":[0.0006674385,0.00064413267,0.0006028173,0.0011603571,0.00039317395,0.0007095419,0.00049255474,0.00057591416,0.000741152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009251869,0.00015918956,0.9946964,0.00001195413,0.00011111992,0.00036952054,0.00023671088,0.00007161194,0.0012251424,0.000011700858,0.00022290074,0.0019585423],"study_design_scores_gemma":[0.00007933628,0.00028824992,0.9982272,0.0000040579685,0.00009552384,0.00049572974,0.00024802153,0.000067273475,0.00012766787,0.000009982911,0.0003508589,0.0000062594913],"about_ca_topic_score_codex":0.008729587,"about_ca_topic_score_gemma":0.0083669955,"teacher_disagreement_score":0.008729587,"about_ca_system_score_codex":0.0005204471,"about_ca_system_score_gemma":0.00030105232,"threshold_uncertainty_score":0.017357528},"labels":[],"label_agreement":null},{"id":"W2044473840","doi":"10.1007/s00277-012-1497-z","title":"Hb Etobicoke mutation in a hybrid HBA212 allele [HBA212 84 (F5) Ser>Arg; HBA212:c.255C>G]","year":2012,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Allele; Genetics; Mutation; Hematology; Internal medicine; Medicine; Molecular biology; Biology; Gene","score_opus":0.031819208709540255,"score_gpt":0.3015187521852668,"score_spread":0.26969954347572656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044473840","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24495454,0.004760728,0.003240418,0.5885419,0.021478593,0.00020549043,0.0009052839,0.0004929269,0.13542007],"genre_scores_gemma":[0.81707275,0.0027016252,0.002093541,0.12042619,0.018072622,0.00007073312,0.00036820956,0.00009494021,0.039099514],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995957,0.000094438474,0.000041945565,0.00008298468,0.00008314858,0.00010179808],"domain_scores_gemma":[0.9994661,0.00025132322,0.000056561934,0.000031437954,0.00005933969,0.00013523766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003339696,0.000858148,0.00064309785,0.00056529127,0.0016375881,0.00082834467,0.00069074315,0.009905469,0.005005404],"category_scores_gemma":[0.0027739399,0.00041259706,0.00067338336,0.0005744767,0.00093729363,0.0011570653,0.00040969026,0.0057830284,0.0021560108],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002173909,0.00012431388,0.008057807,0.000052110314,0.000034536126,0.90034527,0.0002444933,0.00035959337,0.0015194056,0.0026420967,0.07845723,0.007945741],"study_design_scores_gemma":[0.00026607493,0.00027488652,0.015006048,0.0001741632,0.00010936993,0.89989644,0.0005827764,0.0033497408,0.0015127066,0.0065658083,0.07219752,0.000064442414],"about_ca_topic_score_codex":0.0056412187,"about_ca_topic_score_gemma":0.0057549155,"teacher_disagreement_score":0.009905469,"about_ca_system_score_codex":0.0015210804,"about_ca_system_score_gemma":0.0007758593,"threshold_uncertainty_score":0.016744673},"labels":[],"label_agreement":null},{"id":"W2053444416","doi":"10.1007/s00277-013-1921-z","title":"An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A","year":2013,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Tranexamic acid; Thromboelastometry; Medicine; Haemophilia; Haemophilia A; Recombinant factor VIIa; Tissue factor; Coagulation; Recombinant DNA; Surgery; Internal medicine; Blood loss; Chemistry; Biochemistry","score_opus":0.09298984730875784,"score_gpt":0.4368614967141697,"score_spread":0.3438716494054118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053444416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923006,0.0048696212,0.00070766127,0.00010657582,0.000112870606,0.000092089285,0.00046725068,0.0000140703505,0.001329189],"genre_scores_gemma":[0.9938682,0.0020091692,0.0016457267,0.00006899202,0.00007680185,0.000045612072,0.0008762761,0.0000072929574,0.0014019026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865013,0.0007753273,0.00013225748,0.00010372795,0.00021316236,0.00012538808],"domain_scores_gemma":[0.99923587,0.0003282704,0.00010119867,0.00008210557,0.00017502763,0.00007754644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009281691,0.0004780475,0.0008439847,0.00032837727,0.00038012507,0.000911148,0.0004981421,0.0006689988,0.0023839183],"category_scores_gemma":[0.0009552663,0.00028413357,0.00080250483,0.000425722,0.000330634,0.00047669263,0.00029435707,0.000792797,0.0005254323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010838299,0.003870102,0.0017920539,0.0003554326,0.00016634024,0.00032348096,0.00016974012,0.0012071201,0.97122633,0.00018723623,0.00030612925,0.009557699],"study_design_scores_gemma":[0.0007887218,0.07281891,0.015495835,0.000067074216,0.00056790916,0.00093278126,0.00032051987,0.004241502,0.9001549,0.00010086726,0.004464094,0.000046913854],"about_ca_topic_score_codex":0.0020396234,"about_ca_topic_score_gemma":0.0026578761,"teacher_disagreement_score":0.0023839183,"about_ca_system_score_codex":0.00037626986,"about_ca_system_score_gemma":0.00047824343,"threshold_uncertainty_score":0.007974982},"labels":[],"label_agreement":null},{"id":"W2069129653","doi":"10.1007/s00277-011-1391-0","title":"Extreme eosinophilia in a setting of metastatic leiomyosarcoma: An unusual case report","year":2011,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Stornoway Diamond (Canada); University of British Columbia","funders":"","keywords":"Eosinophilia; Hematology; Medicine; Internal medicine; Leiomyosarcoma; Oncology; Pathology; General surgery","score_opus":0.14146417270402464,"score_gpt":0.36067730179708535,"score_spread":0.2192131290930607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069129653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8602383,0.015164947,0.011594077,0.036187664,0.0045131003,0.00088042265,0.0012111136,0.001176104,0.069034226],"genre_scores_gemma":[0.9701947,0.0033458194,0.005470149,0.0044098427,0.012867474,0.00013598603,0.0003079625,0.00012965489,0.0031384504],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99802136,0.00036918742,0.00024022245,0.0004428939,0.00027918324,0.00064717827],"domain_scores_gemma":[0.99303246,0.0024659783,0.0011999597,0.0007273231,0.00043692795,0.0021372996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010058599,0.00454584,0.003019479,0.004406658,0.004580432,0.003906519,0.0038913242,0.015362744,0.0045691514],"category_scores_gemma":[0.011314105,0.002811947,0.0028560627,0.00308162,0.0031562303,0.0060892045,0.0036613874,0.009795033,0.0025976435],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015825837,0.000014272604,0.0008099063,0.000013015447,0.0000030805331,0.9984856,0.000032500146,0.000028084209,0.00008759229,0.00007369113,0.00023847846,0.0001978795],"study_design_scores_gemma":[0.000014663253,0.000032336702,0.0011200509,0.000012270117,0.000010308184,0.9978453,0.00009594206,0.00027349155,0.000113944014,0.00016420569,0.00030765444,0.00000985939],"about_ca_topic_score_codex":0.0019438788,"about_ca_topic_score_gemma":0.0031641691,"teacher_disagreement_score":0.015362744,"about_ca_system_score_codex":0.0030365214,"about_ca_system_score_gemma":0.001561599,"threshold_uncertainty_score":0.022031546},"labels":[],"label_agreement":null},{"id":"W2069270603","doi":"10.1007/s00277-012-1451-0","title":"Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"National Science Foundation","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Flow cytometry; Immunology; Immune tolerance; Dendritic cell; Kynurenine; Mixed lymphocyte reaction; CTLA-4; Cancer research; Medicine; Biology; T cell","score_opus":0.03411859100454438,"score_gpt":0.29070048051653036,"score_spread":0.25658188951198596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069270603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966426,0.0016365873,0.0005499945,0.00005945273,0.00001215824,0.000010908267,0.00009527293,0.000009609213,0.0009835485],"genre_scores_gemma":[0.9985613,0.0004918978,0.0002900935,0.000019809646,0.000012232171,0.000009082759,0.00008266939,0.0000022152713,0.00053063914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992526,0.000015879126,0.000010058064,0.000009739132,0.000015563977,0.000023433073],"domain_scores_gemma":[0.99992716,0.000016335413,0.000016882104,0.000007741584,0.000012869024,0.000018940575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104413964,0.00010366563,0.00012635079,0.0003658991,0.00016416651,0.00026023184,0.0001614368,0.00032361073,0.0008892158],"category_scores_gemma":[0.00020546834,0.00009920096,0.00012573614,0.0001869363,0.0001671525,0.00016036314,0.00012203941,0.0003001364,0.00017970645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011696817,0.00010032616,0.009830934,0.00007383603,0.000016673304,0.0025896886,0.00008175071,0.000073578485,0.9804897,0.00040537657,0.00011568932,0.0050527505],"study_design_scores_gemma":[0.00033116093,0.0011471929,0.29399595,0.000042615055,0.00023524427,0.021069026,0.00072832644,0.0041784346,0.6703523,0.0013694774,0.0065297266,0.000020625517],"about_ca_topic_score_codex":0.0004954538,"about_ca_topic_score_gemma":0.00037153243,"teacher_disagreement_score":0.0008892158,"about_ca_system_score_codex":0.00020211632,"about_ca_system_score_gemma":0.00011023527,"threshold_uncertainty_score":0.002974689},"labels":[],"label_agreement":null},{"id":"W2070121747","doi":"10.1007/s00277-013-1745-x","title":"Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells","year":2013,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Pain Management and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dimethyl sulfoxide; Cryopreservation; Hematology; Hemodynamics; Medicine; Peripheral Blood Stem Cells; Stem cell; Peripheral blood; Cardiology; Internal medicine; Anesthesia; Chemistry; Transplantation; Biology; Hematopoietic stem cell transplantation; Cell biology","score_opus":0.02196304233704037,"score_gpt":0.26024063150277477,"score_spread":0.23827758916573438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070121747","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39961866,0.015272876,0.007065949,0.4950088,0.024637667,0.0005612852,0.00047679376,0.000635655,0.056722287],"genre_scores_gemma":[0.80409986,0.0057372204,0.0027362916,0.14301896,0.033551894,0.00012702997,0.0001853447,0.000059082817,0.0104843825],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994343,0.00016967287,0.00006887712,0.00008699638,0.00012932812,0.000110871566],"domain_scores_gemma":[0.9987042,0.00068786513,0.00021396518,0.00006611135,0.000116294024,0.0002115854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066693523,0.0008317282,0.0010321494,0.00042486965,0.0011962485,0.000947008,0.0010875786,0.009346944,0.0015999387],"category_scores_gemma":[0.004539134,0.00046517138,0.00140365,0.00057462405,0.0009973205,0.0008594127,0.0003622862,0.007781604,0.000658362],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065231824,0.00023084108,0.0054242024,0.0001374941,0.00009077706,0.9524595,0.00016645105,0.0004745567,0.0022238148,0.0014829057,0.026084,0.010573142],"study_design_scores_gemma":[0.0009371649,0.001730752,0.01716596,0.00021589796,0.00029993823,0.9121128,0.0003804676,0.0067695887,0.004093171,0.0043391194,0.051856447,0.00009874825],"about_ca_topic_score_codex":0.0015842724,"about_ca_topic_score_gemma":0.0026026035,"teacher_disagreement_score":0.009346944,"about_ca_system_score_codex":0.0023187161,"about_ca_system_score_gemma":0.00082451705,"threshold_uncertainty_score":0.01682347},"labels":[],"label_agreement":null},{"id":"W2071184266","doi":"10.1007/s00277-011-1193-4","title":"Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions","year":2011,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylenetetrahydrofolate reductase; Myelodysplastic syndromes; Methylation; Myeloid leukemia; DNA methylation; CpG site; Epigenetics; Cancer research; Genotype; Biology; Internal medicine; Medicine; Genetics; Gene; Bone marrow; Gene expression","score_opus":0.059405463235470385,"score_gpt":0.32725283944674993,"score_spread":0.2678473762112795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071184266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413943,0.0011023234,0.0018842702,0.00023000306,0.000052740514,0.00003301481,0.00035021594,0.000058184167,0.0021498005],"genre_scores_gemma":[0.9977386,0.00024417343,0.00073127856,0.00007987398,0.000025589412,0.000014792851,0.00028067201,0.000011647229,0.0008734278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998703,0.000017613596,0.0000141821065,0.0000465763,0.00003425966,0.00001706693],"domain_scores_gemma":[0.9998878,0.000027187629,0.000045986035,0.0000073514243,0.000005567991,0.000026005611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114410366,0.00038057216,0.0002116899,0.00045547367,0.0003072195,0.00029322464,0.00026849308,0.000357345,0.0017129831],"category_scores_gemma":[0.00023558126,0.00015964333,0.0002570334,0.00023739456,0.00034307374,0.00015407692,0.00028763321,0.00039712168,0.00028466503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010662783,0.00011716954,0.025161538,0.00013047407,0.00008335017,0.017181566,0.0001319831,0.000525147,0.94445246,0.001447416,0.0004938449,0.0092087975],"study_design_scores_gemma":[0.00047293634,0.00070975814,0.27734655,0.00005536354,0.00051416224,0.11348879,0.00038755397,0.008381158,0.5767081,0.0023029426,0.019571882,0.0000607933],"about_ca_topic_score_codex":0.00031109655,"about_ca_topic_score_gemma":0.0006607626,"teacher_disagreement_score":0.0017129831,"about_ca_system_score_codex":0.00031290954,"about_ca_system_score_gemma":0.00021424475,"threshold_uncertainty_score":0.0057305098},"labels":[],"label_agreement":null},{"id":"W2071479458","doi":"10.1007/s00277-009-0718-6","title":"Serum ferritin concentrations in Africans with low dietary iron","year":2009,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"National Center for Research Resources; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Ferritin; Medicine; National Health and Nutrition Examination Survey; Serum ferritin; Dietary iron; Iron status; Physiology; Fortification; Internal medicine; Anemia; Environmental health; Food science; Iron deficiency; Population; Biology","score_opus":0.028963787556024367,"score_gpt":0.313056203663771,"score_spread":0.28409241610774666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071479458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939513,0.00010780529,0.000021850527,0.00006388775,0.000005300328,0.0000025553952,0.000035424717,0.0000016728592,0.0003663646],"genre_scores_gemma":[0.9996761,0.000054920365,0.0000397834,0.00003181185,0.000008710481,0.0000025126624,0.000021347998,0.0000011802999,0.00016356913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986684,0.000037227772,0.000015343223,0.00002095159,0.000017936401,0.000041666495],"domain_scores_gemma":[0.99963796,0.000086689084,0.00015650355,0.000014257497,0.000041311574,0.00006324328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020796001,0.0004331382,0.00042021894,0.00095137465,0.0008240584,0.00051157625,0.0002339147,0.00064556894,0.002306469],"category_scores_gemma":[0.0017288737,0.0003771754,0.0002041977,0.000743507,0.0005385654,0.00047267732,0.00024515294,0.00055670325,0.00021824663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016273349,0.00029643133,0.9861057,0.000053811298,0.00006369551,0.0027014527,0.0011195025,0.000046624235,0.0039837784,0.00014518053,0.00025277134,0.0036038142],"study_design_scores_gemma":[0.00004644395,0.00050779537,0.9912081,0.000021977059,0.00007853538,0.005022285,0.0017967973,0.00028572293,0.0005239363,0.00016629887,0.00033196065,0.000010150751],"about_ca_topic_score_codex":0.004715047,"about_ca_topic_score_gemma":0.0038876238,"teacher_disagreement_score":0.004715047,"about_ca_system_score_codex":0.00033925602,"about_ca_system_score_gemma":0.00019821481,"threshold_uncertainty_score":0.009375215},"labels":[],"label_agreement":null},{"id":"W2075994896","doi":"10.1007/s00277-010-1083-1","title":"CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)","year":2010,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Internal medicine; Medicine; International Prognostic Index; Lymphoma; Proportional hazards model; Hazard ratio; Univariate analysis; Stage (stratigraphy); Oncology; Hematology; Pathology; Diffuse large B-cell lymphoma; Multivariate analysis; Confidence interval; Biology","score_opus":0.036924032967801196,"score_gpt":0.34340479288932696,"score_spread":0.3064807599215258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075994896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96099085,0.0038229523,0.0067884084,0.0011122534,0.00029749825,0.00062086526,0.015897539,0.0002586312,0.010211051],"genre_scores_gemma":[0.9690479,0.0007060862,0.0074189757,0.00029779904,0.00038661584,0.00074092747,0.019717012,0.000044208613,0.0016403992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935657,0.00014614913,0.0000655764,0.00009617886,0.00021513879,0.00012046356],"domain_scores_gemma":[0.9976139,0.00040772062,0.00079882616,0.000094791634,0.00050039816,0.00058431335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016869484,0.0010375022,0.0009980305,0.0034987554,0.0005736407,0.0015145895,0.00091066887,0.0007252625,0.0016818045],"category_scores_gemma":[0.0031641435,0.00014669653,0.00077052886,0.0021795046,0.00050534966,0.0011632934,0.0016081195,0.0011304191,0.0007247743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016064424,0.00009632043,0.9692973,0.00010673795,0.00030167625,0.0001247316,0.000045655634,0.0007297882,0.0014271121,0.0002355748,0.0034910007,0.022537757],"study_design_scores_gemma":[0.0003257093,0.0007699076,0.98242515,0.00004749618,0.00047118368,0.00093830086,0.00014349844,0.0068918774,0.0011577379,0.0007298145,0.006048725,0.000050698047],"about_ca_topic_score_codex":0.002051702,"about_ca_topic_score_gemma":0.0020599647,"teacher_disagreement_score":0.0034987554,"about_ca_system_score_codex":0.0010429377,"about_ca_system_score_gemma":0.0010045847,"threshold_uncertainty_score":0.008921504},"labels":[],"label_agreement":null},{"id":"W2081009834","doi":"10.1007/s00277-012-1635-7","title":"Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment","year":2012,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Decitabine; Chronic myelomonocytic leukemia; Medicine; Internal medicine; International Prognostic Scoring System; Oncology; Myelodysplastic syndromes; Single-nucleotide polymorphism; Hematology; Univariate analysis; SNP array; SNP; Leukemia; Gastroenterology; Multivariate analysis; Bone marrow; Genotype; Biology; Genetics; DNA methylation; Gene","score_opus":0.05182636321930983,"score_gpt":0.3443971151118689,"score_spread":0.29257075189255904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081009834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989415,0.00045442962,0.00003636883,0.0001065357,0.000008017007,0.0000031013635,0.00014310674,0.0000019791923,0.00030513163],"genre_scores_gemma":[0.99950886,0.00013706113,0.00005190088,0.00003602815,0.000010015272,0.000003640182,0.0001578435,0.0000010782238,0.0000937064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995976,0.00015686391,0.000044960096,0.00006778518,0.00007956075,0.000053182877],"domain_scores_gemma":[0.9988784,0.0004479215,0.0004307426,0.000039790266,0.000070005735,0.00013319514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036781968,0.00016246337,0.0003665831,0.00037572216,0.00020097656,0.00039072396,0.00021252026,0.00038950137,0.0006918596],"category_scores_gemma":[0.0019743287,0.00010704658,0.00032559162,0.00064271066,0.00017920097,0.00021785911,0.00022335138,0.000462267,0.000096010444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001896079,0.0000767398,0.9860845,0.000013289446,0.00016544134,0.00019005932,0.000040685136,0.00016644388,0.002357504,0.000025273132,0.000120769655,0.008863281],"study_design_scores_gemma":[0.0000141922355,0.00017836527,0.99891496,0.0000027424203,0.00006465367,0.0002053606,0.000050056624,0.00020558281,0.00021277284,0.00003086521,0.000117826705,0.0000026814175],"about_ca_topic_score_codex":0.0016440019,"about_ca_topic_score_gemma":0.0032390915,"teacher_disagreement_score":0.0016440019,"about_ca_system_score_codex":0.00030035392,"about_ca_system_score_gemma":0.00027305208,"threshold_uncertainty_score":0.0032688975},"labels":[],"label_agreement":null},{"id":"W2083159422","doi":"10.1007/s00277-010-0917-1","title":"Future research in ITP: an ICIS consensus","year":2010,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pathogenesis; Immune thrombocytopenia; Disease; Clinical trial; Immunology; Hematology; Identification (biology); Intensive care medicine; Bioinformatics; Internal medicine; Biology; Antibody","score_opus":0.1288942828721013,"score_gpt":0.4501481068582372,"score_spread":0.3212538239861359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083159422","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038499298,0.26767063,0.0018520568,0.7057802,0.020009797,0.000055327568,0.00018442962,0.00005527393,0.004007195],"genre_scores_gemma":[0.022531513,0.37035057,0.01577666,0.5105184,0.07509127,0.0004182923,0.0007622389,0.00012786867,0.004423231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9820873,0.005800927,0.004304852,0.0024858904,0.0033063027,0.002014742],"domain_scores_gemma":[0.8637737,0.076648824,0.0058758166,0.0033973719,0.038205203,0.0120991655],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04847913,0.001780127,0.006752709,0.0045962934,0.004895556,0.012747227,0.0076861233,0.02488949,0.020723766],"category_scores_gemma":[0.06622133,0.0010550406,0.003906868,0.005176986,0.009117901,0.021468168,0.0097264275,0.029014256,0.0071808477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081586227,0.00036028252,0.0034491252,0.01166885,0.0004932835,0.00079588086,0.0008418344,0.00062876166,0.00054552004,0.043587577,0.51455724,0.42225578],"study_design_scores_gemma":[0.0005055213,0.00024746175,0.0024111564,0.03569298,0.0008789369,0.0010422262,0.0040486855,0.0009437821,0.00039292,0.11786766,0.8357793,0.00018947605],"about_ca_topic_score_codex":0.0066543976,"about_ca_topic_score_gemma":0.0132240355,"teacher_disagreement_score":0.95152086,"about_ca_system_score_codex":0.00810633,"about_ca_system_score_gemma":0.038661983,"threshold_uncertainty_score":0.2563852},"labels":[],"label_agreement":null},{"id":"W2090292829","doi":"10.1007/s00277-012-1553-8","title":"Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation","year":2012,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Telangiectasia; Contraindication; Telangiectases; Surgery; Anemia; Gastrointestinal bleeding; Pediatrics; Internal medicine","score_opus":0.04276243947717688,"score_gpt":0.31340934972787987,"score_spread":0.270646910250703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090292829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97267455,0.0012616419,0.0005855502,0.0008680057,0.00007699802,0.000031184034,0.00011794,0.000062941595,0.024321256],"genre_scores_gemma":[0.9980122,0.00023613448,0.00015314946,0.00021705443,0.00005942104,0.0000063211846,0.000086587395,0.000010121185,0.0012190553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980825,0.000043862045,0.000017266066,0.00001941974,0.000047007317,0.000064253225],"domain_scores_gemma":[0.9994968,0.00020946501,0.00011930428,0.00004409849,0.00003441141,0.000095914074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022187244,0.0002467927,0.00037783143,0.00030485122,0.00043586153,0.00046097682,0.00017301757,0.00048261092,0.0038101568],"category_scores_gemma":[0.0019984257,0.000106075066,0.00037878036,0.00034527475,0.00017347267,0.00047489206,0.00022582551,0.0005803276,0.0006467658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028597766,0.0012468139,0.71269035,0.00013012683,0.00037367558,0.09879657,0.0009557112,0.0009288184,0.026949508,0.0017749046,0.005786295,0.14750743],"study_design_scores_gemma":[0.00053759693,0.0030111533,0.7478904,0.000076457305,0.0004768905,0.21368615,0.00097198813,0.002274175,0.0073438855,0.004358025,0.019316638,0.000056597437],"about_ca_topic_score_codex":0.00048144063,"about_ca_topic_score_gemma":0.0005090117,"teacher_disagreement_score":0.0038101568,"about_ca_system_score_codex":0.00017385832,"about_ca_system_score_gemma":0.00014818367,"threshold_uncertainty_score":0.0127462745},"labels":[],"label_agreement":null},{"id":"W2099626767","doi":"10.1007/s00277-014-2288-5","title":"Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Gilead Sciences","keywords":"Medicine; Autologous stem-cell transplantation; Rituximab; Internal medicine; Follicular lymphoma; Transplantation; Oncology; Lymphoma; Gastroenterology; Surgery","score_opus":0.06008705568568157,"score_gpt":0.3245621606122814,"score_spread":0.2644751049265998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099626767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954835,0.0030066355,0.00007507756,0.00011906186,0.000018787297,0.000010871656,0.00006599224,0.000007898624,0.0012122197],"genre_scores_gemma":[0.99953866,0.00019554305,0.000020349273,0.000053380343,0.000020498883,0.0000043635314,0.00007687913,0.0000012935358,0.000088958455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976057,0.000066442335,0.000026048738,0.00003257487,0.000035092413,0.00007932308],"domain_scores_gemma":[0.99931645,0.00022384935,0.00019830363,0.000036865345,0.0000349485,0.0001895642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003811678,0.00014336332,0.00049963983,0.0002525691,0.00037571698,0.00040150975,0.00016671015,0.0003182331,0.0009882881],"category_scores_gemma":[0.0014974816,0.00009177528,0.00031243794,0.0003326233,0.00023874696,0.00030222881,0.00022232327,0.0005104958,0.00014485423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022829713,0.00054320024,0.863956,0.00022052355,0.00036444594,0.011529901,0.00082105113,0.0007008558,0.019860942,0.00033264546,0.0011222026,0.07771859],"study_design_scores_gemma":[0.0006421169,0.0048138015,0.97629887,0.00003448201,0.00029477873,0.0136301825,0.00024017092,0.00047874215,0.00088469085,0.00020103544,0.0024641878,0.000016871492],"about_ca_topic_score_codex":0.00065430236,"about_ca_topic_score_gemma":0.0010053589,"teacher_disagreement_score":0.0009882881,"about_ca_system_score_codex":0.00044715963,"about_ca_system_score_gemma":0.00030288013,"threshold_uncertainty_score":0.0033060908},"labels":[],"label_agreement":null},{"id":"W2117320933","doi":"10.1007/s00277-008-0613-6","title":"Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients","year":2008,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Methylenetetrahydrofolate reductase; Etiology; Medicine; Stroke (engine); Internal medicine; Polymorphism (computer science); Hematology; Genetics; Gastroenterology; Bioinformatics; Gene; Genotype; Biology","score_opus":0.025029076777680518,"score_gpt":0.2677728022419795,"score_spread":0.242743725464299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117320933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994692,0.00006257232,0.000022512697,0.000024446439,0.000002630055,0.0000020756258,0.000072193245,0.0000023797645,0.0003419806],"genre_scores_gemma":[0.9995869,0.00009477733,0.00006240411,0.000019278224,0.000007641257,0.000005389895,0.00010849313,0.0000027827903,0.00011240005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997261,0.000068021145,0.00004810572,0.000045058772,0.000045117333,0.00006745113],"domain_scores_gemma":[0.9991936,0.00021338233,0.000288163,0.00004623659,0.00006468428,0.00019400522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030033017,0.0004390945,0.00036261548,0.00080154574,0.00054607866,0.0005266743,0.00034368556,0.00042166957,0.002408606],"category_scores_gemma":[0.0013775254,0.00034741007,0.00048490777,0.001366114,0.0004000663,0.00035458355,0.0002398238,0.0007000573,0.00025140675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037560036,0.00007330556,0.99527717,0.000009424714,0.00004945045,0.0016738775,0.0002681974,0.000056696084,0.0009806558,0.00006860836,0.00007845938,0.0010886858],"study_design_scores_gemma":[0.00002381496,0.00017752097,0.9938046,0.0000070005303,0.000080575344,0.004591879,0.0005977339,0.00022383065,0.0002843581,0.00004924373,0.00015242408,0.0000070461365],"about_ca_topic_score_codex":0.005567688,"about_ca_topic_score_gemma":0.0043750587,"teacher_disagreement_score":0.005567688,"about_ca_system_score_codex":0.00025165232,"about_ca_system_score_gemma":0.00044921137,"threshold_uncertainty_score":0.011070609},"labels":[],"label_agreement":null},{"id":"W2127762891","doi":"10.1007/s00277-015-2543-4","title":"Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Follicular lymphoma; Hematology; Non-Hodgkin's lymphoma; Gastroenterology","score_opus":0.15940831922656118,"score_gpt":0.3890267915782633,"score_spread":0.22961847235170213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127762891","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58057487,0.40858036,0.00039901235,0.0005259098,0.00018343149,0.000107783846,0.0031477495,0.000028965895,0.0064519844],"genre_scores_gemma":[0.71331006,0.2793249,0.0006756559,0.0005545428,0.000163767,0.00005926238,0.0050247656,0.000018208728,0.00086872914],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99946755,0.00006208515,0.00017849082,0.000078773104,0.0001435002,0.00006966375],"domain_scores_gemma":[0.9991067,0.00024387692,0.0003309386,0.000040434054,0.00019629541,0.000081680744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069110474,0.0003416784,0.00047066514,0.0037354396,0.00043273994,0.0007106206,0.0004805523,0.0003071065,0.001065396],"category_scores_gemma":[0.0010300797,0.00022470542,0.000361552,0.005431797,0.00044992083,0.0007654166,0.00036579065,0.0001594699,0.00031536323],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038080997,0.0000773138,0.764946,0.0049591423,0.0003340031,0.023539111,0.0018752742,0.00017654724,0.003343124,0.00024974532,0.010490298,0.18962874],"study_design_scores_gemma":[0.000020893749,0.00005528782,0.92949593,0.0014420112,0.0003790594,0.03871536,0.0025056605,0.0000518877,0.0003742301,0.00007387188,0.026863469,0.000022391747],"about_ca_topic_score_codex":0.006201348,"about_ca_topic_score_gemma":0.008878641,"teacher_disagreement_score":0.006201348,"about_ca_system_score_codex":0.00047457573,"about_ca_system_score_gemma":0.0008117623,"threshold_uncertainty_score":0.012330532},"labels":[],"label_agreement":null},{"id":"W2128623632","doi":"10.1007/s00277-011-1348-3","title":"Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia","year":2011,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Stornoway Diamond (Canada); BC Cancer Agency","funders":"","keywords":"Vincristine; Medicine; Lymphoblastic Leukemia; Hematology; Internal medicine; Paralysis; Leukemia; Oncology; Cord; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.05568088296862699,"score_gpt":0.33949123928127667,"score_spread":0.28381035631264967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128623632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7645483,0.01208867,0.003249903,0.11393194,0.008176776,0.0005009474,0.0007090251,0.00062138564,0.096173055],"genre_scores_gemma":[0.961476,0.003012784,0.0012424488,0.019435057,0.0062263897,0.00004640693,0.00017485522,0.00008971467,0.008296292],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994642,0.00009215339,0.000072042814,0.00009585425,0.000092003575,0.00018371687],"domain_scores_gemma":[0.99805415,0.0008380614,0.00037651582,0.00012236065,0.00012149391,0.00048746655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003384263,0.0012456327,0.00093795377,0.0010473217,0.0018819851,0.0015769777,0.0014220868,0.009700031,0.0028360146],"category_scores_gemma":[0.0059867366,0.0007903388,0.0013106562,0.00081661047,0.0012139786,0.0017898831,0.0008651105,0.0065903277,0.0013052212],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006896925,0.000032267148,0.0024376486,0.000030041605,0.00001269671,0.9935781,0.000085794505,0.000117771975,0.00039994626,0.00021938627,0.0017641125,0.0012533122],"study_design_scores_gemma":[0.00010869398,0.00028522112,0.007753318,0.00007004713,0.00006973172,0.98333955,0.00030393558,0.001606429,0.00085767405,0.00045101112,0.005131986,0.000022359642],"about_ca_topic_score_codex":0.0046830894,"about_ca_topic_score_gemma":0.00863545,"teacher_disagreement_score":0.009700031,"about_ca_system_score_codex":0.0040646633,"about_ca_system_score_gemma":0.0013298208,"threshold_uncertainty_score":0.029491365},"labels":[],"label_agreement":null},{"id":"W2130851089","doi":"10.1007/s00277-005-1024-6","title":"Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature","year":2005,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Complication; Hematology; Adverse effect; Intravenous Immunoglobulin Therapy; Vasculitis; Vasospasm; Myocardial infarction; Incidence (geometry); Internal medicine; Platelet; Surgery; Antibody; Anesthesia; Immunology; Subarachnoid hemorrhage","score_opus":0.022088821193113083,"score_gpt":0.3509037553465754,"score_spread":0.32881493415346236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130851089","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026795606,0.9953157,0.0002542005,0.00045205446,0.00020202392,0.0000077403365,0.000024585346,0.000010724934,0.001053457],"genre_scores_gemma":[0.014286838,0.98338723,0.0005302853,0.00065021816,0.0006796156,0.0000074164386,0.000049617385,0.0000021005105,0.00040671864],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996915,0.000057082827,0.00009510063,0.00004460147,0.0000866381,0.000025092682],"domain_scores_gemma":[0.99915767,0.00042333023,0.0002500183,0.000018364903,0.00010733982,0.000043311094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046687454,0.00064023095,0.0017030167,0.0020991496,0.0003026365,0.0011333331,0.0010609435,0.0016749821,0.0011911017],"category_scores_gemma":[0.0010842186,0.00024109482,0.00054061133,0.002516489,0.00038746189,0.0012773642,0.00037010916,0.00092092017,0.0006447582],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022377622,0.0001493426,0.011383625,0.027655207,0.0005110291,0.14199051,0.00033855133,0.00048762994,0.004071506,0.0008522404,0.025207527,0.7871289],"study_design_scores_gemma":[0.00010408684,0.00037853513,0.0282845,0.009688244,0.0017450992,0.65734655,0.0008014651,0.0004982032,0.0017944684,0.00123902,0.29800215,0.000117655654],"about_ca_topic_score_codex":0.0009042193,"about_ca_topic_score_gemma":0.0019673738,"teacher_disagreement_score":0.0020991496,"about_ca_system_score_codex":0.00033791273,"about_ca_system_score_gemma":0.0008194084,"threshold_uncertainty_score":0.00398463},"labels":[],"label_agreement":null},{"id":"W2138253305","doi":"10.1007/s00277-009-0822-7","title":"Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts","year":2009,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; Terry Fox Foundation; Imperial College London","keywords":"Imatinib mesylate; Myeloid leukemia; Internal medicine; Medicine; Imatinib; Gastroenterology; Philadelphia chromosome; ABL; Leukemia; Immunology; Biology; Chromosomal translocation; Tyrosine kinase; Receptor","score_opus":0.022921049663615894,"score_gpt":0.30024516466819084,"score_spread":0.27732411500457493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138253305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978537,0.00093568355,0.000038476035,0.00013727763,0.000013596929,0.000012853342,0.00018164197,0.000004886662,0.0008220198],"genre_scores_gemma":[0.9991399,0.00018733226,0.000040210933,0.00007956983,0.000014889785,0.000009006658,0.00034934081,0.0000011826916,0.00017855113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997683,0.00006272734,0.000031087668,0.00004401218,0.000039156712,0.00005457596],"domain_scores_gemma":[0.99963427,0.00015331121,0.00008575311,0.000013550682,0.000021808408,0.000091269445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033974668,0.00023143429,0.00055970054,0.00031413234,0.00018652555,0.00034554445,0.00017033628,0.00034339854,0.0011913083],"category_scores_gemma":[0.0009851091,0.00010719306,0.00035350968,0.0003643998,0.00021774322,0.00031672878,0.00019422092,0.00041885301,0.00017039428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069112375,0.0007891029,0.78036016,0.00020796999,0.00084984704,0.002564318,0.0004280612,0.003314715,0.04921416,0.0003821149,0.0021011198,0.090675965],"study_design_scores_gemma":[0.0019961891,0.010711361,0.9743524,0.000026373462,0.00045469173,0.003043167,0.0002807597,0.0020487627,0.0039920975,0.00022572742,0.0028370526,0.00003158062],"about_ca_topic_score_codex":0.00070671365,"about_ca_topic_score_gemma":0.0017487386,"teacher_disagreement_score":0.0011913083,"about_ca_system_score_codex":0.00043912992,"about_ca_system_score_gemma":0.00020258382,"threshold_uncertainty_score":0.0039853454},"labels":[],"label_agreement":null},{"id":"W2146157708","doi":"10.1007/s00277-009-0882-8","title":"Animal models of immune thrombocytopenia (ITP)","year":2010,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune thrombocytopenia; Animal model; Medicine; Relevance (law); Human studies; Hematology; Immunology; Immune system; Platelet; Internal medicine; Political science","score_opus":0.14461823481796188,"score_gpt":0.4131376891288904,"score_spread":0.2685194543109285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146157708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033503212,0.99803406,0.0003747665,0.00023506835,0.0001591526,0.0000128209185,0.000034227025,0.000013576553,0.0008012719],"genre_scores_gemma":[0.001692725,0.99684614,0.0005067007,0.00025531475,0.00012433711,0.000025164101,0.000091287744,0.0000019032187,0.00045637344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980384,0.00003768988,0.000031228705,0.000027153374,0.00008221157,0.000017882054],"domain_scores_gemma":[0.99958855,0.0002247993,0.00006800017,0.000017617249,0.0000691761,0.000031719912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007482479,0.0012405318,0.001969862,0.0020112933,0.00021511794,0.00075663003,0.0010951489,0.001317173,0.0018433313],"category_scores_gemma":[0.0006220891,0.0002764055,0.0007082671,0.0012515326,0.00050872646,0.00080824026,0.00046879594,0.0023004329,0.0011089251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002905632,0.000389419,0.0002579371,0.013775326,0.00018769206,0.00037816633,0.000030122603,0.00040319667,0.006621123,0.0024846161,0.028906738,0.94627523],"study_design_scores_gemma":[0.00029301277,0.0006754772,0.0018513672,0.0051290826,0.0008142144,0.003919742,0.00006513856,0.0002644957,0.0047137924,0.0034922056,0.9787314,0.00005018047],"about_ca_topic_score_codex":0.000867154,"about_ca_topic_score_gemma":0.0017060206,"teacher_disagreement_score":0.0020112933,"about_ca_system_score_codex":0.0004005691,"about_ca_system_score_gemma":0.0006571872,"threshold_uncertainty_score":0.0061665773},"labels":[],"label_agreement":null},{"id":"W2146655159","doi":"10.1007/s00277-007-0284-8","title":"Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma","year":2007,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Maple Leaf Medical Clinic; St. Paul's Hospital; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Canadian Foundation for AIDS Research; amfAR, The Foundation for AIDS Research","keywords":"Medicine; Rituximab; CHOP; Odds ratio; Internal medicine; Confidence interval; Prednisone; Lymphoma; Vincristine; Cart; Family medicine; Chemotherapy; Cyclophosphamide","score_opus":0.030787256355504767,"score_gpt":0.3192668914084189,"score_spread":0.28847963505291413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146655159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995447,0.00060285156,0.000063088315,0.0010268386,0.000023586033,0.000010567406,0.00003545552,0.0000015749436,0.0027890147],"genre_scores_gemma":[0.99934286,0.00017076393,0.00006633584,0.00025038607,0.000016000084,0.0000031159593,0.000012948787,9.5087046e-7,0.00013665257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977354,0.0015196425,0.00014974666,0.000060858376,0.00034452786,0.00018977524],"domain_scores_gemma":[0.9867026,0.008192004,0.0025883848,0.000102472906,0.0007068494,0.0017077093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023268291,0.00008798058,0.00019329553,0.0004099063,0.0006875045,0.00094546046,0.00016563445,0.0005923567,0.0031762347],"category_scores_gemma":[0.019281251,0.00011644602,0.00031944286,0.00035552823,0.0005368259,0.00043560672,0.00038701008,0.00077076163,0.00014500473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027747166,0.0012304919,0.9155528,0.0003162474,0.00026451645,0.001784253,0.029715253,0.0008168762,0.0020029363,0.00063543126,0.0028483758,0.042058162],"study_design_scores_gemma":[0.00029136514,0.0017762479,0.92201746,0.00017668585,0.00015186136,0.0030920594,0.0650198,0.0016526635,0.000569381,0.00054523494,0.0046444098,0.00006285009],"about_ca_topic_score_codex":0.005771569,"about_ca_topic_score_gemma":0.008069885,"teacher_disagreement_score":0.005771569,"about_ca_system_score_codex":0.000686422,"about_ca_system_score_gemma":0.0005874705,"threshold_uncertainty_score":0.012305617},"labels":[],"label_agreement":null},{"id":"W2149242646","doi":"10.1007/s00277-008-0449-0","title":"Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes","year":2008,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Lenalidomide; Myelodysplastic syndromes; Medicine; Disease; Internal medicine; Intensive care medicine; Hematology; International Prognostic Scoring System; Oncology; Food and drug administration; Multiple myeloma; Bone marrow; Pharmacology","score_opus":0.45914163368655825,"score_gpt":0.489439714819162,"score_spread":0.030298081132603738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149242646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069905963,0.8727879,0.003611596,0.071714185,0.013546405,0.00046972252,0.0006931504,0.00017704799,0.036300864],"genre_scores_gemma":[0.0024922974,0.9434347,0.016297597,0.022174805,0.0026812907,0.00048295807,0.00085172773,0.000023318082,0.011561324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998248,0.00060189754,0.00038659747,0.00009707532,0.0005925056,0.00007390575],"domain_scores_gemma":[0.9966983,0.0010726545,0.0005260325,0.00009752805,0.0013986465,0.00020672598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027789727,0.0010552126,0.0015362478,0.0032137842,0.00047728003,0.0009803132,0.002380805,0.0032780047,0.0077895564],"category_scores_gemma":[0.006343338,0.0005545269,0.001090978,0.0027204612,0.0006780499,0.0016840895,0.00081850705,0.0031207425,0.0075689093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007614974,0.00009910879,0.00025465104,0.011044292,0.000089711604,0.0005701492,0.00014443834,0.00033670597,0.0008857753,0.0034294245,0.37043828,0.6126314],"study_design_scores_gemma":[0.00007735715,0.000052686275,0.00082409853,0.009760236,0.00011408228,0.00078510295,0.00010320067,0.00008646075,0.00014335827,0.003221832,0.9848108,0.000020674866],"about_ca_topic_score_codex":0.0023412348,"about_ca_topic_score_gemma":0.0063422355,"teacher_disagreement_score":0.0077895564,"about_ca_system_score_codex":0.00091794645,"about_ca_system_score_gemma":0.0033330366,"threshold_uncertainty_score":0.026058674},"labels":[],"label_agreement":null},{"id":"W22652894","doi":"10.1007/pl00022788","title":"Therapeutic consequences of pathology and prognostic factors in aggressive NHL – Analysis of ALCL","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hematology; Medicine; Internal medicine; Oncology; Pathology; Aggressive lymphoma; Lymphoma","score_opus":0.13818486139775843,"score_gpt":0.41661491941416445,"score_spread":0.278430058016406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22652894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074711896,0.9981281,0.00011771571,0.00022590371,0.00009529773,0.0000027304884,0.0000102584545,0.0000036973815,0.0006691669],"genre_scores_gemma":[0.0058702314,0.9926649,0.0003933399,0.00037282959,0.00033509464,0.0000050150575,0.000042239535,0.0000015662162,0.0003147788],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997756,0.000054890115,0.000045542274,0.000039725102,0.00007134328,0.0000128297015],"domain_scores_gemma":[0.99945337,0.00030641627,0.000081279606,0.00001773759,0.00011699131,0.000024223009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075345766,0.00042325992,0.0014452216,0.00094173755,0.0001477577,0.0006815646,0.0006581048,0.00048589794,0.00083408866],"category_scores_gemma":[0.0009671316,0.00016688988,0.00041693647,0.0012121651,0.00027622478,0.0006998145,0.00026369173,0.00079341757,0.00052637747],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012728402,0.000050990988,0.0017423773,0.0053007277,0.00020536616,0.0005063004,0.00003313301,0.00032520448,0.0011572195,0.0007279904,0.007211303,0.982612],"study_design_scores_gemma":[0.00014852107,0.0006489665,0.03690622,0.008436252,0.0019696376,0.017574146,0.00022697549,0.00066554116,0.0017707451,0.00418209,0.9273823,0.00008862968],"about_ca_topic_score_codex":0.0005953106,"about_ca_topic_score_gemma":0.001861271,"teacher_disagreement_score":0.0014452216,"about_ca_system_score_codex":0.00035484528,"about_ca_system_score_gemma":0.00061353296,"threshold_uncertainty_score":0.0039847493},"labels":[],"label_agreement":null},{"id":"W2275325872","doi":"10.1007/s00277-015-2580-z","title":"Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ministry of Education, Science and Technology","keywords":"CEBPA; Internal medicine; Medicine; NPM1; Group (periodic table); Oncology; Mutation; Subgroup analysis; Hematology; Biology; Genetics; Confidence interval; Gene; Chemistry","score_opus":0.0443843640306183,"score_gpt":0.31337752795770224,"score_spread":0.26899316392708394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275325872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963201,0.00051432726,0.00022019449,0.00012451362,0.00003527923,0.000007597778,0.00017183354,0.000010401206,0.0025957355],"genre_scores_gemma":[0.9991757,0.000112725276,0.000032910684,0.000049906368,0.00003420238,0.000002686239,0.0003253972,0.0000029462692,0.00026341595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985313,0.000022222586,0.000012130784,0.000022839578,0.000024375498,0.00006522531],"domain_scores_gemma":[0.99956435,0.000060689337,0.00011970988,0.000034050714,0.000017447566,0.00020377732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002953942,0.00016367635,0.00036165316,0.00020904707,0.0002177017,0.000478638,0.00012606039,0.0002028198,0.0019132757],"category_scores_gemma":[0.0007993486,0.00004627839,0.00045287432,0.0001445504,0.00016497607,0.0003799356,0.0003598025,0.00042796036,0.00030068343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074471487,0.00029695602,0.9070496,0.000044897104,0.00034878662,0.0009107559,0.00018167832,0.0009146078,0.007086986,0.0005338919,0.0015187735,0.07366593],"study_design_scores_gemma":[0.00009024151,0.0014419672,0.9934362,0.000018610437,0.00017905774,0.0014217679,0.00018128853,0.00055306574,0.0006895668,0.0007898913,0.0011846032,0.000013633827],"about_ca_topic_score_codex":0.00045180586,"about_ca_topic_score_gemma":0.0010968419,"teacher_disagreement_score":0.0019132757,"about_ca_system_score_codex":0.00019505329,"about_ca_system_score_gemma":0.00022639704,"threshold_uncertainty_score":0.006400585},"labels":[],"label_agreement":null},{"id":"W2342664814","doi":"10.1007/s00277-016-2682-2","title":"Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of General Medical Sciences; Amgen","keywords":"Romiplostim; Medicine; Discontinuation; Internal medicine; Cohort; Adverse effect; Hematology; Eltrombopag; Bone marrow; Platelet; Thrombocytopenic purpura; Gastroenterology; Surgery; Neutropenia; Thrombopoietin; Immune thrombocytopenia; Toxicity; Haematopoiesis","score_opus":0.0404512516185128,"score_gpt":0.3049022252973343,"score_spread":0.2644509736788215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342664814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978561,0.001250775,0.000086651584,0.00003954197,0.0000049651517,0.000029719235,0.00006747627,0.000006324911,0.0006584276],"genre_scores_gemma":[0.9992508,0.0003502166,0.00013095727,0.00006439611,0.00001236752,0.00001002505,0.00008846802,0.0000013061663,0.00009138011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997404,0.00008288896,0.000037621703,0.000040252948,0.000063078565,0.00003577161],"domain_scores_gemma":[0.9995622,0.00008699863,0.00020829403,0.000015151855,0.0000433288,0.00008394726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038235425,0.00022818641,0.00048365537,0.0003616109,0.00018090352,0.0002342383,0.00013327951,0.0002429714,0.00056325184],"category_scores_gemma":[0.0011716556,0.00013136632,0.0002223269,0.00030656558,0.00014394753,0.00016729583,0.00015370316,0.00027128987,0.00011494904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053814803,0.00030616307,0.940017,0.00013288931,0.000094414776,0.0047079795,0.00023219797,0.00017473601,0.0122603355,0.000042078656,0.000466749,0.03618412],"study_design_scores_gemma":[0.00016645498,0.006851077,0.9831154,0.000024979618,0.00009069899,0.0074904244,0.000113476715,0.00024323701,0.0012744783,0.000022982234,0.00060167053,0.000005164392],"about_ca_topic_score_codex":0.00063833763,"about_ca_topic_score_gemma":0.0011444357,"teacher_disagreement_score":0.00063833763,"about_ca_system_score_codex":0.00022441293,"about_ca_system_score_gemma":0.00012757414,"threshold_uncertainty_score":0.0020220876},"labels":[],"label_agreement":null},{"id":"W2344273902","doi":"10.1007/s00277-016-2639-5","title":"Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Universidade Federal de Minas Gerais; Fundação de Amparo à Pesquisa do Estado de Minas Gerais","keywords":"Procalcitonin; Medicine; Internal medicine; Neutropenia; Randomized controlled trial; Antibiotics; Bacteremia; Febrile neutropenia; Gastroenterology; Sepsis; Chemotherapy","score_opus":0.07610126739503766,"score_gpt":0.3982406364092392,"score_spread":0.32213936901420154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344273902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552945,0.019817954,0.0023652557,0.0020709871,0.00420462,0.011122785,0.0011010076,0.00028828965,0.0037345488],"genre_scores_gemma":[0.980415,0.004184643,0.00286288,0.0019446557,0.0012070814,0.007111302,0.0005337634,0.00004198662,0.0016987562],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99634665,0.002224036,0.0003805231,0.00053641474,0.00021560257,0.00029684172],"domain_scores_gemma":[0.9948435,0.0025842774,0.0011606006,0.00040491382,0.00025949924,0.00074729824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004622148,0.0023682038,0.0065636123,0.00066670834,0.00085042627,0.0020663962,0.0016723267,0.0037984212,0.008509597],"category_scores_gemma":[0.0077225156,0.0011726287,0.0044193687,0.0007850246,0.0024173534,0.0020367098,0.00084290694,0.005251911,0.0009960505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99120027,0.0020997487,0.00021237615,0.00083830627,0.0018486223,0.000018746161,0.00002980525,0.00010954187,0.00028611496,0.00007268842,0.00025769448,0.0030261711],"study_design_scores_gemma":[0.97931206,0.01829513,0.00044468796,0.0000706819,0.001332493,0.000008152263,0.000012393962,0.0001858115,0.000058133413,0.000103203114,0.00016448899,0.000012776976],"about_ca_topic_score_codex":0.0014960356,"about_ca_topic_score_gemma":0.0023464756,"teacher_disagreement_score":0.008509597,"about_ca_system_score_codex":0.0016355476,"about_ca_system_score_gemma":0.0020083894,"threshold_uncertainty_score":0.028467476},"labels":[],"label_agreement":null},{"id":"W2414415814","doi":"10.1007/s00277-016-2722-y","title":"Non-anaplastic peripheral T cell lymphoma in children and adolescents—an international review of 143 cases","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Barncancerfonden; National Institute for Health and Care Research","keywords":"Medicine; Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Lymphoma; Internal medicine; Not Otherwise Specified; Hematology; T-cell lymphoma; Retrospective cohort study; Large cell; T cell; Pediatrics; Oncology; Gastroenterology; Cancer; Immunology","score_opus":0.028272861765370597,"score_gpt":0.35300177607363425,"score_spread":0.32472891430826367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414415814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2834901,0.70328206,0.0013660325,0.000392,0.0001996799,0.000087114226,0.0005020268,0.00008573461,0.010595276],"genre_scores_gemma":[0.59922206,0.39558527,0.0018942391,0.0006485771,0.0004433524,0.00006702595,0.000934098,0.00004072201,0.0011646553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995484,0.000060235845,0.00013851938,0.00008874308,0.00009886042,0.00006519784],"domain_scores_gemma":[0.99940896,0.0002399566,0.00019141447,0.000027129814,0.000057565747,0.000074920674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044984173,0.0007197998,0.0006830726,0.0038403962,0.00057441765,0.0009707346,0.0008399824,0.0007908778,0.0018382646],"category_scores_gemma":[0.0009845505,0.00042952097,0.0004404171,0.0035342386,0.0007044781,0.0017046682,0.0006477908,0.0003543257,0.00059188064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040732845,0.00023072548,0.3360345,0.006158364,0.00036381788,0.3091691,0.002336266,0.00044164216,0.008542891,0.0010088545,0.012407644,0.32289883],"study_design_scores_gemma":[0.00003650629,0.00010363784,0.12910232,0.002444206,0.00041716374,0.8147673,0.002285739,0.00014629253,0.001328777,0.0003815828,0.048944846,0.000041597486],"about_ca_topic_score_codex":0.00057781686,"about_ca_topic_score_gemma":0.00089419173,"teacher_disagreement_score":0.0038403962,"about_ca_system_score_codex":0.0002676231,"about_ca_system_score_gemma":0.0005634873,"threshold_uncertainty_score":0.00614959},"labels":[],"label_agreement":null},{"id":"W2468359358","doi":"10.1007/s00277-006-0139-8","title":"Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4","year":2006,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Acute promyelocytic leukemia; Glutathione; Apoptosis; Arsenic trioxide; Cell culture; Glutathione peroxidase; GSTP1; Kinase; Chemistry; Cancer research; Molecular biology; Biology; Biochemistry; Enzyme","score_opus":0.006332288786359706,"score_gpt":0.26219838236557114,"score_spread":0.2558660935792114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468359358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944959,0.0016855466,0.0007725743,0.00033132534,0.000028904293,0.00001954472,0.00055133575,0.00008550056,0.0020294455],"genre_scores_gemma":[0.9957533,0.00072804705,0.0004779275,0.000035937646,0.0000052165665,0.000011888402,0.0005639402,0.000020284275,0.0024035189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998493,0.00004404745,0.000011658108,0.000015087577,0.00003422968,0.00004566428],"domain_scores_gemma":[0.99987483,0.00004163632,0.000017212416,0.000024233223,0.000019929255,0.00002218834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021942073,0.00041078846,0.0005639658,0.00033135634,0.0004741245,0.00067194673,0.00038200538,0.000482067,0.0021089402],"category_scores_gemma":[0.00017804113,0.00021351529,0.00037227126,0.0003868706,0.00061967765,0.00050220604,0.00025140625,0.00070921134,0.00071411586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005311261,0.000045831825,0.00032563304,0.000043548076,0.0000060612897,0.00011436106,0.0000446498,0.000095743344,0.99746275,0.00028830513,0.00006211096,0.0009799122],"study_design_scores_gemma":[0.00003207077,0.00015441624,0.0033417172,0.0000034497084,0.000011982656,0.00011994404,0.00008728429,0.00043420703,0.99409914,0.0000944866,0.0016170649,0.000004249726],"about_ca_topic_score_codex":0.0045000436,"about_ca_topic_score_gemma":0.0040271822,"teacher_disagreement_score":0.0045000436,"about_ca_system_score_codex":0.0008198735,"about_ca_system_score_gemma":0.0006683723,"threshold_uncertainty_score":0.00894767},"labels":[],"label_agreement":null},{"id":"W2515215009","doi":"10.1007/s00277-016-2798-4","title":"Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Calgary; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Peripherally inserted central catheter; Incidence (geometry); Thrombosis; Concomitant; Catheter; Surgery; Venous thrombosis; Acute leukemia; Hematology; Retrospective cohort study; Deep vein; Central venous catheter; Internal medicine; Leukemia","score_opus":0.02616471802247241,"score_gpt":0.29943384657327377,"score_spread":0.2732691285508014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515215009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938285,0.00030467345,0.000044215536,0.000008341737,0.0000031938303,0.0000036153892,0.00008856565,0.0000011320914,0.00016332555],"genre_scores_gemma":[0.99968314,0.00011271252,0.000025839514,0.000013891438,0.000010382282,0.0000025281956,0.000115973766,0.0000010411933,0.000034534478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988895,0.0004094208,0.00016109245,0.00021612192,0.00019256042,0.0001313203],"domain_scores_gemma":[0.9967438,0.0009355823,0.0014770656,0.00021424751,0.00026003458,0.0003693358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082527444,0.0002250635,0.00045916936,0.000962274,0.00033020688,0.0008232492,0.00036136727,0.0006636407,0.0013678501],"category_scores_gemma":[0.0036164357,0.0002794959,0.00057361036,0.0013979119,0.00042494014,0.00072406395,0.00035273746,0.00053311756,0.00021093796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011264937,0.000072133545,0.99726844,0.000012417329,0.00010391055,0.000078531004,0.000051742973,0.000030413308,0.00026127446,0.00001896093,0.000018697256,0.000957105],"study_design_scores_gemma":[0.000056543377,0.001662691,0.9963882,0.000007566047,0.00011774395,0.00090310577,0.0003443699,0.00019136442,0.00016913704,0.000028069831,0.00012327392,0.00000798954],"about_ca_topic_score_codex":0.0011832628,"about_ca_topic_score_gemma":0.00082410517,"teacher_disagreement_score":0.0013678501,"about_ca_system_score_codex":0.00034905755,"about_ca_system_score_gemma":0.00024686847,"threshold_uncertainty_score":0.0045758486},"labels":[],"label_agreement":null},{"id":"W2559341198","doi":"10.1007/s00277-016-2878-5","title":"Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone","year":2016,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Pharmacyclics; Genentech; H. Lundbeck A/S; Baxalta; Celgene; Gilead Sciences; Servier; Astellas Pharma; TG Therapeutics; Amgen; Pfizer; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bendamustine; Rituximab; Obinutuzumab; Internal medicine; Follicular lymphoma; Quality of life (healthcare); Lymphoma; Refractory (planetary science); Oncology; Surgery","score_opus":0.0440020925305904,"score_gpt":0.34137908049744936,"score_spread":0.29737698796685896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559341198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784267,0.0015880305,0.00005667816,0.00006814709,0.00002199948,0.00012044062,0.00012234405,0.0000032765954,0.00017645574],"genre_scores_gemma":[0.99843353,0.0005813655,0.00016391044,0.00017026234,0.00004637455,0.00015971878,0.00028441634,0.0000017252943,0.00015863296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999403,0.0003852003,0.00004601865,0.00004721142,0.00004812752,0.000070425485],"domain_scores_gemma":[0.999153,0.00024990007,0.00025288196,0.000048724825,0.00003938939,0.00025603277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017992732,0.00047109602,0.001297361,0.0002472303,0.00019628837,0.0005509859,0.00036445368,0.0004876672,0.000826961],"category_scores_gemma":[0.0012627322,0.00027428698,0.0012650864,0.00031749456,0.0004051215,0.00036055053,0.00026473813,0.00093561393,0.00013225431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84637135,0.012022209,0.072903894,0.00061445264,0.004240896,0.00011943125,0.00020819726,0.0011942846,0.008245713,0.00007142061,0.00078045874,0.053227764],"study_design_scores_gemma":[0.328694,0.3914796,0.27029982,0.000083317704,0.0039439965,0.00022755268,0.00016059878,0.001616724,0.0015723447,0.00016113649,0.0017218901,0.000039042363],"about_ca_topic_score_codex":0.0006606259,"about_ca_topic_score_gemma":0.0016968005,"teacher_disagreement_score":0.0017992732,"about_ca_system_score_codex":0.0004994867,"about_ca_system_score_gemma":0.00046949784,"threshold_uncertainty_score":0.0095155835},"labels":[],"label_agreement":null},{"id":"W2566603264","doi":"10.1007/s00277-016-2898-1","title":"Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies","year":2016,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Zeaxanthin; Relative risk; Meta-analysis; Lutein; beta-Carotene; Cohort study; Confidence interval; Case-control study; Carotenoid; Oncology; Vitamin; Food science; Biology","score_opus":0.3186279458330317,"score_gpt":0.4612109199280059,"score_spread":0.14258297409497417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566603264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008087326,0.990759,0.00038245655,0.00008281811,0.00009905915,0.000102074955,0.00036511174,0.000013833697,0.00010843091],"genre_scores_gemma":[0.16138391,0.83443713,0.0019669926,0.00070230896,0.00016088151,0.0002750305,0.00075530785,0.000020027672,0.00029843947],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964869,0.0012852077,0.0011579888,0.00057026884,0.00034349933,0.00015615966],"domain_scores_gemma":[0.99289834,0.0050953794,0.0011552633,0.00029069014,0.00045144258,0.0001088808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058002966,0.0024314066,0.013095641,0.0029514537,0.00059279555,0.002207102,0.0017836934,0.002009137,0.0025872607],"category_scores_gemma":[0.014335324,0.0015995336,0.025590088,0.0044168346,0.0005756253,0.0013073687,0.0015533669,0.001898291,0.00025184144],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035298124,0.0000589131,0.008709359,0.27708656,0.69478005,0.00017262249,0.000113264105,0.00038212258,0.0004290301,0.00009159365,0.0005611056,0.01408558],"study_design_scores_gemma":[0.0005889336,0.00019517333,0.0064046583,0.008801944,0.9820234,0.00011719007,0.0000580589,0.00009945878,0.00010086993,0.00014481728,0.0014390897,0.000026334432],"about_ca_topic_score_codex":0.006496001,"about_ca_topic_score_gemma":0.017149545,"teacher_disagreement_score":0.013095641,"about_ca_system_score_codex":0.0012800004,"about_ca_system_score_gemma":0.0021059548,"threshold_uncertainty_score":0.030675232},"labels":[],"label_agreement":null},{"id":"W2571509750","doi":"10.1007/s00277-016-2901-x","title":"Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Melphalan; Oncology; Prednisone; Hematology; Proteasome inhibitor; Cyclophosphamide; Chemotherapy","score_opus":0.11059568306063669,"score_gpt":0.40846087057661845,"score_spread":0.2978651875159818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571509750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77735025,0.16564688,0.002208099,0.0050311005,0.00081293646,0.00033125636,0.0016031967,0.00020809275,0.04680813],"genre_scores_gemma":[0.9709646,0.022230357,0.0012843753,0.001575453,0.00028646266,0.00006359541,0.0010677112,0.000015935891,0.0025115425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998957,0.000029051009,0.000011067914,0.000012980822,0.00002195972,0.000029206098],"domain_scores_gemma":[0.9998528,0.00003357638,0.00004133433,0.0000063533375,0.0000110940255,0.000054781915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017215231,0.00012723652,0.000312443,0.0002003895,0.00035583548,0.0003633392,0.00016315062,0.0001651662,0.0030472714],"category_scores_gemma":[0.0004052283,0.00004621907,0.00027247553,0.00035600734,0.000100711986,0.0001750425,0.0002051166,0.00060345855,0.00036326767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014720683,0.0014080183,0.07633712,0.0023816936,0.00066121103,0.0030575064,0.00021519703,0.0012122896,0.0288647,0.0029958792,0.0281988,0.83994687],"study_design_scores_gemma":[0.008548554,0.020212807,0.59385186,0.002198782,0.0018796618,0.028167741,0.00042371903,0.0026262796,0.01693024,0.0068603507,0.31821954,0.000080452104],"about_ca_topic_score_codex":0.0005244706,"about_ca_topic_score_gemma":0.0028121702,"teacher_disagreement_score":0.0030472714,"about_ca_system_score_codex":0.00039622694,"about_ca_system_score_gemma":0.00063169154,"threshold_uncertainty_score":0.010194063},"labels":[],"label_agreement":null},{"id":"W2588271545","doi":"10.1007/s00277-017-2939-4","title":"Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Internal medicine; Hematology; Medicine; Risk stratification; Eosinophil; Oncology; Lymphocyte; Immunology","score_opus":0.032045675402761355,"score_gpt":0.297068665953835,"score_spread":0.26502299055107365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588271545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737475,0.0043681343,0.011761821,0.0015096616,0.0007798783,0.000106759755,0.0010097997,0.00020894375,0.006507452],"genre_scores_gemma":[0.99545395,0.00027215556,0.0024215863,0.00012362232,0.0005188677,0.000021367876,0.0005710038,0.000023477558,0.0005940706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967422,0.0014927188,0.00024691538,0.0005938053,0.00058132043,0.00034316228],"domain_scores_gemma":[0.99505377,0.0023010154,0.0007029399,0.000660671,0.00073437754,0.00054723874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006065445,0.0013361947,0.0012417051,0.0011621237,0.000355752,0.0019622198,0.0007981224,0.0007038762,0.0032901808],"category_scores_gemma":[0.010194344,0.00027851964,0.0014733768,0.0010000294,0.00034909596,0.0013810766,0.00094597996,0.0018206354,0.00093485834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00169077,0.00015971847,0.91826624,0.00008433766,0.000710255,0.00017720206,0.00007751182,0.0017147118,0.0017154152,0.00029090405,0.0017193787,0.07339355],"study_design_scores_gemma":[0.00034704214,0.002624922,0.92066544,0.00013171618,0.0035265204,0.0017593423,0.00022032135,0.05764916,0.002840232,0.0029862302,0.00711201,0.00013711855],"about_ca_topic_score_codex":0.0010069122,"about_ca_topic_score_gemma":0.0015359436,"teacher_disagreement_score":0.006065445,"about_ca_system_score_codex":0.0002576652,"about_ca_system_score_gemma":0.0009609295,"threshold_uncertainty_score":0.03207749},"labels":[],"label_agreement":null},{"id":"W2588699507","doi":"10.1007/s00277-017-2942-9","title":"Reallocating time to sleep, sedentary, and active behaviours in non-Hodgkin lymphoma survivors: associations with patient-reported outcomes","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Athabasca University","funders":"Cancer Council Western Australia","keywords":"Medicine; Quality of life (healthcare); Pittsburgh Sleep Quality Index; Physical therapy; Sleep (system call); Actigraphy; Physical activity; Gerontology; Internal medicine; Sleep quality; Insomnia; Circadian rhythm; Psychiatry","score_opus":0.029934169634641565,"score_gpt":0.3318507939429147,"score_spread":0.30191662430827315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588699507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913186,0.00029277272,0.00002909722,0.000059087284,0.000008533529,0.000003027449,0.00016119085,0.0000019175725,0.00031238727],"genre_scores_gemma":[0.99952006,0.00012584284,0.000028757415,0.000024235484,0.000011807445,0.000004657773,0.00013630842,9.205391e-7,0.00014748299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997702,0.0000641355,0.000030077686,0.000040222454,0.000031743897,0.00006363136],"domain_scores_gemma":[0.99886084,0.00021765396,0.0005583409,0.000045484812,0.00006914578,0.00024854043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032351603,0.00020926964,0.00021102466,0.00038600215,0.00029737694,0.0006563572,0.0002917545,0.00054782507,0.0017880251],"category_scores_gemma":[0.0017433604,0.00016373661,0.0004063757,0.00060932385,0.00021128255,0.00042439764,0.000506969,0.00080965634,0.00020629793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120165816,0.00006710705,0.9981146,0.000012615332,0.000061485,0.000022621247,0.000067572,0.000025736112,0.000080586615,0.0000052011605,0.00004650383,0.0013757615],"study_design_scores_gemma":[0.0000034855655,0.00008712435,0.9994061,0.0000049223595,0.00003096295,0.000044815024,0.00023686264,0.00008622527,0.000020427125,0.000012234477,0.00006408005,0.000002675199],"about_ca_topic_score_codex":0.0030453946,"about_ca_topic_score_gemma":0.0061063883,"teacher_disagreement_score":0.0030453946,"about_ca_system_score_codex":0.000173367,"about_ca_system_score_gemma":0.00019938246,"threshold_uncertainty_score":0.0060552955},"labels":[],"label_agreement":null},{"id":"W2595717296","doi":"10.1007/s00277-017-2971-4","title":"Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Thrombosis; Heparin; Heparin-induced thrombocytopenia; Albumin; Hematology; Retrospective cohort study; Cohort study; Serum albumin; Observational study; Prospective cohort study; Surgery; Gastroenterology","score_opus":0.310591463495562,"score_gpt":0.4218339014581348,"score_spread":0.11124243796257283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595717296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98243195,0.008731615,0.00080589444,0.003343286,0.000415936,0.000018640532,0.00033927837,0.0000376687,0.0038756505],"genre_scores_gemma":[0.99729794,0.0012813547,0.0002688301,0.00019084118,0.00052131375,0.000006024894,0.00019278383,0.0000043994314,0.00023649806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993338,0.00020999105,0.00010004378,0.00007230017,0.00016787687,0.00011600082],"domain_scores_gemma":[0.9947443,0.0022882302,0.0015347468,0.00021555905,0.00046727658,0.0007498325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010079982,0.0004541503,0.0007551127,0.0012453859,0.00045571712,0.0011577884,0.00076279853,0.0018793195,0.003976266],"category_scores_gemma":[0.0073888786,0.0002824482,0.001072856,0.001652771,0.0008730852,0.0010680717,0.0002858895,0.0018233584,0.0005706006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017168552,0.000055556047,0.9959518,0.000027343573,0.00010045606,0.0004902456,0.000013042157,0.00004921308,0.00016003507,0.000057735,0.00027678625,0.002646131],"study_design_scores_gemma":[0.0000323814,0.00040055555,0.98990285,0.00007717182,0.0005102154,0.005174156,0.00026643235,0.00184905,0.00032097386,0.0005064105,0.0009384812,0.000021328384],"about_ca_topic_score_codex":0.0011281155,"about_ca_topic_score_gemma":0.0011638713,"teacher_disagreement_score":0.003976266,"about_ca_system_score_codex":0.00020761469,"about_ca_system_score_gemma":0.0009493116,"threshold_uncertainty_score":0.013301909},"labels":[],"label_agreement":null},{"id":"W2604822177","doi":"10.1007/s00277-017-2982-1","title":"Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia","year":2017,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Ottawa Hospital; BC Cancer Agency; Université Laval; University of Calgary; McGill University Health Centre","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Medicine; Fludarabine; Venetoclax; Idelalisib; Chronic lymphocytic leukemia; Alemtuzumab; Rituximab; Oncology; Internal medicine; Hematology; Cyclophosphamide; Salvage therapy; Transplantation; Leukemia; Immunology; Lymphoma; Chemotherapy","score_opus":0.18479468047227215,"score_gpt":0.4725117241757338,"score_spread":0.28771704370346163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604822177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086021675,0.99883264,0.000047482084,0.00017073618,0.00013476735,0.0000033830788,0.000011884363,0.0000041853723,0.000708904],"genre_scores_gemma":[0.00051067834,0.9988601,0.000088596425,0.00014838723,0.00013121065,0.0000035550613,0.000023174749,9.822257e-7,0.00023335907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997396,0.00004966819,0.00004746292,0.00004176661,0.00009808749,0.000023452956],"domain_scores_gemma":[0.9996724,0.00016645617,0.000047130383,0.000010507869,0.000076772034,0.00002684202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006404174,0.00059313973,0.0012037514,0.0021006605,0.0002869244,0.0008214391,0.00086968346,0.00077331864,0.003992009],"category_scores_gemma":[0.00090962864,0.00019740305,0.000668344,0.0014032786,0.0003777328,0.001029592,0.00055612467,0.001818768,0.0016604917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059487134,0.000063821535,0.00015948714,0.018063491,0.00008361674,0.0001885418,0.00005676567,0.00021280581,0.0008475336,0.002220446,0.02504846,0.95299554],"study_design_scores_gemma":[0.000020668947,0.00008843219,0.0006645176,0.0049040834,0.00011565962,0.0014615386,0.000043460215,0.000046481142,0.00023523136,0.0013042686,0.99110246,0.000013196988],"about_ca_topic_score_codex":0.0009535072,"about_ca_topic_score_gemma":0.0016739442,"teacher_disagreement_score":0.003992009,"about_ca_system_score_codex":0.00048122066,"about_ca_system_score_gemma":0.00087813527,"threshold_uncertainty_score":0.013354659},"labels":[],"label_agreement":null},{"id":"W2613332598","doi":"10.1007/s00277-017-2993-y","title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"Macrophage activation syndrome; Hemophagocytic lymphohistiocytosis; Medicine; Immunology; Internal medicine; Disease; Cytokine; Hematology; Biomarker; Biology","score_opus":0.2193641589571862,"score_gpt":0.48992383728019084,"score_spread":0.27055967832300465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613332598","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017901747,0.99718434,0.00011953401,0.00018515254,0.00008966551,0.00014970463,0.00028679584,0.000004912091,0.0001896735],"genre_scores_gemma":[0.0443761,0.95321757,0.00073219836,0.00081178086,0.00011875421,0.00030929872,0.00033662096,0.0000063606662,0.00009127658],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925557,0.0018346796,0.0037527964,0.00069727725,0.00094910996,0.00021051652],"domain_scores_gemma":[0.96755475,0.024293458,0.0056097587,0.0004547895,0.0018222705,0.00026498825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010152283,0.0012495386,0.008413435,0.008914172,0.000522129,0.0029706468,0.001874262,0.002453098,0.0024387273],"category_scores_gemma":[0.04026585,0.0011465887,0.009382745,0.007031288,0.0011217705,0.0024375732,0.0017660208,0.0013856487,0.00021974857],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005698678,0.000028719218,0.0053798314,0.9060477,0.04504833,0.00018992956,0.00031347317,0.00017560086,0.00032524104,0.00025488736,0.0013807402,0.04028574],"study_design_scores_gemma":[0.00064273446,0.0002827119,0.012490785,0.6800414,0.2926247,0.0005981022,0.00041109318,0.00018874764,0.00021158297,0.0002836877,0.01215327,0.00007117072],"about_ca_topic_score_codex":0.0076654973,"about_ca_topic_score_gemma":0.025304858,"teacher_disagreement_score":0.010152283,"about_ca_system_score_codex":0.00266476,"about_ca_system_score_gemma":0.00817588,"threshold_uncertainty_score":0.05369103},"labels":[],"label_agreement":null},{"id":"W2622715670","doi":"10.1007/s00277-017-3042-6","title":"Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Acute promyelocytic leukemia; Internal medicine; Hematology; Chemotherapy; Medicine; Oncology; Leukemia; Genetics; Biology; Retinoic acid","score_opus":0.008030338388067828,"score_gpt":0.25204329912590395,"score_spread":0.24401296073783613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622715670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905115,0.00036380297,0.000027659717,0.00004673058,0.000006103079,0.000003254137,0.0001265833,0.0000018106094,0.00037287062],"genre_scores_gemma":[0.99954104,0.000172218,0.00003116442,0.0000146381935,0.00001116941,0.000003463172,0.00014827216,0.0000010961373,0.00007700274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980944,0.00004985846,0.00002469722,0.00002645272,0.000032908323,0.000056728433],"domain_scores_gemma":[0.99887806,0.00033807976,0.00042235717,0.00002911428,0.00006885874,0.00026358146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021428007,0.00017032264,0.00033859623,0.0005520799,0.00030514813,0.00053641235,0.00023519165,0.00042898045,0.0014194538],"category_scores_gemma":[0.0015864997,0.00018819698,0.0003613342,0.00085236813,0.0002765795,0.00035249387,0.00028726817,0.0008501379,0.00013466441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008919162,0.000015653908,0.9991315,0.000003409215,0.000012260276,0.00019429551,0.000027221166,0.000026307102,0.00004780708,0.000012027315,0.00003148998,0.0004088476],"study_design_scores_gemma":[0.000009063185,0.00012572328,0.9976463,0.00000855711,0.000041059287,0.0013799998,0.0003416436,0.00015721151,0.00006612615,0.000026477275,0.00019486726,0.0000029039204],"about_ca_topic_score_codex":0.0025309478,"about_ca_topic_score_gemma":0.0028199165,"teacher_disagreement_score":0.0025309478,"about_ca_system_score_codex":0.00029923467,"about_ca_system_score_gemma":0.00052916416,"threshold_uncertainty_score":0.00503242},"labels":[],"label_agreement":null},{"id":"W2744846745","doi":"10.1007/s00277-017-3082-y","title":"The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation; Incyte; Ariad Pharmaceuticals","keywords":"Medicine; Quality of life (healthcare); Myelofibrosis; Disease; Essential thrombocythemia; Polycythemia vera; Myeloproliferative neoplasm; Disease burden; Physical therapy; Internal medicine; Family medicine; Bone marrow","score_opus":0.12870162063342272,"score_gpt":0.4048097733120325,"score_spread":0.2761081526786098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744846745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970795,0.0003475651,0.00006901594,0.00015968726,0.0000075509042,0.000040347084,0.0014031046,0.000005163274,0.0008881355],"genre_scores_gemma":[0.99840623,0.00020416897,0.00012334678,0.00008344636,0.000008647453,0.000034460023,0.0010191972,0.000001449496,0.00011900034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999076,0.0003807808,0.00013882783,0.00007544988,0.00021502117,0.0001138652],"domain_scores_gemma":[0.9963372,0.0007575667,0.0016031708,0.00010279661,0.0004822469,0.00071700354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018267384,0.00018675656,0.0002880627,0.0008562746,0.00022744724,0.00039822294,0.00025775243,0.00029410463,0.00059190916],"category_scores_gemma":[0.0051665646,0.000094428935,0.0004653297,0.0009824408,0.00021755126,0.00043469493,0.0007559497,0.00041258588,0.00013519476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072097726,0.00006836577,0.9951148,0.000028605698,0.0000465134,0.000024923482,0.00018832483,0.00010424923,0.000049084854,0.000010075271,0.00043090188,0.0038619998],"study_design_scores_gemma":[0.0000076247798,0.00012572091,0.9990546,0.00000895681,0.000014098649,0.000044537064,0.00022786358,0.00013104324,0.000020289086,0.0000059679787,0.00035555806,0.0000038013877],"about_ca_topic_score_codex":0.0045922506,"about_ca_topic_score_gemma":0.006703571,"teacher_disagreement_score":0.0045922506,"about_ca_system_score_codex":0.00052900653,"about_ca_system_score_gemma":0.00030036567,"threshold_uncertainty_score":0.00966078},"labels":[],"label_agreement":null},{"id":"W2747688448","doi":"10.1007/s00277-017-3097-4","title":"Return to work and work-related disability among AML survivors","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Sick leave; Medicine; Hematology; Myeloid leukemia; Productivity; Transplantation; Work productivity; Internal medicine; Gerontology; Physical therapy","score_opus":0.05535312647928641,"score_gpt":0.3657163758760145,"score_spread":0.3103632493967281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747688448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853075,0.00027156106,0.000019450776,0.00016470696,0.0000143158095,0.0000057681355,0.0002738601,0.000002039675,0.0007174875],"genre_scores_gemma":[0.9991503,0.00012667208,0.000010188929,0.000049882976,0.000016565447,0.0000046196305,0.0002747541,0.0000010521582,0.00036607162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994696,0.0000985816,0.000064164604,0.000058291746,0.00008806132,0.00022129706],"domain_scores_gemma":[0.99864167,0.0001284435,0.0005402807,0.00004784502,0.000116729745,0.00052499864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040830363,0.00022296607,0.0003221913,0.0010608202,0.0008484853,0.0010867812,0.00049549673,0.00063635554,0.0030590857],"category_scores_gemma":[0.0024729383,0.00021093716,0.0006159331,0.0011077225,0.00036750967,0.000791073,0.0011898596,0.000965078,0.0004505412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006285609,0.000062285035,0.99844474,0.0000056545396,0.000024808258,0.00004579983,0.000095211384,0.00001974694,0.00003488347,0.000011461898,0.0001055753,0.001086975],"study_design_scores_gemma":[0.000003302446,0.000058727146,0.99867684,0.000009959226,0.000018530158,0.00008852055,0.0008621147,0.000045597382,0.000014079173,0.00002639893,0.00019238672,0.000003447832],"about_ca_topic_score_codex":0.011583437,"about_ca_topic_score_gemma":0.014573995,"teacher_disagreement_score":0.011583437,"about_ca_system_score_codex":0.0004723688,"about_ca_system_score_gemma":0.00066102744,"threshold_uncertainty_score":0.02303207},"labels":[],"label_agreement":null},{"id":"W2751224213","doi":"10.1007/s00277-017-3122-7","title":"Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Thalassemia; Hematology; Medicine; Quality of life (healthcare); Internal medicine; Blood transfusion; Nursing","score_opus":0.13995138521379055,"score_gpt":0.38230641291785555,"score_spread":0.242355027704065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751224213","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321836,0.0006594605,0.0013901683,0.00031809637,0.00007328576,0.00035000194,0.0010660291,0.000019280209,0.0029053618],"genre_scores_gemma":[0.99372053,0.0003762495,0.0035645273,0.00014149472,0.000027061766,0.00037145242,0.0010756709,0.000011077355,0.0007120045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987142,0.0005892997,0.00021292186,0.00008308643,0.00029954177,0.000100953104],"domain_scores_gemma":[0.997218,0.00091166777,0.0008792728,0.00010188353,0.000599501,0.0002896792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026020713,0.00040033524,0.00058385584,0.0009028436,0.00029956436,0.0008142941,0.00036151495,0.00045237064,0.0015319611],"category_scores_gemma":[0.0067384057,0.000119644195,0.0010660554,0.0006312997,0.00033851343,0.00075213914,0.0011389761,0.0007036384,0.00022008721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002105257,0.0011359133,0.83204615,0.00058432115,0.0007623158,0.0003076893,0.002683444,0.0022780434,0.002957012,0.0011120227,0.0039650276,0.15006274],"study_design_scores_gemma":[0.00032298078,0.0029104801,0.97904485,0.000272078,0.00034902638,0.0009991865,0.0024268487,0.005775251,0.0013843112,0.0006800183,0.005767331,0.000067641784],"about_ca_topic_score_codex":0.00103982,"about_ca_topic_score_gemma":0.0011813055,"teacher_disagreement_score":0.0026020713,"about_ca_system_score_codex":0.00072255987,"about_ca_system_score_gemma":0.0007668114,"threshold_uncertainty_score":0.013761222},"labels":[],"label_agreement":null},{"id":"W2762936931","doi":"10.1007/s00277-017-3137-0","title":"A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry","year":2017,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Queen Elizabeth II Health Sciences Centre; McGill University Health Centre; University of Ottawa; Hamilton Health Sciences; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Alberta Hospital Edmonton; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; University Health Network; Health Sciences Centre; University of Alberta Hospital; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Toronto; Jewish General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Manitoba","funders":"Celgene","keywords":"Medicine; Internal medicine; International Prognostic Scoring System; Erythropoietin; Multivariate analysis; Cohort; Univariate analysis; Univariate; Multivariate statistics; Myelodysplastic syndromes","score_opus":0.09251550070832838,"score_gpt":0.37531389489247513,"score_spread":0.28279839418414676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762936931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93766594,0.0011479666,0.002020213,0.0030758323,0.00006194177,0.00016788999,0.05147869,0.00012319813,0.004258394],"genre_scores_gemma":[0.9697342,0.00062714744,0.0017547469,0.00016708109,0.000039643706,0.000067080415,0.026611105,0.000025032725,0.0009739334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998828,0.00029200537,0.000087487315,0.00021137905,0.00030203004,0.00027896982],"domain_scores_gemma":[0.9918926,0.0032805796,0.0009249365,0.00073404243,0.0025422357,0.00062564044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042334003,0.0006667887,0.00082715217,0.0018631696,0.0012495304,0.0016002915,0.0019307663,0.0006221502,0.003662539],"category_scores_gemma":[0.01768945,0.00037310887,0.0011425621,0.0033932822,0.00045514706,0.000577631,0.00079250097,0.0013573517,0.00056362856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045582722,0.00008257039,0.9618859,0.00006436073,0.00034123086,0.00014997207,0.0001994785,0.010420475,0.00010763408,0.0010199238,0.013027146,0.012245403],"study_design_scores_gemma":[0.00027147867,0.00010938468,0.8312269,0.00019942621,0.0011410294,0.00043038695,0.0009429885,0.14694293,0.00027997,0.0017454601,0.01660933,0.00010079218],"about_ca_topic_score_codex":0.93723863,"about_ca_topic_score_gemma":0.93169713,"teacher_disagreement_score":0.06276137,"about_ca_system_score_codex":0.0092845345,"about_ca_system_score_gemma":0.024198871,"threshold_uncertainty_score":0.12626189},"labels":[],"label_agreement":null},{"id":"W2791855937","doi":"10.1007/s00277-018-3285-x","title":"Unmet supportive care needs of haematological cancer survivors: rural versus urban residents","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Waterloo","funders":"Beyond Blue; Cancer Australia","keywords":"Rurality; Medicine; Anxiety; Family medicine; Survivorship curve; Rural area; Gerontology; Cancer; Psychiatry; Internal medicine","score_opus":0.06293426320068421,"score_gpt":0.3768549380855918,"score_spread":0.3139206748849076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791855937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928683,0.000094857016,0.0000127816,0.00014180003,0.0000036526003,0.000003630077,0.00007610419,4.5335926e-7,0.00037994442],"genre_scores_gemma":[0.99960595,0.00008136159,0.000013653853,0.000041259696,0.000007942401,0.000004867011,0.00007202575,5.83428e-7,0.00017230016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975616,0.00006453285,0.000018090908,0.000029157609,0.000031794225,0.00010026022],"domain_scores_gemma":[0.9994485,0.00006986555,0.00018759466,0.0000072570533,0.00006373123,0.00022305842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023889789,0.0001357246,0.00021261186,0.00047470696,0.00054226455,0.0005543517,0.00019271657,0.00033401258,0.0032865019],"category_scores_gemma":[0.0016499872,0.0001233033,0.00020624835,0.000641812,0.00029458053,0.0006648242,0.00076169334,0.00033225058,0.00020592414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043904193,0.00017225526,0.9824064,0.000058932816,0.000046746176,0.00029266923,0.0055822236,0.00006551736,0.0005139871,0.00012267167,0.00058409304,0.009715541],"study_design_scores_gemma":[0.000015935007,0.00032029525,0.9658057,0.000030261894,0.000025459702,0.0003941518,0.03233187,0.00018138133,0.000059075504,0.00011894075,0.00070805714,0.000008810989],"about_ca_topic_score_codex":0.011251995,"about_ca_topic_score_gemma":0.022447277,"teacher_disagreement_score":0.011251995,"about_ca_system_score_codex":0.00034918368,"about_ca_system_score_gemma":0.0004860802,"threshold_uncertainty_score":0.022372961},"labels":[],"label_agreement":null},{"id":"W2792374337","doi":"10.1007/s00277-018-3260-6","title":"Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Internal medicine; Myeloid leukemia; Core binding factor; Hematology; Oncology; Genotype; Medicine; Biology; Gastroenterology; Genetics; Gene; Transcription factor","score_opus":0.08397813695239313,"score_gpt":0.359400887521034,"score_spread":0.27542275056864085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792374337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97307825,0.00054976426,0.019095054,0.0013733093,0.00007234668,0.000046485933,0.004757502,0.0001970392,0.00083004],"genre_scores_gemma":[0.9923603,0.0001300071,0.0019491826,0.000096104166,0.00003797868,0.000047984286,0.0031834708,0.00002021211,0.002174846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928266,0.00027097078,0.000030469533,0.000252104,0.00003870264,0.00012503282],"domain_scores_gemma":[0.998351,0.001104155,0.0001705497,0.00013050088,0.00011201704,0.00013188113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021944311,0.0007482879,0.0013197159,0.0007633774,0.00045205376,0.0011515756,0.0014067207,0.0011022582,0.004854846],"category_scores_gemma":[0.0039367476,0.0003896841,0.0018350423,0.00073706394,0.00038584374,0.00045905248,0.0006255786,0.0014238104,0.00071496016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003924833,0.0005211402,0.7377945,0.000085734806,0.0023560375,0.00088141183,0.00022855161,0.2099549,0.0019666234,0.004307122,0.004991855,0.032987177],"study_design_scores_gemma":[0.00024654984,0.00032751088,0.12523186,0.000032269938,0.0010045765,0.00040137055,0.00016359075,0.86549634,0.00034025178,0.005620707,0.0010767238,0.000058169535],"about_ca_topic_score_codex":0.017653259,"about_ca_topic_score_gemma":0.0113573875,"teacher_disagreement_score":0.017653259,"about_ca_system_score_codex":0.0006382786,"about_ca_system_score_gemma":0.0011234569,"threshold_uncertainty_score":0.035100996},"labels":[],"label_agreement":null},{"id":"W2802200411","doi":"10.1007/s00277-018-3352-3","title":"Bilateral adrenal hemorrhage as a manifestation of extramedullary hematopoiesis in a patient with primary myelofibrosis","year":2018,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba","funders":"","keywords":"Myelofibrosis; Extramedullary hematopoiesis; Medicine; Hematology; Haematopoiesis; Internal medicine; General surgery; Pathology; Bone marrow; Stem cell; Biology","score_opus":0.025721789281286253,"score_gpt":0.28750729572604655,"score_spread":0.2617855064447603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802200411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79168326,0.019501925,0.004631903,0.11031576,0.007264173,0.00038052574,0.0008163863,0.0006911596,0.064714774],"genre_scores_gemma":[0.96957535,0.0031077708,0.001815096,0.009985732,0.012989987,0.00003226874,0.0001653907,0.00004842107,0.0022799429],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99918836,0.0001473098,0.00010777887,0.00015404006,0.0001755802,0.0002269476],"domain_scores_gemma":[0.9966928,0.0015192669,0.00037163057,0.000197482,0.00021830495,0.0010005949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062213535,0.0013974573,0.0012749776,0.0020656087,0.0019872691,0.0018551853,0.0016514348,0.009785128,0.002733651],"category_scores_gemma":[0.0073155994,0.0010623098,0.0014305462,0.0012256129,0.0017879988,0.0023209122,0.0012971967,0.0069498513,0.0009944822],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004412151,0.00002283534,0.0033810218,0.000026633084,0.0000058688584,0.9943658,0.000044065666,0.000051891646,0.00022515545,0.00018571917,0.000958095,0.00068885443],"study_design_scores_gemma":[0.000050602805,0.000067654335,0.004139071,0.000035650613,0.000021961443,0.9930727,0.00010188908,0.0005289057,0.00030212066,0.000462595,0.0012053233,0.000011638867],"about_ca_topic_score_codex":0.0020667256,"about_ca_topic_score_gemma":0.0024307163,"teacher_disagreement_score":0.009785128,"about_ca_system_score_codex":0.0023395158,"about_ca_system_score_gemma":0.001289803,"threshold_uncertainty_score":0.01697445},"labels":[],"label_agreement":null},{"id":"W2802917867","doi":"10.1007/s00277-018-3356-z","title":"Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; March of Dimes Canada; Université Laval; Centre hospitalier universitaire de Québec","funders":"Universität Wien; Medizinische Universität Wien; European Commission; Canadian Institutes of Health Research; European Hematology Association; Université Laval","keywords":"Internal medicine; Hormone; Endocrinology; Testosterone (patch); Chronic lymphocytic leukemia; Luteinizing hormone; Dihydrotestosterone; Medicine; Hazard ratio; Sex hormone-binding globulin; Sex steroid; Estrogen; Hydroxysteroid; Androgen; Biology; Leukemia; Steroid; Enzyme; Dehydrogenase; Confidence interval","score_opus":0.03279791246085099,"score_gpt":0.3156505967715258,"score_spread":0.2828526843106748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802917867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989322,0.0005823394,0.00004065855,0.000016244903,0.000003187246,0.0000016767534,0.00017489752,0.000002846881,0.00024587306],"genre_scores_gemma":[0.99968433,0.000064095686,0.000013006899,0.000006870129,0.0000054941897,0.0000015962416,0.00016193917,8.223294e-7,0.00006179361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998116,0.00004656113,0.000021458713,0.000036472436,0.000031954914,0.000051985513],"domain_scores_gemma":[0.9990594,0.00027719772,0.00036887912,0.000059189362,0.000067642024,0.00016778421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033466026,0.00013581858,0.00023540095,0.00045235487,0.00017669542,0.00033459486,0.00011416864,0.00020638035,0.0011451375],"category_scores_gemma":[0.001144204,0.0000811677,0.00024939486,0.000488019,0.00018510905,0.0002167058,0.00020278615,0.00026220107,0.00012332188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050309766,0.000010276216,0.99663574,0.000005393575,0.00003468346,0.0000429772,0.000023587976,0.00003691524,0.00042006825,0.000007718207,0.000032743977,0.0022467144],"study_design_scores_gemma":[0.000008608827,0.000101578444,0.9993376,0.000001629558,0.000020239826,0.00018626616,0.000036872414,0.00008530204,0.00007684315,0.000017186721,0.0001257967,0.0000020182263],"about_ca_topic_score_codex":0.0012279243,"about_ca_topic_score_gemma":0.0013680969,"teacher_disagreement_score":0.0012279243,"about_ca_system_score_codex":0.00018252926,"about_ca_system_score_gemma":0.00014456612,"threshold_uncertainty_score":0.0038308501},"labels":[],"label_agreement":null},{"id":"W2803346692","doi":"10.1007/s00277-018-3372-z","title":"Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia","year":2018,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Novo Nordisk","keywords":"Medicine; Haemophilia; Meta-analysis; Haemophilia A; Recombinant factor VIIa; Adverse effect; Bleed; MEDLINE; Clinical trial; Internal medicine; Surgery","score_opus":0.13387969742315833,"score_gpt":0.4438102280963706,"score_spread":0.3099305306732123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803346692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090510707,0.99281996,0.00044877038,0.0045466004,0.00055002666,0.00025193492,0.00020268362,0.000012606431,0.00026229757],"genre_scores_gemma":[0.043163728,0.9369136,0.0052127275,0.011370679,0.0013434988,0.0013587244,0.00043469045,0.00003460872,0.00016772903],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.89404416,0.05616168,0.03558643,0.0035856918,0.009756397,0.00086570246],"domain_scores_gemma":[0.6036746,0.3093853,0.04331099,0.00779195,0.033795968,0.0020411052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10588969,0.0022557664,0.013757433,0.017030383,0.00072320946,0.006013586,0.0031186545,0.0048312233,0.0041064117],"category_scores_gemma":[0.31758252,0.0018409007,0.009732666,0.015101701,0.0022332699,0.007075709,0.002772426,0.0030503355,0.00053619564],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034760634,0.000025687568,0.0014809712,0.901751,0.038174905,0.00028977473,0.00060020736,0.00025177866,0.00020884155,0.0010198295,0.0052025793,0.050646838],"study_design_scores_gemma":[0.0004119217,0.00019134911,0.0025504692,0.91062593,0.066976674,0.00026493406,0.0004979369,0.00015509158,0.00013244043,0.0021093057,0.016026683,0.000057198333],"about_ca_topic_score_codex":0.0073746094,"about_ca_topic_score_gemma":0.0246294,"teacher_disagreement_score":0.10588969,"about_ca_system_score_codex":0.007305959,"about_ca_system_score_gemma":0.021495586,"threshold_uncertainty_score":0.56000495},"labels":[],"label_agreement":null},{"id":"W2803381821","doi":"10.1007/s00277-018-3365-y","title":"Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis","keywords":"Ruxolitinib; Medicine; Hematocrit; Polycythemia vera; Internal medicine; Hematology; Anemia; Myelofibrosis; Surgery; Bone marrow","score_opus":0.12358916082952978,"score_gpt":0.3813806818075789,"score_spread":0.25779152097804914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803381821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836338,0.008488672,0.0007464989,0.0007468991,0.00017712076,0.0011069245,0.0017568166,0.0001603879,0.003182877],"genre_scores_gemma":[0.98928237,0.0020933978,0.00079223636,0.0014017523,0.00019509169,0.0010978049,0.0029297671,0.000026464098,0.002181152],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994388,0.00025519566,0.00003217536,0.00006415014,0.00007374305,0.00013590614],"domain_scores_gemma":[0.99913186,0.0002044388,0.00022448605,0.00010029818,0.000057603436,0.00028127205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025838471,0.0006731029,0.0015714953,0.0002927467,0.0004234183,0.0009599888,0.00053300144,0.0011485115,0.0020066097],"category_scores_gemma":[0.0014730232,0.00023282108,0.0012646622,0.00031332296,0.0003133705,0.0006302119,0.00030662696,0.0024527025,0.0005557219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67568046,0.021350436,0.0168628,0.001411943,0.0033637416,0.00086927443,0.0002721538,0.0028917142,0.02586852,0.0005183302,0.013523119,0.23738746],"study_design_scores_gemma":[0.7133426,0.20089851,0.06478245,0.00025638865,0.0017624148,0.0011836673,0.00007934948,0.0037658538,0.0039822767,0.0006737454,0.0092109665,0.0000618551],"about_ca_topic_score_codex":0.00044091506,"about_ca_topic_score_gemma":0.0013247493,"teacher_disagreement_score":0.0025838471,"about_ca_system_score_codex":0.00042704403,"about_ca_system_score_gemma":0.00043069338,"threshold_uncertainty_score":0.013664842},"labels":[],"label_agreement":null},{"id":"W2804451704","doi":"10.1007/s00277-018-3367-9","title":"Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Major Research Plan; National Natural Science Foundation of China; European Hematology Association","keywords":"Medicine; Internal medicine; Platelet; Retrospective cohort study; Prednisone; Risk factor; Hematology; Immune thrombocytopenia; Cohort; Platelet transfusion; Immunology; Gastroenterology","score_opus":0.02489270892865694,"score_gpt":0.32629588850448404,"score_spread":0.30140317957582713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804451704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790394,0.0014368444,0.00011700951,0.000018129313,0.0000056152667,0.000022183156,0.00014461525,0.0000023785747,0.00034939934],"genre_scores_gemma":[0.99931514,0.00030904426,0.000060460083,0.000017554712,0.000019759573,0.000018287188,0.00020547402,0.000001191439,0.00005308192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931,0.00017670698,0.00013133373,0.0001593994,0.00014482219,0.0000777551],"domain_scores_gemma":[0.9981522,0.0005561662,0.00072866323,0.0001690688,0.00017971227,0.00021413079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081501214,0.00019750284,0.00055022363,0.0009932095,0.0002911096,0.0004838615,0.00020686067,0.00035638834,0.0013260318],"category_scores_gemma":[0.0020204864,0.0002490463,0.00053991406,0.0009933008,0.00030190108,0.00034257045,0.00030526248,0.0003914062,0.00019936534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002903867,0.000033167078,0.99799806,0.000025215777,0.00006100784,0.00021735711,0.000027039656,0.000022150958,0.000081431375,0.000012673667,0.00004250026,0.0011890967],"study_design_scores_gemma":[0.000041215346,0.0007430099,0.9946338,0.000022483682,0.00016542648,0.0034167927,0.0001708275,0.00019497542,0.00012677677,0.000028984823,0.00044750722,0.000008218375],"about_ca_topic_score_codex":0.00066103565,"about_ca_topic_score_gemma":0.00045749164,"teacher_disagreement_score":0.0013260318,"about_ca_system_score_codex":0.00022374082,"about_ca_system_score_gemma":0.00031465807,"threshold_uncertainty_score":0.004436016},"labels":[],"label_agreement":null},{"id":"W2806601531","doi":"10.1007/s00277-018-3371-0","title":"The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Dalhousie University; Izaak Walton Killam Health Centre","funders":"IWK Health Centre; Public Health Agency of Canada","keywords":"Medicine; Internal medicine; Cohort; Hematology; Sarcoma; Population; Cancer; Pediatric cancer; Oncology; Proportional hazards model; Cohort study; Surgical oncology; Pathology","score_opus":0.019040008664639063,"score_gpt":0.31592493887685713,"score_spread":0.29688493021221807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806601531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993174,0.00013747913,0.000061313665,0.000031257776,0.0000035590028,0.0000049610508,0.00031405155,0.0000023504895,0.00012755026],"genre_scores_gemma":[0.99930906,0.00017365592,0.00006646073,0.000017798397,0.000006588297,0.000007761912,0.00035958397,0.0000024463193,0.0000566788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938834,0.00013046718,0.00006227408,0.00018985648,0.00009961196,0.00012938953],"domain_scores_gemma":[0.9989268,0.00015268492,0.0004458421,0.00013420482,0.00012302601,0.0002173667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005317377,0.00040392068,0.00056263775,0.0009423816,0.0006278866,0.00087580475,0.00045174966,0.00057946483,0.00114485],"category_scores_gemma":[0.0016807169,0.00051047973,0.0009236068,0.0017471329,0.0003762455,0.0009030552,0.0005764697,0.0009949607,0.0001731019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000518125,0.00002346114,0.9991934,0.0000029371952,0.000075489115,0.00008137798,0.000048465456,0.00002043396,0.00009872688,0.000011093625,0.00005534491,0.000337423],"study_design_scores_gemma":[0.000007047518,0.00009287083,0.9989066,0.0000038206163,0.000058661106,0.00044389043,0.00022426834,0.00011096763,0.0000330478,0.000013123196,0.00010216521,0.0000035534506],"about_ca_topic_score_codex":0.009548561,"about_ca_topic_score_gemma":0.009117841,"teacher_disagreement_score":0.009548561,"about_ca_system_score_codex":0.00052658294,"about_ca_system_score_gemma":0.000654506,"threshold_uncertainty_score":0.018985987},"labels":[],"label_agreement":null},{"id":"W2808070896","doi":"10.1007/s00277-018-3391-9","title":"Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fludarabine; Busulfan; Internal medicine; Cumulative incidence; Univariate analysis; Myeloid leukemia; Regimen; Myeloid; Gastroenterology; Transplantation; Hematopoietic stem cell transplantation; Hematology; Total body irradiation; Surgery; Oncology; Chemotherapy; Cyclophosphamide; Multivariate analysis","score_opus":0.02724184897063517,"score_gpt":0.29508013721496223,"score_spread":0.2678382882443271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808070896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958988,0.0031970274,0.000051416297,0.00022799954,0.000061995765,0.00001486263,0.000038762046,0.0000036558408,0.0005054353],"genre_scores_gemma":[0.9984139,0.0009670002,0.0001122171,0.0001774416,0.000089767345,0.000011224691,0.00007463026,0.0000010318086,0.00015267158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998921,0.000038407106,0.000016138898,0.000013365792,0.000016655807,0.00002328767],"domain_scores_gemma":[0.9998036,0.00004817814,0.0000413401,0.0000052708324,0.000008020628,0.00009366067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029555868,0.00017647201,0.00045831705,0.00016006555,0.00019520137,0.00023504505,0.00015463136,0.0003068849,0.00068563246],"category_scores_gemma":[0.0009695284,0.00008824391,0.00033774672,0.00023816038,0.00013754927,0.0002551134,0.0001565481,0.0004623468,0.0000580571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12855737,0.0033698669,0.5863342,0.0005647441,0.0009678551,0.0032967743,0.00052807276,0.0026695493,0.01536609,0.00046897805,0.0037097484,0.25416666],"study_design_scores_gemma":[0.005017849,0.033663675,0.94366395,0.00019800113,0.0015784875,0.0037459417,0.00068542536,0.0020808512,0.001882298,0.0004757629,0.006967334,0.000040446055],"about_ca_topic_score_codex":0.0010992069,"about_ca_topic_score_gemma":0.0039119874,"teacher_disagreement_score":0.0010992069,"about_ca_system_score_codex":0.0003084342,"about_ca_system_score_gemma":0.00048713916,"threshold_uncertainty_score":0.0022936463},"labels":[],"label_agreement":null},{"id":"W2810028745","doi":"10.1007/s00277-018-3394-6","title":"Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study","year":2018,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Venous thromboembolism; Hematology; Internal medicine; Cohort; Cohort study; Oncology; Cancer; Population; Thrombosis; Environmental health","score_opus":0.01789833175410305,"score_gpt":0.31071538213597283,"score_spread":0.2928170503818698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810028745","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016924246,0.0007549044,0.00026422858,0.046863798,0.9495237,0.000027389182,0.0015671137,0.00010050932,0.00072920823],"genre_scores_gemma":[0.019841483,0.01025184,0.004394568,0.12853274,0.73355395,0.0005488296,0.0061881663,0.0013383733,0.095350094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932294,0.0014813489,0.0016858435,0.0010006034,0.0019728802,0.0006298876],"domain_scores_gemma":[0.9473382,0.014697798,0.0040707993,0.002634391,0.028348275,0.0029104098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066705174,0.0025743907,0.002361528,0.0038323689,0.0023009246,0.0039534145,0.0040494273,0.005503644,0.04018581],"category_scores_gemma":[0.10289755,0.0015774717,0.0021847747,0.0031253311,0.001747968,0.0021001466,0.0016079389,0.011312287,0.016539551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048387803,0.000007995963,0.0003803111,0.00017933693,0.000034368386,0.00022794728,0.000023220951,0.000033388842,0.000016248772,0.00024918467,0.99609226,0.0027072045],"study_design_scores_gemma":[0.000364867,0.00006304105,0.006631511,0.0019098094,0.00028720626,0.0017231137,0.00027471202,0.0006069816,0.0004134179,0.0014266314,0.98617655,0.00012215583],"about_ca_topic_score_codex":0.01922991,"about_ca_topic_score_gemma":0.021180032,"teacher_disagreement_score":0.04018581,"about_ca_system_score_codex":0.0040438906,"about_ca_system_score_gemma":0.0076716295,"threshold_uncertainty_score":0.13443494},"labels":[],"label_agreement":null},{"id":"W2836641641","doi":"10.1007/s00277-018-3422-6","title":"Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"LEO Pharma; McMaster University","keywords":"Argatroban; Fondaparinux; Medicine; Heparin-induced thrombocytopenia; Retrospective cohort study; Heparin; Anticoagulant; Internal medicine; Surgery; Anesthesia; Thrombosis; Platelet","score_opus":0.08893455261505184,"score_gpt":0.3838631015821317,"score_spread":0.2949285489670799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2836641641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96043235,0.035647914,0.00035145355,0.000880468,0.00038005647,0.00009882262,0.00016620135,0.000020833333,0.0020221071],"genre_scores_gemma":[0.9912826,0.006852103,0.00055294484,0.00038303545,0.00045289638,0.00006090879,0.00019843437,0.0000058510236,0.00021130705],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99875844,0.0006394449,0.00020652854,0.00013460747,0.00016606877,0.00009485497],"domain_scores_gemma":[0.9981305,0.0010172155,0.0003182991,0.000053839183,0.0000716547,0.0004085837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013569826,0.0005559537,0.0029354917,0.00049551326,0.00022862328,0.0008289531,0.0006309746,0.0009818139,0.0014750831],"category_scores_gemma":[0.003953668,0.00024328224,0.0014583381,0.00043693458,0.0004581777,0.0011757654,0.00032253333,0.0019181499,0.00019554731],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7805146,0.004347838,0.020031057,0.0015092255,0.0038726623,0.000802965,0.00019437874,0.001523638,0.004431532,0.0005339136,0.00092488824,0.18131328],"study_design_scores_gemma":[0.39806062,0.3632118,0.20121865,0.0011322163,0.010815765,0.0038372998,0.0007326689,0.007773214,0.0030170658,0.0013977812,0.008581618,0.00022124],"about_ca_topic_score_codex":0.0004019216,"about_ca_topic_score_gemma":0.0010469935,"teacher_disagreement_score":0.0029354917,"about_ca_system_score_codex":0.0006333937,"about_ca_system_score_gemma":0.00078152434,"threshold_uncertainty_score":0.0071765184},"labels":[],"label_agreement":null},{"id":"W2893687383","doi":"10.1007/s00277-018-3504-5","title":"Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia","year":2018,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Internet portal; Haemophilia; Medicine; Impact factor; Recombinant factor VIIa; Recombinant DNA; Haemophilia A; Meta-analysis; Internal medicine; Surgery; The Internet; World Wide Web; Computer science; Political science; Biology; Law; Genetics","score_opus":0.05579959509173528,"score_gpt":0.38618447188693,"score_spread":0.33038487679519474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893687383","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020965253,0.023858551,0.0009730603,0.3260202,0.6445801,0.00019627436,0.0025679523,0.00017814405,0.0014159415],"genre_scores_gemma":[0.01968348,0.0856553,0.01097556,0.48628992,0.37175053,0.0019638408,0.004247523,0.0010626568,0.018371185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.92954654,0.02203968,0.021569032,0.0044207023,0.020339992,0.002084042],"domain_scores_gemma":[0.59201175,0.19230735,0.03347645,0.010815033,0.16390063,0.007488747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06996048,0.002825141,0.0044361064,0.010614466,0.0024455483,0.007492681,0.005323626,0.008571295,0.03103319],"category_scores_gemma":[0.52760583,0.0018055238,0.0031914604,0.014850124,0.0033018559,0.0064853933,0.0045721955,0.011421607,0.00818314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008473812,0.0000069786515,0.00020812928,0.008137925,0.00026092667,0.00017520711,0.00018099078,0.00005413664,0.000023828834,0.0007331158,0.9797077,0.010426258],"study_design_scores_gemma":[0.0008074519,0.00009145964,0.002156165,0.06515886,0.0021305522,0.0008021304,0.0006173747,0.00037364548,0.00026201588,0.0044597536,0.9229503,0.00019029113],"about_ca_topic_score_codex":0.023802387,"about_ca_topic_score_gemma":0.046343356,"teacher_disagreement_score":0.06996048,"about_ca_system_score_codex":0.010684731,"about_ca_system_score_gemma":0.037544977,"threshold_uncertainty_score":0.36999083},"labels":[],"label_agreement":null},{"id":"W2899806166","doi":"10.1007/s00277-018-3539-7","title":"Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes","year":2018,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Corporation; University of British Columbia; University of Arizona; Celgene","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Hematology; Meta-analysis; Chelation therapy; Oncology; Disease; Bone marrow; Thalassemia","score_opus":0.057904941213714825,"score_gpt":0.3848248380881768,"score_spread":0.326919896874462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899806166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053499686,0.99341303,0.00026871817,0.0001324023,0.00015012822,0.00012923953,0.00036027184,0.000013654666,0.00018271623],"genre_scores_gemma":[0.18660337,0.8088033,0.0015632208,0.0011936931,0.00028008287,0.00041026846,0.0007566562,0.000021471678,0.0003680056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99557805,0.001778705,0.0015010808,0.0005313763,0.00042252883,0.00018834442],"domain_scores_gemma":[0.9919119,0.0059912507,0.001262705,0.00023994158,0.00046664913,0.00012757318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061321785,0.002226266,0.014921615,0.0029618684,0.0005204664,0.0020409205,0.0017679493,0.0019719368,0.0036330495],"category_scores_gemma":[0.018525055,0.0011288809,0.028144164,0.0039305915,0.00060942984,0.0012763804,0.0012468018,0.002054722,0.00026003493],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035471274,0.00004463022,0.0035324274,0.3468549,0.6310953,0.00014313823,0.000087389235,0.00039157947,0.00027283924,0.0001131015,0.0006924717,0.013225094],"study_design_scores_gemma":[0.00090117985,0.00018906048,0.0030940962,0.012373564,0.98179513,0.0000767739,0.00003108559,0.00007707983,0.000058184403,0.00012700561,0.001257508,0.000019396362],"about_ca_topic_score_codex":0.008797057,"about_ca_topic_score_gemma":0.02155821,"teacher_disagreement_score":0.014921615,"about_ca_system_score_codex":0.0018220389,"about_ca_system_score_gemma":0.0029717828,"threshold_uncertainty_score":0.03243047},"labels":[],"label_agreement":null},{"id":"W2921272064","doi":"10.1007/s00277-015-2563-0","title":"Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant","year":2015,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"CEBPA; Hematology; Myeloid leukemia; Karyotype; Internal medicine; Oncology; Medicine; Stem cell; Mutation; Leukemia; Cancer research; Biology; Genetics; Chromosome; Gene","score_opus":0.03626374896610787,"score_gpt":0.29222279866856005,"score_spread":0.2559590497024522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921272064","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009727299,0.003091254,0.00034854384,0.15606274,0.833838,0.000043595643,0.00060137693,0.00013123477,0.0049105384],"genre_scores_gemma":[0.025286019,0.016622325,0.003306021,0.33388674,0.49235174,0.00012751024,0.002234783,0.00044812093,0.1257367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900335,0.00014191928,0.00025864,0.00010883467,0.00035833556,0.0001289639],"domain_scores_gemma":[0.9946808,0.0016142051,0.000533003,0.00023912448,0.0024790252,0.0004538413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012592612,0.0012848929,0.0014757209,0.0021076098,0.0015478329,0.0013401672,0.0012954337,0.0065831016,0.012084014],"category_scores_gemma":[0.0153387,0.00082292216,0.0011352564,0.0010466265,0.0009968503,0.0011850591,0.0007161099,0.006292245,0.0105816955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006578181,0.000020223448,0.0005394645,0.00010102239,0.000016818627,0.0030077081,0.000016841754,0.000055546083,0.00008209202,0.0002805027,0.98870826,0.0071058488],"study_design_scores_gemma":[0.0001738308,0.00009784578,0.005695892,0.0005457413,0.0001382323,0.009998675,0.00016333182,0.0004882907,0.000629175,0.0011639677,0.98084325,0.00006171445],"about_ca_topic_score_codex":0.005067417,"about_ca_topic_score_gemma":0.0075337742,"teacher_disagreement_score":0.012084014,"about_ca_system_score_codex":0.0016802778,"about_ca_system_score_gemma":0.002071492,"threshold_uncertainty_score":0.040425003},"labels":[],"label_agreement":null},{"id":"W2946682034","doi":"10.1007/s00277-019-03713-y","title":"Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo","year":2019,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); University of British Columbia; BC Cancer Agency","funders":"Horizon 2020; Deutsche Krebshilfe; Deutsches Krebsforschungszentrum","keywords":"In vivo; Myeloid leukemia; Oncogene; Leukemia; Cancer research; Small interfering RNA; RNA interference; Cationic liposome; Haematopoiesis; Chemistry; Medicine; Transfection; Biology; Immunology; Stem cell; RNA; Apoptosis; Cell biology; Biochemistry; Biotechnology","score_opus":0.026003909395064043,"score_gpt":0.30037273097451433,"score_spread":0.2743688215794503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946682034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582068,0.0045935856,0.03132298,0.0003731164,0.00010781886,0.00015402226,0.00022875723,0.00026330046,0.0047497023],"genre_scores_gemma":[0.9869487,0.0013905362,0.0074002515,0.000085746426,0.0000129041855,0.000060397786,0.00014196966,0.000033806144,0.0039257333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999387,0.000010554865,0.0000047843037,0.000013597184,0.000019871582,0.000012400288],"domain_scores_gemma":[0.9999809,0.00000441295,0.0000053094973,0.000001919246,0.000003845309,0.0000035595187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017004207,0.00020369461,0.0001652891,0.000139255,0.0001384071,0.00018697874,0.00012460952,0.00024180202,0.0007042009],"category_scores_gemma":[0.000083121544,0.00010665085,0.00013708354,0.000075011136,0.00013869074,0.00014574871,0.0001817521,0.00025200454,0.00025231924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008066506,0.00001355793,0.000031252264,0.000029038561,0.000002330675,0.00003210973,0.000012758306,0.00006665681,0.9971661,0.00012123888,0.000058181813,0.0023859192],"study_design_scores_gemma":[0.000019808202,0.00017059973,0.00025411334,0.0000024724657,0.000015186736,0.00013764048,0.0000057663133,0.00089654536,0.9961061,0.000035370045,0.0023535432,0.0000028202858],"about_ca_topic_score_codex":0.0006199305,"about_ca_topic_score_gemma":0.0008221106,"teacher_disagreement_score":0.0007042009,"about_ca_system_score_codex":0.00025590637,"about_ca_system_score_gemma":0.00029309775,"threshold_uncertainty_score":0.0023557544},"labels":[],"label_agreement":null},{"id":"W2949365580","doi":"10.1007/s00277-019-03747-2","title":"Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A","year":2019,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"Chugai Pharmaceutical; LEO Pharma; Grifols; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Swedish Orphan Biovitrum; Baxalta; CSL Behring; Biogen; Novo Nordisk; Alnylam Pharmaceuticals; Pfizer","keywords":"Medicine; Crossover study; Confidence interval; Pharmacokinetics; Adverse effect; Randomized controlled trial; Population; Half-life; Internal medicine; Gastroenterology; Placebo","score_opus":0.044336060710164764,"score_gpt":0.38298603840081596,"score_spread":0.3386499776906512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949365580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959794,0.0010892602,0.0006048399,0.00013601301,0.00023656637,0.0012941633,0.00025685696,0.000046971454,0.00035589645],"genre_scores_gemma":[0.99441874,0.0008565657,0.0011155487,0.00033741829,0.0003737046,0.0016523827,0.000404078,0.000018762297,0.0008229774],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981382,0.0009741968,0.00013634526,0.0003978445,0.00013315013,0.00022021751],"domain_scores_gemma":[0.9970229,0.00087766914,0.0006584911,0.0003767802,0.00020561516,0.0008585751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028795432,0.0018692308,0.0050991387,0.0005350135,0.00047092207,0.0013696157,0.00086645683,0.0018062287,0.0034879278],"category_scores_gemma":[0.003178618,0.0011799948,0.0023490733,0.0005592563,0.0017306316,0.001605258,0.0005081086,0.0033029967,0.0008118934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97783136,0.01174894,0.0006995956,0.00012195945,0.0005946472,0.0000304154,0.000054535165,0.00019261608,0.0033060934,0.000046240424,0.00014765529,0.0052260226],"study_design_scores_gemma":[0.70725244,0.28838962,0.0024933286,0.00000814508,0.0004615041,0.000038061236,0.000025078658,0.00040812022,0.0005014357,0.000082452614,0.00031889335,0.000020931973],"about_ca_topic_score_codex":0.0006653693,"about_ca_topic_score_gemma":0.000980442,"teacher_disagreement_score":0.0050991387,"about_ca_system_score_codex":0.0009232378,"about_ca_system_score_gemma":0.001347223,"threshold_uncertainty_score":0.015228689},"labels":[],"label_agreement":null},{"id":"W3021230218","doi":"10.1007/s00277-020-04033-2","title":"Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Anti-thymocyte globulin; Internal medicine; Cumulative incidence; Incidence (geometry); Cyclophosphamide; Graft-versus-host disease; Gastroenterology; Confidence interval; Hematopoietic stem cell transplantation; Transplantation; Hematology; Immunology; Chemotherapy","score_opus":0.016985072706018702,"score_gpt":0.2654368961894524,"score_spread":0.24845182348343367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021230218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964085,0.0023015449,0.00006850356,0.00014223321,0.000072044684,0.000009625517,0.000055762415,0.000012085845,0.0009295455],"genre_scores_gemma":[0.99829644,0.0008384431,0.00011989109,0.00015459259,0.0001050752,0.0000064094265,0.00011880685,0.0000023581752,0.00035801524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99995875,0.000012384203,0.0000039738197,0.0000056354543,0.000007770084,0.000011488216],"domain_scores_gemma":[0.99981314,0.000033005534,0.000061656334,0.000008509187,0.000012416422,0.00007140103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011179094,0.00016282099,0.0003754291,0.00011439694,0.00013201265,0.00020056039,0.000097786986,0.00013500963,0.0013514908],"category_scores_gemma":[0.0005154327,0.000044647895,0.00019019993,0.000118345,0.000069546244,0.0000969068,0.00009594282,0.00035374012,0.00014714175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048412282,0.0067379246,0.54119974,0.0004354812,0.0010536405,0.00065524766,0.00017276536,0.000613729,0.029056787,0.00018011127,0.0043433234,0.36713886],"study_design_scores_gemma":[0.0013350009,0.016694477,0.97539943,0.00005815012,0.000595129,0.00094177906,0.00008770865,0.0004109795,0.0019085438,0.00010281441,0.0024578485,0.000008130788],"about_ca_topic_score_codex":0.00032828085,"about_ca_topic_score_gemma":0.000924032,"teacher_disagreement_score":0.0013514908,"about_ca_system_score_codex":0.000085258085,"about_ca_system_score_gemma":0.00017193954,"threshold_uncertainty_score":0.0045212507},"labels":[],"label_agreement":null},{"id":"W3022268070","doi":"10.1007/s00277-020-04052-z","title":"Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry","year":2020,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Internal medicine; Cohort; Disease registry; clone (Java method); Immunology; Anemia; Disease; Biology","score_opus":0.03706104995905859,"score_gpt":0.3073133456960637,"score_spread":0.27025229573700515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022268070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101067,0.00036707523,0.00026482652,0.000048001446,0.000006724554,0.00003840017,0.0074328342,0.000013924951,0.0008176398],"genre_scores_gemma":[0.9852706,0.0003231437,0.0004265743,0.00006705166,0.000030691812,0.00009463784,0.013564567,0.000007000829,0.00021572538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996487,0.000080799735,0.00006762709,0.000090514375,0.00006677823,0.000045644105],"domain_scores_gemma":[0.99860436,0.00017229421,0.00076043914,0.00015350097,0.00016459616,0.00014472325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083636324,0.00019146563,0.0004092289,0.00083766173,0.0002139008,0.0004200403,0.0002849045,0.00022079996,0.0008650054],"category_scores_gemma":[0.0013681888,0.0001777753,0.00040479144,0.001206457,0.00010590224,0.00050555944,0.0003770165,0.0004994691,0.00017073809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011794358,0.000016459428,0.9973078,0.000012949091,0.000063172265,0.00003572863,0.00002906269,0.00006838105,0.0001567929,0.000020225141,0.00044735114,0.0017242442],"study_design_scores_gemma":[0.000013776511,0.000046534544,0.99894816,0.000004967203,0.000036447123,0.00023817722,0.000032978587,0.00017629983,0.00003752405,0.000016859402,0.0004447301,0.0000035025644],"about_ca_topic_score_codex":0.002192445,"about_ca_topic_score_gemma":0.0030692501,"teacher_disagreement_score":0.002192445,"about_ca_system_score_codex":0.0001680543,"about_ca_system_score_gemma":0.00028376674,"threshold_uncertainty_score":0.0044231415},"labels":[],"label_agreement":null},{"id":"W3036606956","doi":"10.1007/s00277-020-04074-7","title":"Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC","year":2020,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Clofarabine; Internal medicine; Transplantation; Fludarabine; Gastroenterology; Busulfan; Hematopoietic stem cell transplantation; Surgery; Cytarabine; Myeloid leukemia; Hematology; Cyclophosphamide; Oncology; Chemotherapy","score_opus":0.05012476924367989,"score_gpt":0.3210703684726141,"score_spread":0.27094559922893424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036606956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992501,0.00022425626,0.00007222327,0.00000858366,0.000004572097,0.000011058204,0.000085046515,0.000001707339,0.0003424578],"genre_scores_gemma":[0.99937975,0.000100758574,0.00006321139,0.000020569896,0.000016784754,0.0000069998296,0.00030041678,0.000001785565,0.000109747394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997278,0.00006941851,0.00002970719,0.000073488845,0.00005315841,0.00004643055],"domain_scores_gemma":[0.99955744,0.00009745809,0.000106695974,0.000064702785,0.000029342906,0.00014445384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037429415,0.0002975389,0.00039080012,0.00034101648,0.00032053626,0.00040279288,0.00023278956,0.0003191202,0.0010845616],"category_scores_gemma":[0.00048310062,0.00017647268,0.00044320323,0.00045203482,0.00035633228,0.00024363787,0.0001759181,0.0003289996,0.00024318509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012497327,0.0010768146,0.9522208,0.000039873048,0.00022299972,0.0034843292,0.00012955733,0.00038678086,0.012019354,0.00010705604,0.00022792211,0.017587215],"study_design_scores_gemma":[0.0004974697,0.007792051,0.97791195,0.00001382373,0.00033235986,0.008575593,0.00020055039,0.0005052103,0.0025994875,0.000121968464,0.0014356234,0.000013933719],"about_ca_topic_score_codex":0.0006115189,"about_ca_topic_score_gemma":0.0007518697,"teacher_disagreement_score":0.0010845616,"about_ca_system_score_codex":0.00028224953,"about_ca_system_score_gemma":0.00048662032,"threshold_uncertainty_score":0.003628254},"labels":[],"label_agreement":null},{"id":"W3120955797","doi":"10.1007/s00277-020-04363-1","title":"Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Internal medicine; Ferritin; Hematopoietic stem cell transplantation; Transplantation; Hematology; Hematopoietic cell; Gastroenterology; Graft-versus-host disease; Prospective cohort study; Multivariate analysis; Oncology; Stem cell; Haematopoiesis","score_opus":0.0584022361519325,"score_gpt":0.3020009434030196,"score_spread":0.2435987072510871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120955797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828017,0.0003084158,0.00008873324,0.00012326782,0.000022269283,0.0000024226908,0.000104791594,0.0000070022706,0.0010629316],"genre_scores_gemma":[0.99948263,0.00007194136,0.00003446025,0.000032021755,0.00002974832,0.0000011804193,0.00015185925,0.0000024343365,0.00019366846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997676,0.00005290638,0.000019778778,0.00003375169,0.000055896744,0.000070077804],"domain_scores_gemma":[0.99811053,0.0005340016,0.0006827335,0.00013477566,0.00014124949,0.0003967561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057267403,0.00023284418,0.00026449066,0.00033351907,0.00022275848,0.0006679785,0.00027796815,0.000485336,0.001712939],"category_scores_gemma":[0.002372762,0.000113424474,0.00037180915,0.00039150732,0.0003444934,0.00035209654,0.00026136867,0.0009967007,0.00030223484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071597646,0.00008113769,0.99484926,0.0000068461786,0.00006146501,0.000095254996,0.000018072507,0.00010311167,0.0005953264,0.000040163653,0.00019470882,0.0032386621],"study_design_scores_gemma":[0.000015407253,0.00020058308,0.99810326,0.000007599365,0.00006106672,0.00040928135,0.00004496975,0.00062254025,0.00023596444,0.000111652786,0.00018310716,0.0000045063834],"about_ca_topic_score_codex":0.0013597193,"about_ca_topic_score_gemma":0.0020861053,"teacher_disagreement_score":0.001712939,"about_ca_system_score_codex":0.00030482654,"about_ca_system_score_gemma":0.00032865163,"threshold_uncertainty_score":0.0057303905},"labels":[],"label_agreement":null},{"id":"W3125051035","doi":"10.1007/s00277-021-04402-5","title":"Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrition International","funders":"Consejo Nacional de Ciencia y Tecnología","keywords":"Ferritin; Hepcidin; Soluble transferrin receptor; Medicine; Internal medicine; Inflammation; Hemoglobin; Endocrinology; Immunology; Iron deficiency; Physiology; Anemia; Iron status","score_opus":0.02337418325094814,"score_gpt":0.3175540347590543,"score_spread":0.29417985150810616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125051035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99975926,0.00007865427,0.000019633493,0.000010082063,0.0000014972521,0.0000019070811,0.000069561254,9.2643444e-7,0.000058575446],"genre_scores_gemma":[0.99941695,0.00012563884,0.00006653552,0.000013846756,0.0000049661417,0.000009413373,0.00019656697,0.0000013209749,0.00016473354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998884,0.000025120113,0.0000074859427,0.000032589414,0.000017359303,0.00002890378],"domain_scores_gemma":[0.99969244,0.00003059684,0.00014301449,0.00003116028,0.000037439655,0.000065351735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003491447,0.00032420922,0.00021131944,0.000424287,0.00039083348,0.0004701853,0.0001927041,0.00029724912,0.00042961494],"category_scores_gemma":[0.0008288488,0.0002495238,0.00032382156,0.0004104072,0.00015556824,0.00033027833,0.00024084303,0.0004396868,0.0000972036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016971483,0.000043974498,0.99791723,0.0000037321508,0.000016807182,0.00015246369,0.0001979801,0.000011222959,0.0005809574,0.0000098299815,0.000040383722,0.00085574354],"study_design_scores_gemma":[0.0000028087763,0.00010793692,0.99919456,0.0000027232165,0.000011874527,0.00019699964,0.00024418253,0.000057609188,0.00005395845,0.0000064277165,0.00011929517,0.0000016192606],"about_ca_topic_score_codex":0.008634556,"about_ca_topic_score_gemma":0.0059809764,"teacher_disagreement_score":0.008634556,"about_ca_system_score_codex":0.0002678904,"about_ca_system_score_gemma":0.00022477613,"threshold_uncertainty_score":0.017168641},"labels":[],"label_agreement":null},{"id":"W3126084169","doi":"10.1007/s00277-021-04420-3","title":"Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality","keywords":"Carfilzomib; Medicine; Multiple myeloma; Internal medicine; Comorbidity; Hazard ratio; Hematology; Adverse effect; Dialysis; Proportional hazards model; Kidney disease; Intensive care medicine; Epidemiology; Oncology; Proteasome inhibitor; Confidence interval","score_opus":0.060605959715778736,"score_gpt":0.34046886891887235,"score_spread":0.2798629092030936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126084169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786913,0.00040094508,0.00004368202,0.00032311285,0.000017902597,0.0000067524693,0.00037120454,0.0000044081526,0.00096278125],"genre_scores_gemma":[0.999371,0.00014983387,0.000028723443,0.00008799572,0.000034645334,0.0000032307034,0.00024842913,9.807125e-7,0.00007520918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999554,0.000111379886,0.000043532382,0.00008328931,0.00007919414,0.00012857237],"domain_scores_gemma":[0.9991573,0.00012852479,0.00037668293,0.00003099971,0.000078777346,0.00022764286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033141702,0.0001952427,0.0003407136,0.0006218689,0.0005832851,0.0008912405,0.0003025355,0.0005327381,0.001694597],"category_scores_gemma":[0.0017573679,0.00017948348,0.00036477382,0.0012707865,0.0003553712,0.0007591777,0.0004480392,0.0008417091,0.00014969645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002073462,0.00008973626,0.9973375,0.000015270323,0.00005239319,0.00026446814,0.00006668645,0.00004280157,0.00008027262,0.000044710152,0.00031256254,0.0014861834],"study_design_scores_gemma":[0.000013750888,0.00012916069,0.99762565,0.0000111092895,0.00005342395,0.00074908795,0.00060989585,0.00025232162,0.000038297036,0.00007852595,0.0004299897,0.000008747243],"about_ca_topic_score_codex":0.009627526,"about_ca_topic_score_gemma":0.012789669,"teacher_disagreement_score":0.009627526,"about_ca_system_score_codex":0.00054286624,"about_ca_system_score_gemma":0.00063595147,"threshold_uncertainty_score":0.019142985},"labels":[],"label_agreement":null},{"id":"W3129944430","doi":"10.1007/s00277-021-04405-2","title":"Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Janssen Research and Development","keywords":"Daratumumab; Medicine; Internal medicine; Cohort; Gastroenterology; Population; Multiple myeloma; Hazard ratio; Confidence interval; Bortezomib","score_opus":0.0680167143978006,"score_gpt":0.3963128372205184,"score_spread":0.3282961228227178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129944430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587667,0.0028259251,0.00021566206,0.00012870539,0.000051771385,0.0001882646,0.00040705042,0.000009032116,0.0002969185],"genre_scores_gemma":[0.9983032,0.0003842663,0.00021458209,0.0002010078,0.00006661029,0.00017603333,0.00050771015,0.000005312264,0.00014125141],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985085,0.0008452176,0.00017066595,0.00018699725,0.00013690749,0.00015166219],"domain_scores_gemma":[0.9985422,0.00040209747,0.00044849815,0.0002483538,0.000115951596,0.00024290977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004155782,0.0011037976,0.0022063921,0.00048429408,0.00041595584,0.0009873821,0.0005407907,0.00066330435,0.0013646114],"category_scores_gemma":[0.0021859508,0.000432668,0.005661484,0.00082335284,0.0003786751,0.00047524553,0.00061640795,0.0011397006,0.00016559703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5359346,0.0020824024,0.35980567,0.0012469887,0.04788789,0.0006330379,0.0004815051,0.001114304,0.013311125,0.0001905882,0.0019363441,0.035375442],"study_design_scores_gemma":[0.09598544,0.03436131,0.8152294,0.00016006472,0.04192102,0.0008007849,0.0007942004,0.004178197,0.0020442584,0.00061450026,0.003781657,0.00012921754],"about_ca_topic_score_codex":0.0012570969,"about_ca_topic_score_gemma":0.003747478,"teacher_disagreement_score":0.004155782,"about_ca_system_score_codex":0.0005000417,"about_ca_system_score_gemma":0.0008986583,"threshold_uncertainty_score":0.02197814},"labels":[],"label_agreement":null},{"id":"W3134521773","doi":"10.1007/s00277-021-04480-5","title":"Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Hazard ratio; Transplantation; Univariate analysis; Risk factor; Graft-versus-host disease; Framingham Risk Score; Hematopoietic stem cell transplantation; Hematology; Avascular necrosis; Proportional hazards model; Incidence (geometry); Surgery; Gastroenterology; Multivariate analysis; Disease; Confidence interval; Femoral head","score_opus":0.03234816892131842,"score_gpt":0.2782705008435842,"score_spread":0.24592233192226576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134521773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977654,0.0008304365,0.00014162951,0.00012394886,0.000036114714,0.0000046944456,0.00012534607,0.000005318692,0.0009669746],"genre_scores_gemma":[0.999246,0.00025606467,0.00007583773,0.000047588564,0.00007563188,0.000002474124,0.00012298343,0.000002097114,0.00017129637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980396,0.000042924854,0.000032594802,0.000026374864,0.000049242462,0.000045038305],"domain_scores_gemma":[0.99879384,0.00019537425,0.0005562499,0.000050722127,0.000057128687,0.00034662941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022863307,0.0002463465,0.00032313075,0.0006162869,0.00031052643,0.00053408445,0.00020948604,0.0003803152,0.0023887586],"category_scores_gemma":[0.0012952756,0.00015236391,0.00044840237,0.000679772,0.00024523475,0.00029741778,0.00026918566,0.00073891605,0.00020553693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001073262,0.000027314401,0.99795675,0.00000858569,0.00003375546,0.00029747942,0.000015596157,0.000026446041,0.00029083862,0.000018310986,0.00008903418,0.0011285301],"study_design_scores_gemma":[0.000005610261,0.00009727636,0.9966987,0.0000088761,0.00004986176,0.002431116,0.0001369218,0.00017170518,0.0000737724,0.00007278578,0.0002490051,0.000004311253],"about_ca_topic_score_codex":0.0006870895,"about_ca_topic_score_gemma":0.0014591016,"teacher_disagreement_score":0.0023887586,"about_ca_system_score_codex":0.00009492014,"about_ca_system_score_gemma":0.000326797,"threshold_uncertainty_score":0.007991135},"labels":[],"label_agreement":null},{"id":"W3138063460","doi":"10.1007/s00277-021-04465-4","title":"Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"Incyte; Daiichi Sankyo Europe; Agios Pharmaceuticals; Jazz Pharmaceuticals; Celgene; Astellas Pharma; Ariad Pharmaceuticals; Alexion Pharmaceuticals; Servier; Pfizer; Amgen","keywords":"Medicine; Cytarabine; Internal medicine; Myeloid leukemia; Hazard ratio; Leukemia; Oncology; Confidence interval","score_opus":0.032711054536759834,"score_gpt":0.3778921484179776,"score_spread":0.34518109388121776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138063460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850594,0.010428095,0.0006793376,0.00069660664,0.00023950308,0.00084551465,0.00069593434,0.000059473987,0.001295999],"genre_scores_gemma":[0.9914231,0.0028460708,0.00086686015,0.00096243736,0.0003410746,0.0011048709,0.0015548336,0.00001596708,0.0008849021],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983316,0.0011866752,0.00008475347,0.00016720564,0.00009288253,0.00013692447],"domain_scores_gemma":[0.99758875,0.0007846451,0.0006049212,0.0002124561,0.00011083656,0.00069841737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004236921,0.00096769974,0.0022947262,0.0003528942,0.0003308002,0.0013652614,0.00062996417,0.0012009288,0.002192442],"category_scores_gemma":[0.0025783475,0.00033337667,0.0028841882,0.0004961932,0.00076599047,0.0010097346,0.0005022321,0.0027483304,0.00038851122],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9631967,0.0035173194,0.0028988542,0.00044117807,0.00242061,0.000041600997,0.000044483524,0.00049601344,0.0027463655,0.00009986168,0.0006271678,0.023470005],"study_design_scores_gemma":[0.8508423,0.13208582,0.0116175,0.00007259546,0.0020241002,0.000096969634,0.00003932496,0.0010664993,0.00068217353,0.0003065368,0.0011375551,0.00002866078],"about_ca_topic_score_codex":0.00037567382,"about_ca_topic_score_gemma":0.0012328916,"teacher_disagreement_score":0.004236921,"about_ca_system_score_codex":0.00078969775,"about_ca_system_score_gemma":0.0009863263,"threshold_uncertainty_score":0.022407234},"labels":[],"label_agreement":null},{"id":"W31457797","doi":"10.1007/pl00022794","title":"Management of localized (stage I and II) clinically aggressive lymphomas","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Disease; Lymphoma; Radiation therapy; Internal medicine; Hematology; Aggressive lymphoma; Clinical trial; Oncology; Refractory (planetary science); Chemotherapy; Randomized controlled trial; B symptoms; Rituximab","score_opus":0.11536952752844024,"score_gpt":0.43295082305079474,"score_spread":0.3175812955223545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31457797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027752537,0.99880195,0.00019242788,0.0001524659,0.00012580844,0.00000433597,0.000007544454,0.0000074261347,0.00043049772],"genre_scores_gemma":[0.0023173215,0.99626666,0.00045266747,0.00033040068,0.0002704989,0.0000067252377,0.00003089399,0.0000017921067,0.00032307336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971884,0.00006890481,0.000058995043,0.000043936492,0.00008921717,0.000020070445],"domain_scores_gemma":[0.9996164,0.00020257881,0.000073208845,0.000010098576,0.000070484406,0.000027341488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006433161,0.0007006841,0.0017980969,0.0016176692,0.00023415167,0.0008013185,0.001319198,0.00085035415,0.0013656633],"category_scores_gemma":[0.0009524158,0.000246246,0.00053055404,0.0012334854,0.00038132188,0.0009336718,0.00041470514,0.0013353335,0.00066193426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000902313,0.0000769811,0.00053637667,0.0095238015,0.00010936808,0.00072492094,0.000044629236,0.00038627163,0.0007891003,0.00041339453,0.015268767,0.9720362],"study_design_scores_gemma":[0.00021740228,0.0005930343,0.008104354,0.012457425,0.0011193301,0.021096416,0.00021426928,0.0005124992,0.0011044325,0.001916767,0.9526024,0.00006165284],"about_ca_topic_score_codex":0.0009787034,"about_ca_topic_score_gemma":0.002996955,"teacher_disagreement_score":0.0017980969,"about_ca_system_score_codex":0.00044645558,"about_ca_system_score_gemma":0.00055023783,"threshold_uncertainty_score":0.004568577},"labels":[],"label_agreement":null},{"id":"W3146722950","doi":"10.1007/s00277-020-04375-x","title":"Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review","year":2021,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Intensive care; Disease; Intensive care medicine; Performance status; Clinical trial; Internal medicine; Comorbidity; Myeloid leukemia; Physical therapy; Chemotherapy","score_opus":0.1707211758480028,"score_gpt":0.4611661922410932,"score_spread":0.2904450163930904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146722950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013564243,0.999627,0.0000126750465,0.0000845446,0.000045621837,0.0000025795357,0.000033261982,0.0000012351078,0.00005732217],"genre_scores_gemma":[0.000950343,0.99877316,0.000041047337,0.00011760501,0.000059150287,0.0000038413605,0.000030571326,3.6920147e-7,0.000023912167],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99964833,0.000067547,0.00010586882,0.000058753732,0.00009638566,0.000023141336],"domain_scores_gemma":[0.9986345,0.00092400424,0.00026461214,0.000011252393,0.00012685978,0.000038656486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093423325,0.00072333904,0.002563276,0.0019230767,0.00018321419,0.0009372745,0.001072879,0.00079655537,0.0021084372],"category_scores_gemma":[0.0031980886,0.0002462385,0.0016559795,0.002892587,0.00028716933,0.0008394803,0.00065851293,0.000908771,0.00028559932],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029673876,0.0000726092,0.004106062,0.23527244,0.0033179587,0.00018422329,0.00011509022,0.00036875997,0.00026691557,0.0006281208,0.026136702,0.72923434],"study_design_scores_gemma":[0.0003945358,0.00056380604,0.05279906,0.3749731,0.035968516,0.0036293592,0.0007876127,0.00042928153,0.00036245407,0.0024683026,0.52740663,0.00021737383],"about_ca_topic_score_codex":0.003034234,"about_ca_topic_score_gemma":0.006702606,"teacher_disagreement_score":0.003034234,"about_ca_system_score_codex":0.0004811053,"about_ca_system_score_gemma":0.0017352626,"threshold_uncertainty_score":0.0070533752},"labels":[],"label_agreement":null},{"id":"W3162966937","doi":"10.1007/s00277-021-04536-6","title":"Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Janssen Research and Development; Pharmacyclics; Paracelsus Medizinische Privatuniversität","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Internal medicine; Pharmacology; Oncology; Immunology; Leukemia; Chemotherapy","score_opus":0.028575980671565436,"score_gpt":0.3096534037363102,"score_spread":0.28107742306474476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162966937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776137,0.0014414912,0.00011137764,0.000028304266,0.000005535112,0.00003450068,0.00021019918,0.000005798535,0.0004013503],"genre_scores_gemma":[0.99837625,0.00043096172,0.00014754393,0.000091030095,0.00002250973,0.000048945,0.0007097413,0.0000038056344,0.00016924742],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952006,0.00022456107,0.000040983145,0.00006414974,0.00007593206,0.00007429189],"domain_scores_gemma":[0.9992637,0.0002029127,0.00022517977,0.00010304645,0.00004534158,0.00015983329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010902196,0.000383676,0.0010243932,0.00022508774,0.00015569631,0.0007145246,0.00022219445,0.00033023173,0.0008880842],"category_scores_gemma":[0.0012146946,0.00019781549,0.00085987995,0.00031999123,0.00018281909,0.00022050712,0.00030838008,0.00054794154,0.00017693535],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33266768,0.0025017406,0.4652404,0.00051405333,0.0033626275,0.00040982105,0.00040551418,0.001879592,0.05541036,0.00014191863,0.001513891,0.13595235],"study_design_scores_gemma":[0.017045772,0.047540937,0.9193786,0.00007670398,0.0023741592,0.00096459663,0.00015092385,0.0015924431,0.004663088,0.00011409574,0.0060568554,0.00004182954],"about_ca_topic_score_codex":0.000313386,"about_ca_topic_score_gemma":0.00045780596,"teacher_disagreement_score":0.0010902196,"about_ca_system_score_codex":0.0002727505,"about_ca_system_score_gemma":0.00025206967,"threshold_uncertainty_score":0.0057656765},"labels":[],"label_agreement":null},{"id":"W3171624023","doi":"10.1007/s00277-021-04545-5","title":"Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial","year":2021,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Cytarabine; Internal medicine; Myeloid leukemia; Hematology; Oncology; Term (time); Clinical trial","score_opus":0.030088834126722988,"score_gpt":0.3805823575140232,"score_spread":0.3504935233873002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171624023","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104935134,0.0012232283,0.00044827632,0.05580737,0.93828,0.000050162806,0.0021453488,0.00025356395,0.0016872005],"genre_scores_gemma":[0.0098728025,0.010732709,0.005474003,0.1743915,0.64937896,0.0006496882,0.006115466,0.001991836,0.14139296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99203765,0.0020498715,0.0014662761,0.00086133706,0.002952558,0.0006322197],"domain_scores_gemma":[0.936033,0.024909405,0.0041033193,0.0028759986,0.028341986,0.0037363213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00926357,0.002337123,0.002800095,0.003261341,0.0022183624,0.005321766,0.0039283726,0.0067243017,0.07504771],"category_scores_gemma":[0.100512795,0.0014171313,0.0027518887,0.0030080718,0.002166801,0.0020117231,0.0014655573,0.013722088,0.03607066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091536065,0.0000073455926,0.000043548574,0.0001936976,0.000021997397,0.00006832974,0.000008063078,0.000033243283,0.00002446367,0.00020726786,0.99558395,0.0037165012],"study_design_scores_gemma":[0.0006997559,0.00009062178,0.0012124865,0.0011621435,0.00014978029,0.0005203272,0.00004703074,0.0003821248,0.00038634922,0.0016388102,0.99364704,0.00006351775],"about_ca_topic_score_codex":0.009423372,"about_ca_topic_score_gemma":0.012499206,"teacher_disagreement_score":0.07504771,"about_ca_system_score_codex":0.004788057,"about_ca_system_score_gemma":0.008175179,"threshold_uncertainty_score":0.2510596},"labels":[],"label_agreement":null},{"id":"W3185145180","doi":"10.1007/s00277-021-04591-z","title":"N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institution","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Internal medicine; Multivariate analysis; Natriuretic peptide; Brain natriuretic peptide; Hematology; Univariate analysis; Cardiology; Cohort; Multiple myeloma; Gastroenterology; Academic institution; Heart failure; Oncology","score_opus":0.03998587440098521,"score_gpt":0.31988444559654516,"score_spread":0.27989857119555994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185145180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838924,0.00029649326,0.00013419887,0.00013723935,0.0000113183605,0.000011466553,0.000089923466,0.000011706825,0.00091847323],"genre_scores_gemma":[0.9993205,0.00014637163,0.00013652173,0.00014110978,0.000031499636,0.0000032146481,0.00007649161,0.000006044239,0.00013833468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991922,0.00007920255,0.00013004632,0.00019994182,0.0001991471,0.00019944723],"domain_scores_gemma":[0.99850684,0.00031458036,0.00037383146,0.000110016255,0.00022021546,0.00047439785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003452754,0.0004540767,0.00045329717,0.0011381643,0.0011887539,0.0014195883,0.00074545335,0.00083033624,0.0013402904],"category_scores_gemma":[0.0019396777,0.00049340015,0.00050184206,0.0013795254,0.0006423221,0.0007626794,0.0007960166,0.00090742565,0.0003851066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015190395,0.00022568657,0.9551508,0.000026721711,0.00005058033,0.037942857,0.0005139606,0.00008007982,0.0018512388,0.000040198785,0.00033543204,0.003630448],"study_design_scores_gemma":[0.000029231873,0.00033930803,0.8797437,0.000030311001,0.00010066984,0.11537273,0.0023917125,0.00043325793,0.00086633774,0.000058346468,0.0006018774,0.000032478172],"about_ca_topic_score_codex":0.0052037495,"about_ca_topic_score_gemma":0.0069154305,"teacher_disagreement_score":0.0052037495,"about_ca_system_score_codex":0.0007367837,"about_ca_system_score_gemma":0.001184047,"threshold_uncertainty_score":0.010346949},"labels":[],"label_agreement":null},{"id":"W3196694240","doi":"10.1007/s00277-021-04657-y","title":"A rare de novo pure erythroid leukemia with JAK2 R683S mutation","year":2021,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Hematology; Mutation; Cancer research; Medicine; Leukemia; Internal medicine; Genetics; Biology; Gene","score_opus":0.04394175270848683,"score_gpt":0.3145461106660042,"score_spread":0.27060435795751736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196694240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6242517,0.016884912,0.00706137,0.21330222,0.017544432,0.0004549805,0.0011938118,0.00074573146,0.11856078],"genre_scores_gemma":[0.90538406,0.004522941,0.0037398038,0.04088214,0.027284695,0.000099228455,0.00044418848,0.00018351089,0.017459456],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991441,0.00014197476,0.00009986533,0.00016228488,0.00016334899,0.00028858904],"domain_scores_gemma":[0.99819297,0.0007467732,0.0002909233,0.00010760488,0.00016229144,0.0004994011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039382422,0.0014978874,0.0012734715,0.0016911157,0.0023121522,0.0018819754,0.0011604539,0.011293839,0.004245893],"category_scores_gemma":[0.005450828,0.00074865407,0.00124216,0.0010585095,0.001379835,0.0020556855,0.0013919107,0.006514072,0.0017876645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036584865,0.000021866788,0.0013344471,0.000020294012,0.0000051904503,0.99324965,0.000042761312,0.0000643436,0.0004101883,0.0004828249,0.003113074,0.0012189222],"study_design_scores_gemma":[0.000028585899,0.000038592825,0.0013952237,0.000023358758,0.000016722912,0.9936373,0.00006051681,0.00046727722,0.00025289608,0.00074820843,0.0033234148,0.000007881375],"about_ca_topic_score_codex":0.0012712277,"about_ca_topic_score_gemma":0.0015732102,"teacher_disagreement_score":0.011293839,"about_ca_system_score_codex":0.0021231177,"about_ca_system_score_gemma":0.0010361356,"threshold_uncertainty_score":0.015404344},"labels":[],"label_agreement":null},{"id":"W3201556146","doi":"10.1007/s00277-021-04651-4","title":"Platelet features allow to differentiate immune thrombocytopenia from inherited thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Novartis Foundation","keywords":"Platelet; Immune thrombocytopenia; Hematology analyzer; Medicine; Hematology; P-selectin; Platelet activation; Flow cytometry; Immunology; Internal medicine; Immune system; Gastroenterology","score_opus":0.04649019951805516,"score_gpt":0.3338126727349513,"score_spread":0.28732247321689613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201556146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9144401,0.013773398,0.013267808,0.003103692,0.0009219316,0.00017512788,0.0010753799,0.0004108574,0.05283181],"genre_scores_gemma":[0.9874399,0.0026510875,0.0052646347,0.00085006416,0.00083490973,0.0000522923,0.000986165,0.00005953646,0.0018615457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957055,0.00007574828,0.000092892325,0.00005075605,0.00012659357,0.00008346961],"domain_scores_gemma":[0.9991842,0.0002794989,0.00017590243,0.00006653195,0.00019232775,0.000101510275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048072115,0.00073122355,0.00041607267,0.0022313136,0.0003423238,0.0011297017,0.0003440992,0.0011569478,0.0029233012],"category_scores_gemma":[0.0025341567,0.00015317295,0.00043898594,0.00058894046,0.00039935907,0.0006245875,0.000560912,0.0011329066,0.0013616198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016462193,0.00026331996,0.5233017,0.000768507,0.00026630008,0.15801752,0.00070376846,0.00074627285,0.12675405,0.008725696,0.009796439,0.16901025],"study_design_scores_gemma":[0.00019615935,0.0008580227,0.36694634,0.00062153867,0.0004916175,0.5547322,0.00082337507,0.0035760803,0.036847368,0.0051873857,0.029662436,0.00005746004],"about_ca_topic_score_codex":0.00036515982,"about_ca_topic_score_gemma":0.00033826454,"teacher_disagreement_score":0.0029233012,"about_ca_system_score_codex":0.00018381403,"about_ca_system_score_gemma":0.0001972087,"threshold_uncertainty_score":0.009779453},"labels":[],"label_agreement":null},{"id":"W3202558811","doi":"10.1007/s00277-021-04688-5","title":"Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia","year":2021,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Mercaptopurine; Hematology; Medicine; Lymphoblastic Leukemia; Internal medicine; Oncology; Leukemia","score_opus":0.06058482396000166,"score_gpt":0.3603903511839632,"score_spread":0.29980552722396153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202558811","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32571912,0.021786604,0.002362854,0.52593076,0.013046734,0.00016803607,0.00028412676,0.0002314299,0.11047037],"genre_scores_gemma":[0.8640069,0.007936027,0.0013619731,0.08403931,0.03314342,0.000049367885,0.0001569278,0.000059293972,0.009246845],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99921703,0.00031186495,0.000074832315,0.000065050786,0.00015178748,0.00017951477],"domain_scores_gemma":[0.99830484,0.0008078703,0.00021054024,0.000055764896,0.00012579092,0.0004952287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006283404,0.0007208521,0.00076654734,0.0008059999,0.0019017815,0.0012963488,0.00095345185,0.008231231,0.0024377666],"category_scores_gemma":[0.0056475424,0.00041086518,0.00070957467,0.00072440214,0.0011946805,0.001121451,0.00053358625,0.006573902,0.00071887503],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025736334,0.00012579172,0.021022478,0.00009405411,0.000038751135,0.93049634,0.00026572036,0.00035321002,0.0008440968,0.0022433877,0.03771375,0.0065449853],"study_design_scores_gemma":[0.0001737298,0.00036885487,0.0165527,0.0002769097,0.00007440325,0.9412077,0.00078488357,0.0021055127,0.0007090903,0.0042014658,0.033511404,0.000033376964],"about_ca_topic_score_codex":0.0026539338,"about_ca_topic_score_gemma":0.004266125,"teacher_disagreement_score":0.008231231,"about_ca_system_score_codex":0.0021311075,"about_ca_system_score_gemma":0.0014165423,"threshold_uncertainty_score":0.015462339},"labels":[],"label_agreement":null},{"id":"W3203054698","doi":"10.1007/s00277-021-04678-7","title":"Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita","year":2021,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Dyskeratosis congenita; Hematology; Gene; Medicine; Genetics; Genodermatosis; Biology; Internal medicine; Dermatology; Telomere","score_opus":0.05282750090357518,"score_gpt":0.2971630891695887,"score_spread":0.24433558826601354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203054698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8162292,0.008491346,0.002314593,0.12733966,0.005962634,0.00011162711,0.0004509776,0.00026301452,0.038836826],"genre_scores_gemma":[0.9725954,0.0015358292,0.00097475224,0.013002264,0.006412117,0.000021176973,0.00007980719,0.000041281673,0.005337398],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99950385,0.00008828221,0.00005602581,0.00012978588,0.00009469195,0.0001273476],"domain_scores_gemma":[0.998415,0.0009860487,0.00014454684,0.000070802125,0.00009907981,0.0002845858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005002541,0.0011298868,0.00086993875,0.0011848108,0.0014120115,0.0010038294,0.00078013923,0.008254303,0.0021487877],"category_scores_gemma":[0.004057678,0.00037775582,0.00062837335,0.0007473411,0.0010732219,0.0008546501,0.00055187364,0.003256945,0.0005074759],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001049501,0.0000468766,0.007903113,0.000021880705,0.000013048134,0.9848429,0.00016528628,0.00010485055,0.0008297609,0.0004319247,0.0037645937,0.0017708354],"study_design_scores_gemma":[0.0000653845,0.00013583068,0.008684835,0.000064874555,0.00006684344,0.982896,0.00026041525,0.0009970001,0.00069642166,0.0012851848,0.0048285383,0.000018663783],"about_ca_topic_score_codex":0.0015243582,"about_ca_topic_score_gemma":0.0018441246,"teacher_disagreement_score":0.008254303,"about_ca_system_score_codex":0.0009222636,"about_ca_system_score_gemma":0.00048096885,"threshold_uncertainty_score":0.0071883798},"labels":[],"label_agreement":null},{"id":"W336660519","doi":"10.1007/pl00022799","title":"Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma","year":2001,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Hematology; Internal medicine; Medicine; Histology; Lymphoma; Aggressive lymphoma; Oncology; Rituximab","score_opus":0.06579895834791276,"score_gpt":0.36604472815729977,"score_spread":0.300245769809387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W336660519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034519125,0.9986846,0.00011367024,0.00018299533,0.00013895077,0.00000407872,0.00001215299,0.0000061950814,0.000512187],"genre_scores_gemma":[0.0037564319,0.9945984,0.00037088286,0.0005866311,0.00031783158,0.000011098089,0.000038642123,0.0000015106309,0.0003186425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982977,0.000045561905,0.000044127024,0.000027815837,0.000039645052,0.0000129835935],"domain_scores_gemma":[0.99967504,0.0001884796,0.00007611713,0.0000058206033,0.000036771387,0.000017747749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004194687,0.00064345653,0.0016341016,0.0012663322,0.0001868702,0.00056893047,0.0006018781,0.00064378866,0.0017205914],"category_scores_gemma":[0.0009783463,0.00018633786,0.0005330363,0.0011940309,0.00020219208,0.0007753873,0.00028389852,0.00094600115,0.00055709126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016863419,0.00007537609,0.0013357179,0.014348999,0.00020990106,0.00083118165,0.000054315395,0.000398519,0.0005470984,0.00040639387,0.020268086,0.9613557],"study_design_scores_gemma":[0.00045606936,0.00088602444,0.02081512,0.030359857,0.003926563,0.025462067,0.00033454224,0.0006781345,0.0009867448,0.0018415694,0.9141749,0.00007840408],"about_ca_topic_score_codex":0.0008675287,"about_ca_topic_score_gemma":0.0027657868,"teacher_disagreement_score":0.0017205914,"about_ca_system_score_codex":0.00040960222,"about_ca_system_score_gemma":0.0005527952,"threshold_uncertainty_score":0.0057559013},"labels":[],"label_agreement":null},{"id":"W4205682020","doi":"10.1007/s00277-021-04728-0","title":"The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease","year":2022,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Toronto; Centre Hospitalier de l’Université de Montréal","funders":"Chiesi USA","keywords":"Deferiprone; Medicine; Dosing; Thalassemia; Pharmacokinetics; Urine; Deferasirox; Deferoxamine; Adverse effect; Internal medicine; Pharmacology; Hematology; Anemia; Gastroenterology","score_opus":0.01796521055900754,"score_gpt":0.2665880147804651,"score_spread":0.24862280422145758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205682020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988587,0.00072051643,0.00017418823,0.000019793897,0.00000270006,0.000021760668,0.000060984035,0.0000083901,0.00013302278],"genre_scores_gemma":[0.9989718,0.00034364732,0.000290135,0.000047733796,0.000011739658,0.000015767182,0.00010426188,0.0000017047959,0.00021321618],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998745,0.00005208823,0.000009082412,0.000023593917,0.000031135565,0.000009664934],"domain_scores_gemma":[0.99975306,0.000072193776,0.00008400677,0.000014246564,0.000028062957,0.000048433587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037672333,0.00019247858,0.0003653604,0.00008731529,0.00013538943,0.00020627196,0.000080312166,0.00024633593,0.0004947808],"category_scores_gemma":[0.00061448803,0.00009223114,0.00014857475,0.00008809854,0.00012372341,0.00013233593,0.00007062566,0.000246001,0.00012388467],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09359961,0.005316991,0.24577372,0.0007777428,0.000617437,0.0014592708,0.0012687811,0.002315454,0.39705402,0.00014423358,0.0013388379,0.25033385],"study_design_scores_gemma":[0.0031784722,0.21173622,0.72901475,0.00006166191,0.0005646876,0.004644008,0.00038627497,0.0037936957,0.041554566,0.00013346296,0.004887786,0.000044286433],"about_ca_topic_score_codex":0.0004688357,"about_ca_topic_score_gemma":0.0007234011,"teacher_disagreement_score":0.0004947808,"about_ca_system_score_codex":0.00014010769,"about_ca_system_score_gemma":0.00020420975,"threshold_uncertainty_score":0.0019922853},"labels":[],"label_agreement":null},{"id":"W4210768949","doi":"10.1007/s00277-021-04741-3","title":"Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor","year":2022,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Imatinib; Medicine; Hematology; Edema; Cotransporter; Internal medicine; Pharmacology; Sodium; Chemistry","score_opus":0.04498074340292752,"score_gpt":0.3127137283626949,"score_spread":0.2677329849597674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210768949","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.334989,0.017382836,0.009392751,0.5526785,0.028250366,0.0004730863,0.00038020313,0.0004850457,0.055968117],"genre_scores_gemma":[0.8294223,0.006091166,0.0035693895,0.12593246,0.018230725,0.00021264715,0.00023897234,0.00005324983,0.01624912],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99966943,0.000074794756,0.00003671746,0.000030025161,0.00008132076,0.000107731066],"domain_scores_gemma":[0.9995035,0.00023155479,0.00005614485,0.000027758115,0.000043184675,0.00013788384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033652407,0.00055479154,0.0006374898,0.00031617607,0.0009759659,0.0006171953,0.00043449504,0.0048409165,0.0010085073],"category_scores_gemma":[0.0021082968,0.0002107307,0.00101138,0.00021211944,0.00056856644,0.00084450154,0.0004251042,0.0051976065,0.0005428334],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012741908,0.00075812347,0.005857701,0.00020958616,0.00015570279,0.8507996,0.0002804982,0.0010409406,0.0058531556,0.005293315,0.07778714,0.05069001],"study_design_scores_gemma":[0.0025058968,0.0026926144,0.01749297,0.00033625792,0.00026582173,0.8122522,0.0003435525,0.011480646,0.0078109424,0.010921378,0.13377282,0.0001249215],"about_ca_topic_score_codex":0.0007015403,"about_ca_topic_score_gemma":0.0016737578,"teacher_disagreement_score":0.0048409165,"about_ca_system_score_codex":0.0010939592,"about_ca_system_score_gemma":0.0006951016,"threshold_uncertainty_score":0.0079372525},"labels":[],"label_agreement":null},{"id":"W4220705606","doi":"10.1007/s00277-022-04819-6","title":"Acquired hemophilia A following allogeneic stem cell transplantation for acute lymphoblastic leukemia","year":2022,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Hematology; Medicine; Transplantation; Lymphoblastic Leukemia; Stem cell; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Acute lymphocytic leukemia; Leukemia; Immunology; Biology; Genetics","score_opus":0.05336101954748524,"score_gpt":0.34118825414752507,"score_spread":0.28782723460003984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220705606","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26788655,0.008408405,0.0020407673,0.58676434,0.020211402,0.00024593825,0.00040085515,0.00018280065,0.11385902],"genre_scores_gemma":[0.73165625,0.0054479404,0.0011787066,0.18569903,0.04720475,0.00007841682,0.0003825675,0.000091705835,0.02826068],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99908316,0.00026154952,0.000101564205,0.00008307973,0.0001712562,0.00029937652],"domain_scores_gemma":[0.9975241,0.0010670059,0.00037475524,0.00009599939,0.00018995866,0.00074826565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008211624,0.00065758347,0.000762884,0.0007572518,0.0027798512,0.001711406,0.0010686355,0.013697516,0.0044550705],"category_scores_gemma":[0.0064095305,0.0003807792,0.0011204168,0.00081018003,0.0013280147,0.0012539302,0.0008469566,0.009723901,0.0013528888],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023211699,0.0002596564,0.013772059,0.00006526544,0.00004573807,0.92746764,0.00030693872,0.00022570723,0.00057190255,0.0027810135,0.04844579,0.0058261147],"study_design_scores_gemma":[0.00039605878,0.00071531534,0.022288792,0.00027971627,0.00016771784,0.9013441,0.0013892475,0.0029074962,0.0008328063,0.006575665,0.063045695,0.00005731739],"about_ca_topic_score_codex":0.0037331905,"about_ca_topic_score_gemma":0.006501823,"teacher_disagreement_score":0.013697516,"about_ca_system_score_codex":0.0031009777,"about_ca_system_score_gemma":0.002273769,"threshold_uncertainty_score":0.022499263},"labels":[],"label_agreement":null},{"id":"W4225666888","doi":"10.1007/s00277-022-04802-1","title":"The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes","year":2022,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Work & Health; Princess Margaret Cancer Centre; Ottawa Hospital; University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Internal medicine; Metformin; Proportional hazards model; Prospective cohort study; Observational study; Lower risk; Univariate analysis; Cohort study; Gastroenterology; Multivariate analysis; Confidence interval; Insulin","score_opus":0.05729911595939554,"score_gpt":0.38082765852620953,"score_spread":0.323528542566814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225666888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966929,0.026142066,0.00014527078,0.0017869932,0.00017558598,0.000013856871,0.00054389075,0.000010468877,0.004252893],"genre_scores_gemma":[0.9925719,0.0058147577,0.00014070862,0.0004201064,0.00025479647,0.000006852324,0.00042222874,0.00000325995,0.00036532682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929404,0.0002656238,0.00009246541,0.000058470687,0.00016883078,0.00012060868],"domain_scores_gemma":[0.9983432,0.0005125484,0.00064169447,0.00006377208,0.0001271449,0.00031164841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176474,0.00023590785,0.00046869472,0.00031843063,0.00019189733,0.0008981828,0.00021189384,0.00030788893,0.0008930541],"category_scores_gemma":[0.0035379014,0.00009183122,0.0009454033,0.00052862626,0.00020515981,0.00033063843,0.00034191852,0.00082049484,0.00009714189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028490815,0.000709686,0.80360097,0.00033814728,0.0033160439,0.00050746475,0.00006777266,0.00076663087,0.0013363485,0.00047243442,0.0020722125,0.15832156],"study_design_scores_gemma":[0.00083332893,0.0030154448,0.98893625,0.00014630001,0.0020670134,0.0004517998,0.00020455227,0.00075913966,0.00052297354,0.0005451297,0.0024984032,0.000019703564],"about_ca_topic_score_codex":0.0021192823,"about_ca_topic_score_gemma":0.0041338406,"teacher_disagreement_score":0.0021192823,"about_ca_system_score_codex":0.00052035233,"about_ca_system_score_gemma":0.0007213964,"threshold_uncertainty_score":0.005381882},"labels":[],"label_agreement":null},{"id":"W4246592208","doi":"10.1007/s00277-020-04280-3","title":"Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A","year":2020,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Bayer","keywords":"Pharmacokinetics; Medicine; Crossover study; Certolizumab pegol; Bioequivalence; Pharmacology; NONMEM; Adverse effect; Dosing; Internal medicine; Placebo","score_opus":0.06846704112382167,"score_gpt":0.386363915627459,"score_spread":0.3178968745036373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246592208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567837,0.0008822292,0.00073624594,0.00010303829,0.00016156228,0.0017896367,0.00025858998,0.000042521096,0.00034775608],"genre_scores_gemma":[0.99400866,0.0005613211,0.001680067,0.00026859608,0.0003177201,0.002156495,0.0003348485,0.000014013803,0.0006583778],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756074,0.0013606977,0.00017358967,0.0004866646,0.00018495697,0.00023335664],"domain_scores_gemma":[0.99646413,0.0011474354,0.00081298733,0.00050055207,0.00022169063,0.00085317873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036295853,0.001654402,0.004777781,0.0005172493,0.0004704545,0.0012467685,0.0008526398,0.0018134303,0.00380201],"category_scores_gemma":[0.003542002,0.0010134485,0.002240395,0.0005652334,0.0017473141,0.0015974804,0.00047590648,0.002642628,0.00077261217],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.972132,0.013186277,0.0010543735,0.0001588819,0.0004984283,0.000035862697,0.00006806758,0.00024580408,0.005409145,0.00007616987,0.0001321087,0.0070028114],"study_design_scores_gemma":[0.56642807,0.42832345,0.0031687473,0.000009597942,0.00036912167,0.000041947,0.00002651634,0.00048605504,0.00066603674,0.00008272433,0.00037637862,0.000021271739],"about_ca_topic_score_codex":0.0004708334,"about_ca_topic_score_gemma":0.0006044515,"teacher_disagreement_score":0.004777781,"about_ca_system_score_codex":0.0007634887,"about_ca_system_score_gemma":0.001227937,"threshold_uncertainty_score":0.019195259},"labels":[],"label_agreement":null},{"id":"W4281664443","doi":"10.1007/s00277-022-04873-0","title":"Successful treatment of Kimura disease with benralizumab","year":2022,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Benralizumab; Medicine; Internal medicine; Hematology; Kimura's disease; Dermatology; Oncology; Disease; Eosinophil","score_opus":0.042284075268748014,"score_gpt":0.3099470528048578,"score_spread":0.2676629775361098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281664443","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18847466,0.018138507,0.005750747,0.6468021,0.04463099,0.00037516118,0.00044469972,0.00042153444,0.09496168],"genre_scores_gemma":[0.70406395,0.0072844727,0.0038302622,0.18899876,0.056196712,0.00019018173,0.0004002055,0.00012561976,0.038909826],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999416,0.00015913288,0.000059663445,0.000064100735,0.00011095808,0.00019017053],"domain_scores_gemma":[0.99911135,0.00042402858,0.000058604626,0.00006801868,0.000066448345,0.0002715283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007415589,0.0009124624,0.00094045495,0.0005788173,0.0019031505,0.0011633908,0.00090005086,0.012467065,0.0013108355],"category_scores_gemma":[0.0034558875,0.0004196883,0.0013164883,0.00033596565,0.0009698024,0.0011690358,0.0005803641,0.0076886807,0.0008950385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007272184,0.0003994317,0.007161768,0.00012154719,0.00010436357,0.9025992,0.00018983222,0.000781457,0.0022370273,0.0035893465,0.0653744,0.016714407],"study_design_scores_gemma":[0.0015384125,0.001723887,0.018827427,0.00032366795,0.00022087037,0.75328267,0.0003841065,0.0076797195,0.0042759017,0.009696569,0.20192814,0.00011859899],"about_ca_topic_score_codex":0.0012948107,"about_ca_topic_score_gemma":0.003388941,"teacher_disagreement_score":0.012467065,"about_ca_system_score_codex":0.0015657583,"about_ca_system_score_gemma":0.00078049727,"threshold_uncertainty_score":0.011360407},"labels":[],"label_agreement":null},{"id":"W4292148259","doi":"10.1007/s00277-022-04960-2","title":"Practice patterns and outcomes of hemophagocytic lymphohistiocytosis in adults: a 2-decade provincial retrospective review","year":2022,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Etoposide; Retrospective cohort study; Internal medicine; Malignancy; Pediatrics; Disease; Chemotherapy","score_opus":0.02781274192636644,"score_gpt":0.35904159555415005,"score_spread":0.3312288536277836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292148259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814674,0.013916139,0.00014939749,0.00029055655,0.00002151298,0.000029483157,0.0031916602,0.000008204099,0.00092557777],"genre_scores_gemma":[0.9927222,0.005138133,0.00011888162,0.00019438444,0.000021706495,0.000027960928,0.0016046248,0.000005323876,0.00016671978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998283,0.00023233493,0.00049368513,0.00042747322,0.00029586043,0.0002677576],"domain_scores_gemma":[0.99465734,0.00089800416,0.0029055225,0.00018473901,0.00092741643,0.0004269176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096419896,0.00021685977,0.00058122294,0.002156096,0.00059797964,0.001247422,0.0005612861,0.0005851048,0.0017077106],"category_scores_gemma":[0.004863063,0.00045383247,0.0008517267,0.0055265278,0.00045198313,0.0012191597,0.0008471504,0.00042668614,0.00026972746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039325238,0.00001536006,0.99706167,0.00019528926,0.00011262825,0.00021155957,0.00026841805,0.000021498368,0.000054113836,0.000037644193,0.0003336559,0.0016488262],"study_design_scores_gemma":[0.000010550443,0.000046875673,0.99509525,0.00031983375,0.00013819373,0.001456948,0.0017483652,0.000112243295,0.000041758187,0.000026533704,0.0009918709,0.000011637251],"about_ca_topic_score_codex":0.047997776,"about_ca_topic_score_gemma":0.055035196,"teacher_disagreement_score":0.047997776,"about_ca_system_score_codex":0.0016097778,"about_ca_system_score_gemma":0.0023850186,"threshold_uncertainty_score":0.09543681},"labels":[],"label_agreement":null},{"id":"W4293795326","doi":"10.1007/s00277-022-04964-y","title":"Amyloidosis and COVID-19: experience from an amyloid program in Canada","year":2022,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Foothills Medical Centre; Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Amyloidosis; Pandemic; Internal medicine; Transthyretin; Hematology; Population; Cohort; Concomitant; Disease; Pediatrics; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.03470222533392248,"score_gpt":0.34394131559428476,"score_spread":0.3092390902603623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293795326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517334,0.0015118713,0.0002313172,0.0029151367,0.000080862344,0.00019062942,0.0008698207,0.000019173713,0.009007776],"genre_scores_gemma":[0.98659074,0.0030957044,0.0006243114,0.00139035,0.00006787835,0.000044579603,0.0009135703,0.00004294348,0.007229966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985336,0.00014468869,0.000049186838,0.000096850796,0.00041546204,0.0007602105],"domain_scores_gemma":[0.99470466,0.00021617876,0.00027999099,0.000059145597,0.001355039,0.003385051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092660374,0.00049820996,0.0004448449,0.00060767937,0.0056715645,0.0020945002,0.0010230839,0.00091240724,0.0026226032],"category_scores_gemma":[0.0021561997,0.00031907094,0.00038165718,0.00243882,0.0011871092,0.00043709937,0.0016488982,0.0011777176,0.00045461007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012551043,0.0029512853,0.88393205,0.00016027752,0.000114294955,0.013530782,0.012161091,0.00063086784,0.0018593324,0.0009666331,0.011673845,0.070764445],"study_design_scores_gemma":[0.00026748696,0.0018538543,0.9317709,0.00027031504,0.0001239416,0.0068494724,0.027429212,0.00087700255,0.0007633772,0.00034175778,0.029337876,0.00011480688],"about_ca_topic_score_codex":0.943743,"about_ca_topic_score_gemma":0.97912794,"teacher_disagreement_score":0.05625701,"about_ca_system_score_codex":0.034980517,"about_ca_system_score_gemma":0.060052026,"threshold_uncertainty_score":0.25380266},"labels":[],"label_agreement":null},{"id":"W4295897797","doi":"10.1007/s00277-022-04969-7","title":"Catheter management across patients with hematologic malignancies and catheter-related blood stream infections: a systematic review","year":2022,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; McMaster University; Mount Sinai Hospital; Health Sciences Centre; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Observational study; Internal medicine; Catheter; Bacteremia; Population; Coagulopathy; Hematology; Intensive care medicine; Surgery; Antibiotics","score_opus":0.07435339723439391,"score_gpt":0.3967337928334751,"score_spread":0.32238039559908116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295897797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013426455,0.998078,0.000052548527,0.00010171169,0.00005293436,0.00007002425,0.00020736919,0.000004288168,0.00009039],"genre_scores_gemma":[0.024974147,0.9736544,0.0003865464,0.0006118859,0.000048988863,0.00009390458,0.00015376128,0.0000039274205,0.00007244111],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99716175,0.0006817463,0.0012589967,0.00035234055,0.00039522976,0.0001499623],"domain_scores_gemma":[0.9926017,0.004438274,0.0021576956,0.00009150572,0.0005552069,0.00015564164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027025666,0.0011572548,0.006057585,0.0049918033,0.00044081296,0.0018020612,0.0012646718,0.0017097637,0.003597159],"category_scores_gemma":[0.013615327,0.000916704,0.007380703,0.00609348,0.00061619765,0.0016749557,0.0014381238,0.0013244371,0.00020259175],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004127352,0.00003762283,0.0032085946,0.92528224,0.032670017,0.00012859765,0.00023634845,0.00015244269,0.00020676936,0.000118241376,0.0021015354,0.035444893],"study_design_scores_gemma":[0.00094753073,0.00043208673,0.015300833,0.6525175,0.3098441,0.00066970434,0.0006479614,0.00013097034,0.00019499678,0.00025742498,0.018965956,0.000090956135],"about_ca_topic_score_codex":0.0106010735,"about_ca_topic_score_gemma":0.041292578,"teacher_disagreement_score":0.0106010735,"about_ca_system_score_codex":0.0019266806,"about_ca_system_score_gemma":0.005142696,"threshold_uncertainty_score":0.021078765},"labels":[],"label_agreement":null},{"id":"W4310117789","doi":"10.1007/s00277-022-05060-x","title":"EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia","year":2022,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Alemtuzumab; Prolymphocytic leukemia; Hematology; Medicine; Lymphoma; Internal medicine; Leukemia; Oncology; Cancer research; Pathology; Immunology; Chronic lymphocytic leukemia; Transplantation","score_opus":0.04180540435871588,"score_gpt":0.3331331674825112,"score_spread":0.2913277631237953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310117789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42201704,0.017427968,0.0030825757,0.3842689,0.014864467,0.00044319255,0.00068640907,0.00043011567,0.15677935],"genre_scores_gemma":[0.87588775,0.0050848196,0.001202301,0.079989366,0.020382319,0.000078818935,0.00033437327,0.000085151296,0.016955107],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99934334,0.00016583296,0.000077807395,0.00006637523,0.0001232428,0.00022332167],"domain_scores_gemma":[0.9981275,0.0008540697,0.00023507579,0.00010332307,0.00018013162,0.0004998322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068218686,0.00079453504,0.0009124029,0.0007733554,0.002181893,0.0015348158,0.0009855547,0.008032432,0.0026619153],"category_scores_gemma":[0.004974999,0.0004291604,0.0010534228,0.0007549835,0.0010945717,0.0012433378,0.00053620327,0.0050768135,0.0011733689],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039501002,0.0001486474,0.012716349,0.00006927028,0.00004562872,0.9569388,0.00019484607,0.00026424747,0.00092556124,0.0009285689,0.020687228,0.006685821],"study_design_scores_gemma":[0.00035490593,0.0007019804,0.023561884,0.00023346662,0.00026154754,0.9199467,0.0007445888,0.0039936136,0.0017549183,0.0030433824,0.045353454,0.000049694547],"about_ca_topic_score_codex":0.0042263707,"about_ca_topic_score_gemma":0.0071716616,"teacher_disagreement_score":0.008032432,"about_ca_system_score_codex":0.0032031254,"about_ca_system_score_gemma":0.0018579052,"threshold_uncertainty_score":0.023240387},"labels":[],"label_agreement":null},{"id":"W4312066395","doi":"10.1007/s00277-022-05064-7","title":"The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure","year":2022,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Frailty Network","keywords":"Medicine; Internal medicine; Mechanical ventilation; Retrospective cohort study; Respiratory failure; Mortality rate; Risk of mortality","score_opus":0.040020149706732,"score_gpt":0.3560583108014074,"score_spread":0.31603816109467536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312066395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983127,0.00043133373,0.00005793172,0.00015393691,0.000026302645,0.000005188181,0.0002965653,0.0000025195582,0.0007134846],"genre_scores_gemma":[0.99928313,0.000092636605,0.000036004727,0.00006589914,0.00003116556,0.0000046767623,0.00036429873,0.000001501657,0.000120636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992582,0.00015538956,0.00012423827,0.00015042112,0.000118843534,0.00019280186],"domain_scores_gemma":[0.9978206,0.0003918029,0.00093455875,0.00011078348,0.00020798427,0.0005341205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007402072,0.00032931875,0.0005206805,0.0007330362,0.0005092861,0.0012954633,0.00051570445,0.0006912822,0.0020979075],"category_scores_gemma":[0.003338728,0.00021661342,0.0009381469,0.0011443725,0.0003681542,0.00077383383,0.0011202071,0.0014438721,0.00023369245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000172909,0.000022747421,0.9988205,0.0000067940114,0.00013481136,0.000039934046,0.000027425416,0.000029650835,0.00010217619,0.000019439096,0.00006825446,0.0005554013],"study_design_scores_gemma":[0.0000072416306,0.00007924964,0.9992505,0.0000061925007,0.000054637294,0.00009039026,0.00018657988,0.00018337253,0.000025051158,0.00003208593,0.00008123095,0.0000034853817],"about_ca_topic_score_codex":0.0045908205,"about_ca_topic_score_gemma":0.00601319,"teacher_disagreement_score":0.0045908205,"about_ca_system_score_codex":0.0005409752,"about_ca_system_score_gemma":0.00057077437,"threshold_uncertainty_score":0.009128153},"labels":[],"label_agreement":null},{"id":"W4315782895","doi":"10.1007/s00277-022-05071-8","title":"Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; Acceleron; Bristol-Myers Squibb","keywords":"Medicine; Myelodysplastic syndromes; Blood transfusion; Internal medicine; Serum ferritin; Anemia; Placebo; Ferritin; Hemoglobin; Surgery; Bone marrow","score_opus":0.03680524295353615,"score_gpt":0.34079650312235943,"score_spread":0.3039912601688233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315782895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982311,0.0005249462,0.00008472975,0.000051699604,0.000010698302,0.00006610241,0.00054854894,0.000007083571,0.0004750067],"genre_scores_gemma":[0.9978719,0.00011151231,0.00013021044,0.0001152546,0.000044124186,0.000050096478,0.0012655815,0.000003394192,0.00040794275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956065,0.00016029591,0.000045098168,0.000092167465,0.00007443866,0.00006734228],"domain_scores_gemma":[0.9990363,0.00021487323,0.00027889016,0.000109549816,0.000083834784,0.00027655152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013284702,0.0005420338,0.0014683659,0.00030151245,0.00026137292,0.00072949077,0.00031804046,0.00047864637,0.0015943439],"category_scores_gemma":[0.0010651118,0.00018836484,0.0015648878,0.00030610678,0.00022799092,0.0003683959,0.0003018611,0.00092969224,0.0002549279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3270033,0.002937794,0.5868494,0.0005030512,0.004769229,0.00075036194,0.0003231407,0.0015118438,0.023321513,0.00021187072,0.0027007775,0.049117655],"study_design_scores_gemma":[0.018534595,0.032552153,0.9397296,0.000031895022,0.0022304826,0.00094736443,0.00011998615,0.0019404115,0.0015681772,0.00018283632,0.002120701,0.000041848838],"about_ca_topic_score_codex":0.00047999152,"about_ca_topic_score_gemma":0.00098528,"teacher_disagreement_score":0.0015943439,"about_ca_system_score_codex":0.00030522727,"about_ca_system_score_gemma":0.00031646737,"threshold_uncertainty_score":0.0070257187},"labels":[],"label_agreement":null},{"id":"W4321611085","doi":"10.1007/s00277-023-05135-3","title":"Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hematopoietic cell; Hematology; Single Center; Medicine; Transplantation; Hematopoietic stem cell transplantation; Outcome (game theory); Center (category theory); Internal medicine; Oncology; Haematopoiesis; Stem cell; Biology","score_opus":0.05498500921512752,"score_gpt":0.3607971566290518,"score_spread":0.3058121474139243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956304,0.00007070098,0.000021953838,0.000025255486,0.0000044069016,0.0000027705378,0.000036690766,9.1099014e-7,0.00027430223],"genre_scores_gemma":[0.9997707,0.000052612955,0.000022332417,0.000020122276,0.000012948749,0.000002082312,0.000064744054,0.0000013081801,0.00005303486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995864,0.000098956065,0.00004314063,0.00006324955,0.000060815186,0.0001475064],"domain_scores_gemma":[0.9990109,0.00018464435,0.0002671972,0.00004956685,0.00008920995,0.00039835396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043369454,0.00023383419,0.00037986663,0.00047689554,0.00082128023,0.00079475425,0.00029787043,0.00039106735,0.0015862173],"category_scores_gemma":[0.001366708,0.00016172719,0.00044163543,0.00061760726,0.00039092722,0.00055925257,0.0005616591,0.00061215454,0.00017852629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025526198,0.0002353704,0.99467564,0.0000063853695,0.000042652784,0.0014603217,0.0002893747,0.00008242501,0.0002910153,0.000043112534,0.00014594271,0.0024724992],"study_design_scores_gemma":[0.000020588079,0.00074897095,0.99372166,0.000010454655,0.00004078637,0.0031716754,0.0016615513,0.0002034336,0.00016002398,0.000061771694,0.00018611837,0.000012920974],"about_ca_topic_score_codex":0.0033442925,"about_ca_topic_score_gemma":0.004842918,"teacher_disagreement_score":0.0033442925,"about_ca_system_score_codex":0.00066925323,"about_ca_system_score_gemma":0.0006444671,"threshold_uncertainty_score":0.006649673},"labels":[],"label_agreement":null},{"id":"W4376225548","doi":"10.1007/s00277-023-05196-4","title":"RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"National Cancer Institute; MorphoSys","keywords":"Lenalidomide; Medicine; Rituximab; Internal medicine; Bendamustine; Oncology; Clinical endpoint; Surgery; Multiple myeloma; Lymphoma; Clinical trial","score_opus":0.0815092479124416,"score_gpt":0.3680034390507228,"score_spread":0.28649419113828123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376225548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700874,0.0011525879,0.00021527398,0.00009709943,0.000052954812,0.0003173634,0.00048084644,0.000013229591,0.0006618532],"genre_scores_gemma":[0.997358,0.00040510113,0.00043415377,0.00014105189,0.00008603954,0.0002494007,0.0009400501,0.0000049687073,0.0003812095],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99916625,0.00053324876,0.000063203915,0.00011916727,0.00005469149,0.00006347549],"domain_scores_gemma":[0.9987218,0.00042213188,0.00043001925,0.000118759686,0.00004608699,0.00026117402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021441479,0.0007989789,0.0011109307,0.00030634177,0.00012260044,0.0006969848,0.0007558996,0.00060222094,0.001622512],"category_scores_gemma":[0.0019678972,0.00034319088,0.0021840534,0.00023185568,0.00046293047,0.0006073837,0.0005021038,0.0014145956,0.0002245131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9532242,0.0049781944,0.008596424,0.00033735333,0.0029264265,0.00004188895,0.000057600108,0.0018193788,0.0042765928,0.00012182693,0.0003822599,0.023237858],"study_design_scores_gemma":[0.4595904,0.4721213,0.050117124,0.00008140953,0.0053469706,0.00031933896,0.00010707799,0.0055257133,0.0037950461,0.00054541306,0.0023835704,0.00006666274],"about_ca_topic_score_codex":0.00056680304,"about_ca_topic_score_gemma":0.0014252316,"teacher_disagreement_score":0.0021441479,"about_ca_system_score_codex":0.00088332023,"about_ca_system_score_gemma":0.0005540079,"threshold_uncertainty_score":0.011339426},"labels":[],"label_agreement":null},{"id":"W4377011803","doi":"10.1007/s00277-023-05269-4","title":"Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry","year":2023,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Alexion Pharmaceuticals; AstraZeneca","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Internal medicine; Eculizumab; clone (Java method); Hematology; Gastroenterology; CD59; Lactate dehydrogenase; Immunology; Hemolysis; Complement system; Biology","score_opus":0.060358837615350304,"score_gpt":0.3334364273960921,"score_spread":0.27307758978074176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377011803","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855655,0.00024378656,0.00008711939,0.000011619673,0.000002100195,0.0000063932803,0.0008332361,0.0000040009886,0.00025510436],"genre_scores_gemma":[0.99847955,0.00012389675,0.00006872017,0.000011619066,0.000007765838,0.000008703125,0.0012257611,0.000002314493,0.00007179113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994991,0.00015981698,0.000065622415,0.00012629668,0.0001055504,0.000043552875],"domain_scores_gemma":[0.9976413,0.00045428763,0.0011984275,0.0002940985,0.00018103095,0.00023085176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077635027,0.00014909658,0.00041325742,0.00064325175,0.00018318938,0.00043599593,0.0002894375,0.0002947182,0.00073829415],"category_scores_gemma":[0.002411495,0.00015126952,0.00041854125,0.00081431,0.00012310359,0.00028426063,0.00033642576,0.00031583352,0.00012658062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016884028,0.000011905669,0.9985776,0.000005412682,0.000063680614,0.000032049036,0.00001785079,0.00004280802,0.000099333716,0.000007632049,0.00006461778,0.00090818986],"study_design_scores_gemma":[0.000010739066,0.000058848847,0.99945885,0.000002031357,0.000030964704,0.00018031514,0.000016955435,0.00011227778,0.000034522418,0.000007385809,0.00008522912,0.0000019696233],"about_ca_topic_score_codex":0.0019145682,"about_ca_topic_score_gemma":0.0019409659,"teacher_disagreement_score":0.0019145682,"about_ca_system_score_codex":0.00015043152,"about_ca_system_score_gemma":0.00014121544,"threshold_uncertainty_score":0.0041058064},"labels":[],"label_agreement":null},{"id":"W4383873053","doi":"10.1007/s00277-023-05321-3","title":"Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma","year":2023,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Bendamustine; Internal medicine; Oncology; Hematology; Multiple myeloma; Lymphoma","score_opus":0.05545757967693467,"score_gpt":0.33499105010752045,"score_spread":0.2795334704305858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383873053","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017098965,0.0011068016,0.000309975,0.07213001,0.92448443,0.00002811441,0.000614754,0.00012829772,0.0010266744],"genre_scores_gemma":[0.01150387,0.007078629,0.0033852893,0.18378167,0.7360835,0.0002595366,0.0015263017,0.00074003736,0.05564109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948113,0.0013151885,0.0011664227,0.0005656977,0.0017586232,0.00038272637],"domain_scores_gemma":[0.9565439,0.019315295,0.0024657652,0.0012666889,0.018571552,0.0018367365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006690502,0.002126522,0.0024088533,0.0025261946,0.0017133076,0.0038088644,0.0028643531,0.0061319745,0.024463603],"category_scores_gemma":[0.08604423,0.0010588922,0.0024433346,0.001815268,0.0017206183,0.0016268999,0.0010009139,0.012024469,0.0118269725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008227795,0.00000726885,0.00005726053,0.00014437834,0.000023830415,0.00016423302,0.00001543688,0.00003853555,0.000031636475,0.00024337244,0.99609154,0.0031002022],"study_design_scores_gemma":[0.00044333722,0.000077601355,0.0012212645,0.0010538842,0.00021746637,0.0011218737,0.00010509541,0.0005564506,0.00049970136,0.0017207543,0.9929172,0.00006547283],"about_ca_topic_score_codex":0.010593714,"about_ca_topic_score_gemma":0.010790257,"teacher_disagreement_score":0.024463603,"about_ca_system_score_codex":0.0039756787,"about_ca_system_score_gemma":0.0055565527,"threshold_uncertainty_score":0.081838846},"labels":[],"label_agreement":null},{"id":"W4386438360","doi":"10.1007/s00277-023-05402-3","title":"Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Alexion Pharmaceuticals; Universität Ulm; AstraZeneca","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Odds ratio; Hemoglobinuria; Hematology; Gastroenterology; Confidence interval; Anemia","score_opus":0.0374355744573933,"score_gpt":0.31940972014754354,"score_spread":0.2819741456901502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386438360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909914,0.00013865561,0.00033041858,0.00001821489,0.0000069814523,0.00001796041,0.00017007955,0.0000024799704,0.00021603187],"genre_scores_gemma":[0.9993063,0.00006528334,0.00023234342,0.000031753174,0.000014232785,0.000022655084,0.00023796514,0.0000019573545,0.00008757814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890614,0.00042174375,0.000078527446,0.0003509877,0.00015878266,0.00008388792],"domain_scores_gemma":[0.9985152,0.0003521137,0.00056051183,0.00030540748,0.0001064219,0.00016029678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015742554,0.00029753038,0.00047000515,0.00043441635,0.0005732641,0.0005661057,0.0004852858,0.00040260266,0.0006900043],"category_scores_gemma":[0.002773924,0.00047660427,0.0005829228,0.0006254668,0.00039714001,0.00036008953,0.00037905015,0.00058919674,0.000104357925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028213786,0.000103029895,0.99786806,0.000010593977,0.00017329492,0.00016887499,0.00015446439,0.000027287058,0.0004123861,0.000053232,0.00011862604,0.00062793825],"study_design_scores_gemma":[0.00007487357,0.00023684558,0.9973756,0.000009761038,0.00015506885,0.0010244065,0.00015754013,0.00045189433,0.00011153511,0.000055503937,0.00033981382,0.000007197084],"about_ca_topic_score_codex":0.00455787,"about_ca_topic_score_gemma":0.0048048384,"teacher_disagreement_score":0.00455787,"about_ca_system_score_codex":0.00026553823,"about_ca_system_score_gemma":0.00033485782,"threshold_uncertainty_score":0.009062707},"labels":[],"label_agreement":null},{"id":"W4386944793","doi":"10.1007/s00277-023-05457-2","title":"CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia","year":2023,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CRISPR; Chimeric antigen receptor; Genome editing; Cas9; Genetic enhancement; Hematology; Leukemia; Medicine; Immunotherapy; Cancer; Computational biology; Cancer research; Immunology; Bioinformatics; Biology; Gene; Internal medicine; Genetics","score_opus":0.08393311741432646,"score_gpt":0.3954667325821671,"score_spread":0.3115336151678406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386944793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018231664,0.99669385,0.00071604433,0.0005880288,0.00052999693,0.0000072437633,0.00004657006,0.000041758947,0.0011941193],"genre_scores_gemma":[0.0015264753,0.9952755,0.00078594947,0.0006729224,0.0003241286,0.000010268152,0.000106098574,0.0000059285994,0.0012926746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998115,0.00003005295,0.000020157766,0.000033421526,0.00008132548,0.000023709266],"domain_scores_gemma":[0.9997602,0.00011238192,0.000026970836,0.00000727788,0.00006129364,0.000031928357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005383449,0.00073616754,0.0010577268,0.0014784315,0.00020184343,0.00084435835,0.00092176726,0.0011125994,0.0028829472],"category_scores_gemma":[0.0006137216,0.00017735711,0.0005033152,0.0010725008,0.00038920218,0.0007927635,0.00053868035,0.0022972669,0.0012499421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106752654,0.000078964695,0.00012728958,0.0064679673,0.0000858325,0.00017966257,0.000021895585,0.00027322868,0.004505458,0.0037557427,0.04910353,0.9352936],"study_design_scores_gemma":[0.00004626412,0.00013857342,0.0005599617,0.0010378007,0.00015515105,0.0011662482,0.000024453153,0.00020411362,0.0021420484,0.0020661019,0.992432,0.000027323595],"about_ca_topic_score_codex":0.00090658903,"about_ca_topic_score_gemma":0.0016511603,"teacher_disagreement_score":0.0028829472,"about_ca_system_score_codex":0.0005743798,"about_ca_system_score_gemma":0.0009498807,"threshold_uncertainty_score":0.009644449},"labels":[],"label_agreement":null},{"id":"W4387130674","doi":"10.1007/s00277-023-05462-5","title":"TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches","year":2023,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Venetoclax; Azacitidine; Myeloid leukemia; Myelodysplastic syndromes; Medicine; Myeloid; Oncology; Hematology; Immunotherapy; Internal medicine; Immunology; Immune system; Leukemia; Biology; Chronic lymphocytic leukemia; Bone marrow; DNA methylation","score_opus":0.29477799576228064,"score_gpt":0.4145194577664131,"score_spread":0.11974146200413244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387130674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003499577,0.99901175,0.00004304233,0.00040535763,0.00023428116,0.0000016329852,0.000010714369,0.000003664545,0.00025449903],"genre_scores_gemma":[0.00028893325,0.99868006,0.00009275683,0.00040995554,0.00030591415,0.0000027727826,0.00002457455,9.047074e-7,0.0001941342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971837,0.000059651506,0.000041163952,0.00004345948,0.000105130384,0.00003223228],"domain_scores_gemma":[0.99917465,0.0004394779,0.00009862368,0.000017142835,0.00019699892,0.00007307761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669724,0.00072962046,0.00222778,0.0015564975,0.00026855094,0.001430741,0.001198947,0.0013687811,0.0044041695],"category_scores_gemma":[0.0017727325,0.00026090036,0.000732077,0.0015738276,0.0005303849,0.0020084698,0.0008993033,0.0029526888,0.0019412596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014529504,0.000058819776,0.0002247056,0.0146384975,0.00013094666,0.00019201804,0.00003273598,0.00028696135,0.00065167976,0.0037992483,0.05657536,0.9232637],"study_design_scores_gemma":[0.00006827374,0.00012990175,0.00077848387,0.008224859,0.00030378293,0.0012070066,0.00007987072,0.00013989836,0.00017026872,0.0028890688,0.9859823,0.00002633244],"about_ca_topic_score_codex":0.00095944013,"about_ca_topic_score_gemma":0.0026796767,"teacher_disagreement_score":0.0044041695,"about_ca_system_score_codex":0.000656774,"about_ca_system_score_gemma":0.0016883655,"threshold_uncertainty_score":0.014733374},"labels":[],"label_agreement":null},{"id":"W4387424812","doi":"10.1007/s00277-023-05483-0","title":"Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals; Universität Ulm; AstraZeneca","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Internal medicine; Post-hoc analysis; Hematology; Hemoglobinuria; Quality of life (healthcare); Randomized controlled trial; Anemia; Physical therapy; Immunology; Complement system; Antibody","score_opus":0.043083662614748296,"score_gpt":0.34987764528154064,"score_spread":0.30679398266679236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387424812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889475,0.00029183918,0.0001698817,0.00004302428,0.000033125692,0.00018144674,0.00022604316,0.0000073216747,0.00015270812],"genre_scores_gemma":[0.9983273,0.000097562785,0.00035800412,0.000087089255,0.00006212135,0.0003424546,0.00050339196,0.0000054027187,0.0002167733],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9951793,0.0032755632,0.00026684746,0.00058169843,0.00032814598,0.00036850944],"domain_scores_gemma":[0.9920649,0.004390385,0.0016825483,0.0006879831,0.0003286121,0.0008455404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071544885,0.00096754864,0.0022149624,0.00027204098,0.00035057092,0.001008233,0.000700358,0.0009514894,0.002163701],"category_scores_gemma":[0.005881955,0.0004009316,0.0036801554,0.0003336622,0.0007102733,0.0009538225,0.000549487,0.002090786,0.00022155026],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92726046,0.006809247,0.04516608,0.00017944339,0.0058067353,0.00008042666,0.000107903536,0.0010720824,0.00287891,0.000059713217,0.00046329648,0.010115524],"study_design_scores_gemma":[0.2517237,0.36580896,0.3573274,0.000044443746,0.009606688,0.00021075354,0.00019956115,0.0100077335,0.0036272288,0.0003212572,0.0010161533,0.00010615561],"about_ca_topic_score_codex":0.00035885343,"about_ca_topic_score_gemma":0.00073653593,"teacher_disagreement_score":0.0071544885,"about_ca_system_score_codex":0.0006555664,"about_ca_system_score_gemma":0.0009716293,"threshold_uncertainty_score":0.03783703},"labels":[],"label_agreement":null},{"id":"W4387965367","doi":"10.1007/s00277-023-05505-x","title":"Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis","year":2023,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Daunorubicin; Cytarabine; Medicine; Myeloid leukemia; Hematology; Internal medicine; Oncology; Sample (material); Leukemia; Emergency medicine","score_opus":0.07351378639481465,"score_gpt":0.3241936470834496,"score_spread":0.25067986068863496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387965367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971762,0.0002136857,0.000052131443,0.00061163655,0.00003731238,0.0000146362,0.0012475771,0.0000044979106,0.00064225437],"genre_scores_gemma":[0.99675554,0.00022268006,0.00012153026,0.000747712,0.00010037878,0.000035314846,0.0016541701,0.000003797656,0.00035884284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932826,0.00017020297,0.0001466746,0.000077919394,0.00013566785,0.00014131732],"domain_scores_gemma":[0.9981774,0.0003538557,0.0007060712,0.000112696565,0.00028679386,0.00036318542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014108,0.00024919215,0.0005401022,0.0004972924,0.00048760188,0.00063515373,0.00034914672,0.0006790898,0.000931253],"category_scores_gemma":[0.002349698,0.00032368078,0.0007773564,0.0010980462,0.000122762,0.0004204221,0.0005004818,0.0008629958,0.00017706158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011327587,0.000043427655,0.99787986,0.0000065798845,0.000050951687,0.00013927564,0.000029202029,0.00003047642,0.00007929612,0.000010069455,0.00073347555,0.0008842389],"study_design_scores_gemma":[0.000011001778,0.0000621813,0.9989517,0.0000065551426,0.000035034638,0.00022218555,0.00021051157,0.00024697493,0.000031092088,0.000012003129,0.00020732637,0.0000034062812],"about_ca_topic_score_codex":0.010437036,"about_ca_topic_score_gemma":0.02506819,"teacher_disagreement_score":0.010437036,"about_ca_system_score_codex":0.0007581247,"about_ca_system_score_gemma":0.001005504,"threshold_uncertainty_score":0.020752609},"labels":[],"label_agreement":null},{"id":"W4388418018","doi":"10.1007/s00277-023-05535-5","title":"Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia","year":2023,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Autoimmune hemolytic anemia; Hematology; Anemia; Internal medicine; Immunology; Bone marrow","score_opus":0.07482621262517429,"score_gpt":0.3393682397040566,"score_spread":0.2645420270788823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388418018","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20573531,0.02262636,0.0058591743,0.6770238,0.013333365,0.00008777579,0.00030493696,0.00041481506,0.07461442],"genre_scores_gemma":[0.7487248,0.005250094,0.002432265,0.19298597,0.04120518,0.000048470647,0.00022101284,0.00008813866,0.009044006],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994332,0.00017469679,0.000080689315,0.000059420356,0.00013522251,0.00011672282],"domain_scores_gemma":[0.9978886,0.0010776316,0.00024076547,0.000092165574,0.00017499061,0.0005258279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058529247,0.00028411867,0.00054758444,0.0005057127,0.0011248046,0.0011912975,0.00052274327,0.0070694364,0.0022554682],"category_scores_gemma":[0.0052251252,0.00023457847,0.0007815172,0.00031490205,0.00063145737,0.0009596893,0.0005103046,0.004707854,0.0010908034],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095744606,0.00040110748,0.0631609,0.00018729774,0.0001873533,0.6330129,0.00036161437,0.001274401,0.0036298314,0.006715682,0.20799066,0.082120925],"study_design_scores_gemma":[0.00037377366,0.0009950856,0.029042142,0.00054177816,0.00027399274,0.72445315,0.00066333474,0.0071086036,0.0029710846,0.015734902,0.21775314,0.000089054454],"about_ca_topic_score_codex":0.0012427375,"about_ca_topic_score_gemma":0.0031022234,"teacher_disagreement_score":0.0070694364,"about_ca_system_score_codex":0.0015388298,"about_ca_system_score_gemma":0.0015426229,"threshold_uncertainty_score":0.011165023},"labels":[],"label_agreement":null},{"id":"W4389241247","doi":"10.1007/s00277-023-05552-4","title":"A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Astellas Pharma; Sierra Oncology; Taiho Pharmaceutical; Incyte; CTI Biopharma; MorphoSys; Celgene; Astex Pharmaceuticals; Servier; Pfizer; Constellation Pharmaceuticals; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Hypomethylating agent; Oncology; Pembrolizumab; Myeloid leukemia; Lenalidomide; Decitabine; Cancer; Bone marrow; Multiple myeloma; Immunotherapy; DNA methylation","score_opus":0.04112445603740638,"score_gpt":0.35822954392604023,"score_spread":0.31710508788863384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911623,0.002667561,0.0004488407,0.0010752382,0.0003062527,0.0011783194,0.00089264073,0.0000845696,0.002184303],"genre_scores_gemma":[0.98841465,0.0024358197,0.0015561543,0.0010401024,0.00025639698,0.0014812325,0.0022740113,0.000032431908,0.0025092242],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996271,0.00016998405,0.0000187396,0.00006917415,0.000025422594,0.00008961793],"domain_scores_gemma":[0.99945825,0.000082602666,0.00007594243,0.000038623857,0.000027417973,0.0003172236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013838718,0.0014623496,0.0023695717,0.00040867296,0.00052912784,0.0012503446,0.0008735499,0.0010685831,0.00411879],"category_scores_gemma":[0.0008349861,0.0005958427,0.0016652849,0.0005026234,0.000988329,0.0012414284,0.00036333382,0.004081515,0.0009565495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8711222,0.029283363,0.0030779664,0.00051348214,0.0020289165,0.0001622378,0.00017934605,0.0022531792,0.019926181,0.0003878862,0.004300551,0.066764675],"study_design_scores_gemma":[0.8012963,0.18652162,0.0060597104,0.000030567942,0.00067486777,0.00015956785,0.00007162948,0.0011908552,0.0015253539,0.0002131252,0.0022325427,0.000023902841],"about_ca_topic_score_codex":0.001363567,"about_ca_topic_score_gemma":0.004038927,"teacher_disagreement_score":0.00411879,"about_ca_system_score_codex":0.0011621065,"about_ca_system_score_gemma":0.0015870822,"threshold_uncertainty_score":0.013778746},"labels":[],"label_agreement":null},{"id":"W4391339024","doi":"10.1007/s00277-024-05639-6","title":"Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Minimal residual disease; Transplantation; Hematology; Hematopoietic stem cell transplantation; Adverse effect; Myeloid leukemia; Flow cytometry; Leukemia; Immunology","score_opus":0.0370599322030564,"score_gpt":0.3180151213639174,"score_spread":0.280955189160861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391339024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970515,0.00043791966,0.00041925116,0.00020281543,0.000016746033,0.00002826439,0.00015563052,0.00002108306,0.0016667724],"genre_scores_gemma":[0.9989759,0.000105816776,0.0003642439,0.000097517855,0.000028218656,0.000009762751,0.00022964073,0.0000040506075,0.0001849641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998554,0.00002973451,0.000017039874,0.000027686658,0.000031192212,0.000038901646],"domain_scores_gemma":[0.9996213,0.0001355006,0.0001043463,0.00001742161,0.00003343193,0.000087878274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150654,0.00023398138,0.0003778331,0.0006612792,0.00018984679,0.00068625645,0.0002390075,0.0003534467,0.0013275677],"category_scores_gemma":[0.001065156,0.00007725668,0.00018008104,0.00029488627,0.00024145,0.00038269995,0.00025823605,0.00033731278,0.00029094284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025283638,0.00022501708,0.9295023,0.00003443214,0.000038282844,0.00067005673,0.00007932602,0.0005592522,0.02771762,0.00037891653,0.00078000757,0.03748634],"study_design_scores_gemma":[0.00016696364,0.0016680395,0.97160655,0.00003065125,0.00018378107,0.00381113,0.0003444238,0.007234685,0.00991271,0.0013966141,0.003626828,0.000017588676],"about_ca_topic_score_codex":0.00035488314,"about_ca_topic_score_gemma":0.0007330718,"teacher_disagreement_score":0.0013275677,"about_ca_system_score_codex":0.00022862175,"about_ca_system_score_gemma":0.00024872928,"threshold_uncertainty_score":0.0044412017},"labels":[],"label_agreement":null},{"id":"W4392023045","doi":"10.1007/s00277-024-05657-4","title":"Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ain Shams University","keywords":"Guideline; Medicine; Transfusion medicine; Context (archaeology); Blood transfusion; Fresh frozen plasma; Family medicine; Dosing; Evidence-based practice; Aplastic anemia; Intensive care medicine; Alternative medicine; Surgery; Pathology; Platelet; Internal medicine","score_opus":0.38631063739838095,"score_gpt":0.45248175797937507,"score_spread":0.06617112058099411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392023045","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03530017,0.24543476,0.10152089,0.38190317,0.01808368,0.06576276,0.021359237,0.0022964864,0.12833883],"genre_scores_gemma":[0.060882464,0.1649743,0.6538958,0.059527606,0.0014939506,0.02128225,0.017143017,0.00030443925,0.02049622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98713374,0.00478497,0.0047346544,0.00050583837,0.0022294822,0.0006113184],"domain_scores_gemma":[0.97837985,0.0047914074,0.0023413068,0.0005296223,0.013009561,0.0009483124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014860843,0.0010833808,0.0019081007,0.0053496966,0.0009593574,0.0031166007,0.0029975607,0.0042342064,0.0030690415],"category_scores_gemma":[0.041148778,0.00085788313,0.0035101438,0.0055006435,0.00097521616,0.002471418,0.0028922793,0.005693909,0.0017141332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022096463,0.0005597706,0.006256582,0.03557489,0.0006382867,0.0022920126,0.0041597136,0.002929494,0.0025734792,0.00855319,0.46433008,0.4719115],"study_design_scores_gemma":[0.0008641518,0.0002630981,0.024468582,0.1154722,0.0015199777,0.0021096913,0.0020432177,0.0023063228,0.001408958,0.0063286577,0.8429718,0.0002433014],"about_ca_topic_score_codex":0.023873225,"about_ca_topic_score_gemma":0.05827305,"teacher_disagreement_score":0.023873225,"about_ca_system_score_codex":0.006093402,"about_ca_system_score_gemma":0.022888705,"threshold_uncertainty_score":0.07859254},"labels":[],"label_agreement":null},{"id":"W4392351859","doi":"10.1007/s00277-024-05676-1","title":"Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS","year":2024,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Venetoclax; Adverse Event Reporting System; Medicine; Adverse effect; Internal medicine; Randomized controlled trial; Odds ratio; Oncology; Neutropenia; Meta-analysis; Leukemia; Chemotherapy","score_opus":0.3613101957248982,"score_gpt":0.5259064205257676,"score_spread":0.16459622480086944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392351859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012250207,0.98555404,0.00087470294,0.00018647315,0.00020944457,0.00019625983,0.00034778717,0.000026204914,0.00035496117],"genre_scores_gemma":[0.36731863,0.62344694,0.004713251,0.0017334963,0.00050904363,0.0005584396,0.00095595536,0.000055479915,0.00070876675],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98982567,0.0061865067,0.0018906507,0.0010375929,0.00082175824,0.00023787425],"domain_scores_gemma":[0.9813416,0.014219634,0.0031051664,0.00063042884,0.0005327036,0.00017049522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014999762,0.001821896,0.010230687,0.0016609778,0.00034393027,0.0024785143,0.0015523207,0.0017944033,0.0044975644],"category_scores_gemma":[0.025436113,0.0009128242,0.02167171,0.002313739,0.0006638489,0.0015560782,0.0009901215,0.0028921445,0.0002484894],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035392202,0.000085506384,0.0055695125,0.18351449,0.7126315,0.00011004605,0.00008102866,0.0007669671,0.00047028335,0.0003428222,0.0014130726,0.059622575],"study_design_scores_gemma":[0.019948013,0.0016330057,0.008951967,0.013787189,0.9501288,0.00019725104,0.00006900694,0.0005081837,0.00027726198,0.00065003266,0.003791967,0.000057392866],"about_ca_topic_score_codex":0.0015904078,"about_ca_topic_score_gemma":0.0044618687,"teacher_disagreement_score":0.014999762,"about_ca_system_score_codex":0.001108775,"about_ca_system_score_gemma":0.0012972257,"threshold_uncertainty_score":0.079327285},"labels":[],"label_agreement":null},{"id":"W4394872938","doi":"10.1007/s00277-024-05732-w","title":"Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report","year":2024,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Alberta Health Services; Canadian Blood Services; University of Calgary","funders":"","keywords":"Medicine; Hematology; Internal medicine; Gangrene; Disease; Intensive care medicine; Surgery","score_opus":0.01778401256260804,"score_gpt":0.27629400837126794,"score_spread":0.2585099958086599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394872938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8879918,0.017550772,0.005878689,0.031805657,0.0053236634,0.0006086695,0.000853838,0.0006609083,0.04932606],"genre_scores_gemma":[0.97092754,0.0040790047,0.0028735697,0.0064718956,0.009664796,0.00008054138,0.00022823899,0.00009541659,0.0055789626],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988164,0.00019462583,0.00014760406,0.000253823,0.00018205734,0.0004054931],"domain_scores_gemma":[0.9963582,0.0012559755,0.00066959107,0.00032108187,0.00019023834,0.0012049358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063740474,0.0034563688,0.002143031,0.004151985,0.004465831,0.0038087307,0.002437456,0.013360597,0.0039199963],"category_scores_gemma":[0.006381684,0.0022864975,0.003016155,0.0026128688,0.0026737042,0.004570752,0.002613561,0.0075109294,0.0018129764],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013400254,0.000021023176,0.00078142463,0.000011890358,0.000003881301,0.9985353,0.000040288673,0.000016538586,0.000085793,0.000060216986,0.00022900093,0.00020125674],"study_design_scores_gemma":[0.000014637543,0.000040386694,0.001384934,0.000012448861,0.000015756626,0.9974503,0.0001239382,0.0001799085,0.00012662285,0.00014656129,0.0004946137,0.000009941144],"about_ca_topic_score_codex":0.0023425382,"about_ca_topic_score_gemma":0.00304931,"teacher_disagreement_score":0.013360597,"about_ca_system_score_codex":0.0026227203,"about_ca_system_score_gemma":0.0013053413,"threshold_uncertainty_score":0.01902926},"labels":[],"label_agreement":null},{"id":"W4400797335","doi":"10.1007/s00277-024-05851-4","title":"Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia","year":2024,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Medicine; Tolerability; Dosing; Myeloid leukemia; Adverse effect; Tyrosine-kinase inhibitor; Dasatinib; Oncology; Clinical trial; Internal medicine; Pharmacology; Intensive care medicine; Imatinib; Cancer","score_opus":0.12282163316628093,"score_gpt":0.42124725404727853,"score_spread":0.2984256208809976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400797335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009455301,0.6593029,0.0087343175,0.28533712,0.006886869,0.00023289914,0.00033543582,0.00024791746,0.029467285],"genre_scores_gemma":[0.12591861,0.67096627,0.038092833,0.1324236,0.022235172,0.00082195754,0.0007453053,0.00014016299,0.008656172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659145,0.0020856059,0.00052176084,0.00014420332,0.00053507363,0.000121877114],"domain_scores_gemma":[0.9944687,0.0032344698,0.0006589426,0.00012747277,0.0010570643,0.0004533963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041105365,0.00042908618,0.0009856311,0.00055201567,0.00080143305,0.0020591374,0.0008231355,0.0019504293,0.005072234],"category_scores_gemma":[0.015967961,0.00019828438,0.0009195519,0.0004811346,0.00063144474,0.0025302893,0.001134264,0.004708232,0.0014965401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043034673,0.00019671975,0.0028994891,0.0053507895,0.00018534507,0.0022840335,0.0013795466,0.00066918496,0.00094820996,0.0052915537,0.16587657,0.81448823],"study_design_scores_gemma":[0.0003886561,0.00054132944,0.0076743276,0.015888512,0.00039090723,0.0071769063,0.002369329,0.0008474736,0.00066440477,0.019779418,0.94414634,0.00013246582],"about_ca_topic_score_codex":0.0013635111,"about_ca_topic_score_gemma":0.00438731,"teacher_disagreement_score":0.005072234,"about_ca_system_score_codex":0.00075482955,"about_ca_system_score_gemma":0.0027751813,"threshold_uncertainty_score":0.021738827},"labels":[],"label_agreement":null},{"id":"W4400931001","doi":"10.1007/s00277-024-05889-4","title":"Serum hepcidin recalibrated values in Mexican schoolchildren by demographic characteristics, nutritional and infection/inflammation status","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrition International","funders":"Consejo Nacional de Ciencia y Tecnología","keywords":"Hepcidin; Hematology; Iron status; Inflammation; Medicine; Internal medicine; Physiology; Immunology; Iron deficiency; Anemia","score_opus":0.017400097935691746,"score_gpt":0.29796850285786136,"score_spread":0.2805684049221696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400931001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957615,0.00006005322,0.000021355208,0.000018917373,0.000003045226,0.0000018524069,0.000097088756,0.0000022836527,0.00021924342],"genre_scores_gemma":[0.9994936,0.000032006774,0.00003176485,0.000012176937,0.000002964577,0.0000043239693,0.0001131361,0.0000012563708,0.00030876097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998092,0.00004046723,0.000012901962,0.00005623593,0.000022249198,0.000058947848],"domain_scores_gemma":[0.99966764,0.000047890793,0.00015976741,0.000019889476,0.00003703856,0.000067713816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002508515,0.0003007706,0.0002699832,0.00057285116,0.0003548094,0.0005229137,0.0002230037,0.00029892358,0.0018826715],"category_scores_gemma":[0.0007541325,0.0002546381,0.00033915852,0.00051723473,0.00021243822,0.0003051874,0.00025322035,0.0005390332,0.00023275337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030536158,0.000113716604,0.9976618,0.0000069875573,0.000024769757,0.00008118995,0.00017358392,0.000016160098,0.00049267616,0.000016121294,0.000080584716,0.0010269536],"study_design_scores_gemma":[0.0000042813285,0.00012730794,0.99910873,0.0000030777026,0.000019909621,0.000071233844,0.00041121617,0.00007315903,0.00007051219,0.000005560852,0.00010322451,0.0000017280588],"about_ca_topic_score_codex":0.009101635,"about_ca_topic_score_gemma":0.008518058,"teacher_disagreement_score":0.009101635,"about_ca_system_score_codex":0.00032162076,"about_ca_system_score_gemma":0.0002669249,"threshold_uncertainty_score":0.018097281},"labels":[],"label_agreement":null},{"id":"W4401800199","doi":"10.1007/s00277-024-05955-x","title":"Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Cytopenia; Hematology; Internal medicine; Hepatosplenomegaly; Rash; Chemotherapy; Etoposide; Langerhans cell histiocytosis; Histiocytosis; Lymphoma; Gastroenterology; Immunology; Bone marrow","score_opus":0.03935801809960203,"score_gpt":0.3621139247304165,"score_spread":0.32275590663081444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401800199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993943,0.00007410409,0.00003945579,0.000014182399,0.000002847826,0.000010146787,0.00007825759,0.0000031095735,0.00038361654],"genre_scores_gemma":[0.9995158,0.000057114397,0.00009131224,0.00001697439,0.00000874759,0.000011579815,0.00018182883,0.0000027459128,0.00011401987],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99953973,0.00005803557,0.00007508929,0.00008777563,0.00007065849,0.00016880884],"domain_scores_gemma":[0.9990226,0.00018398996,0.0002856797,0.000051071806,0.00007970113,0.0003769883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037200432,0.0005904985,0.0005466179,0.0010122369,0.0009906141,0.00060874334,0.00028449355,0.0005045124,0.0012233865],"category_scores_gemma":[0.0014055502,0.00037337714,0.00045304644,0.0007418501,0.00081796554,0.0005458278,0.00083522004,0.0005187651,0.00024336205],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001735382,0.000104001796,0.9750371,0.0000128133,0.000019308463,0.021830432,0.00033103596,0.0000886103,0.00062653766,0.000039586066,0.00008254176,0.0016544957],"study_design_scores_gemma":[0.000030346353,0.0007377294,0.93686485,0.0000128603415,0.000034355682,0.060345367,0.0010175831,0.00018516657,0.00037527355,0.00005384642,0.0003276797,0.0000149780735],"about_ca_topic_score_codex":0.002904906,"about_ca_topic_score_gemma":0.0031443958,"teacher_disagreement_score":0.002904906,"about_ca_system_score_codex":0.00071255193,"about_ca_system_score_gemma":0.0004892283,"threshold_uncertainty_score":0.005775988},"labels":[],"label_agreement":null},{"id":"W4402245613","doi":"10.1007/s00277-024-05983-7","title":"Impact of clinically unsuspected venous thrombotic events on CVC removal and survival in pediatric cancer patients: A population-based study from the Maritimes, Canada","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"IWK Health Centre","keywords":"Medicine; Hematology; Internal medicine; Cancer; Post-thrombotic syndrome; Overall survival; Cancer registry; Population; Oncology; Surgery; Venous thrombosis; Thrombosis","score_opus":0.054860881241077505,"score_gpt":0.4158017973656449,"score_spread":0.36094091612456736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402245613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761176,0.00032676003,0.000034058754,0.000111042464,0.000004666946,0.000010833366,0.0011016111,0.0000037178945,0.0007956263],"genre_scores_gemma":[0.99860054,0.0003850467,0.00005878205,0.000059174083,0.000005333693,0.0000069326843,0.0006483454,0.0000050095186,0.00023086712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914074,0.00006580478,0.000058002777,0.00014877613,0.00026812952,0.00031850458],"domain_scores_gemma":[0.99833006,0.00011797241,0.0005184463,0.0000582794,0.0005513956,0.00042395832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285924,0.00045355345,0.0005926298,0.0013771174,0.0017564136,0.0016252594,0.0012700303,0.00062316883,0.0016014172],"category_scores_gemma":[0.0016404142,0.0004900465,0.0008233171,0.0043505514,0.0008832171,0.00042997918,0.00072480366,0.0011983509,0.00017359412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018744822,0.0000133782305,0.9990946,0.0000051798706,0.000026613503,0.000064448024,0.00016665689,0.000022880698,0.000039650487,0.000021634747,0.00011823673,0.00040796396],"study_design_scores_gemma":[0.0000027080569,0.000016354179,0.99892247,0.000009109175,0.000017564726,0.00009072991,0.0007320307,0.00006107885,0.000014527422,0.0000065922395,0.00012258723,0.0000043865143],"about_ca_topic_score_codex":0.95205945,"about_ca_topic_score_gemma":0.97312284,"teacher_disagreement_score":0.047940552,"about_ca_system_score_codex":0.012814214,"about_ca_system_score_gemma":0.014899847,"threshold_uncertainty_score":0.09644574},"labels":[],"label_agreement":null},{"id":"W4402765583","doi":"10.1007/s00277-024-06007-0","title":"Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait","year":2024,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hematology; Thalassemia; Trait; Heterozygote advantage; Internal medicine; Medicine; Beta thalassemia; Genetics; Oncology; Biology; Genotype; Gene","score_opus":0.16029361662147504,"score_gpt":0.4551356102849716,"score_spread":0.2948419936634966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402765583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042174305,0.9988354,0.00007229465,0.00013274695,0.000108969965,0.0000025935844,0.000026640468,0.0000047491876,0.00039486922],"genre_scores_gemma":[0.0039675585,0.99466187,0.00022649547,0.00031900706,0.0003556752,0.000008044839,0.000087193715,0.0000014951174,0.00037264635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998839,0.000025997746,0.000026883748,0.00002273601,0.000030342517,0.000010004603],"domain_scores_gemma":[0.99977595,0.00012766272,0.000055695382,0.000005084892,0.000023300292,0.000012271016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002974731,0.0005223567,0.0012414419,0.00093381014,0.00008178187,0.0003901532,0.0005496913,0.00046934796,0.0020491437],"category_scores_gemma":[0.00065337983,0.00012756819,0.0004562607,0.0010299953,0.00017558946,0.0002613186,0.00029946727,0.0006630361,0.00043205987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002785336,0.000056601566,0.0018838646,0.012452714,0.00047427492,0.000413552,0.000026470698,0.00017599022,0.0012332674,0.00078891177,0.017171444,0.96504444],"study_design_scores_gemma":[0.0005415916,0.00059056806,0.03277551,0.018850848,0.008498413,0.008900668,0.00013713968,0.00039327372,0.0016647646,0.0027623242,0.9248063,0.000078602636],"about_ca_topic_score_codex":0.00066834874,"about_ca_topic_score_gemma":0.0013062734,"teacher_disagreement_score":0.0020491437,"about_ca_system_score_codex":0.00019182688,"about_ca_system_score_gemma":0.00042462384,"threshold_uncertainty_score":0.0068550706},"labels":[],"label_agreement":null},{"id":"W4402931643","doi":"10.1007/s00277-024-06019-w","title":"Rosai-Dorfman-Destombes disease in adults: a single center experience","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Dalhousie University; Université de Montréal; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Victoria General Hospital Foundation","keywords":"Rosai–Dorfman disease; Hematology; Center (category theory); Medicine; Disease; Internal medicine; Single Center","score_opus":0.04101205905801389,"score_gpt":0.3492403775614922,"score_spread":0.3082283185034783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402931643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374795,0.0010189237,0.000585833,0.0004937308,0.00006760246,0.000040035295,0.00012647231,0.000024244664,0.0038951237],"genre_scores_gemma":[0.99800783,0.0005557735,0.00025590227,0.00028418744,0.00013366883,0.000011205902,0.00011669405,0.000011859383,0.0006227939],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9996666,0.00004597568,0.000048883114,0.0000609974,0.00004638283,0.0001311898],"domain_scores_gemma":[0.9993266,0.000083637584,0.00010758715,0.00004038899,0.000051165265,0.00039072707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024694073,0.0006928054,0.00060164265,0.00063922646,0.0013026417,0.0010118845,0.00044172237,0.0013412161,0.0027020937],"category_scores_gemma":[0.0010403581,0.0003319229,0.0005064201,0.0007578947,0.0005486013,0.0010798892,0.0007037994,0.0008914792,0.0007806739],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003562472,0.001049358,0.5011489,0.000050479524,0.000068591355,0.47567612,0.0012100462,0.00018477016,0.002590758,0.00044759904,0.002318389,0.014898833],"study_design_scores_gemma":[0.00012753677,0.0012652393,0.2195485,0.000068321,0.00007525681,0.77254564,0.0025515931,0.00050082983,0.00072831445,0.00032154509,0.0022148497,0.00005237833],"about_ca_topic_score_codex":0.0012331418,"about_ca_topic_score_gemma":0.00223271,"teacher_disagreement_score":0.0027020937,"about_ca_system_score_codex":0.00050615205,"about_ca_system_score_gemma":0.0005102139,"threshold_uncertainty_score":0.009039402},"labels":[],"label_agreement":null},{"id":"W4404513548","doi":"10.1007/s00277-024-06085-0","title":"Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; CancerCare Manitoba; Health Sciences Centre; Vancouver General Hospital; Sunnybrook Health Science Centre; University of Manitoba","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Intensive care medicine; Regimen; Internal medicine; Population; Clinical trial; Pediatrics; Bone marrow","score_opus":0.04330395317788847,"score_gpt":0.3474044085156508,"score_spread":0.3041004553377623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404513548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97901493,0.0041123577,0.00011879951,0.0028782364,0.00006553915,0.00009662588,0.0059020473,0.00001420664,0.007797259],"genre_scores_gemma":[0.9935417,0.002707663,0.00023695301,0.0010255986,0.000032042426,0.000029533507,0.001660696,0.0000047861486,0.0007609981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983012,0.00013296159,0.00017856398,0.00014056594,0.0007060018,0.000540798],"domain_scores_gemma":[0.9955052,0.00031696822,0.0015592647,0.00006220764,0.0015210266,0.0010352434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009010453,0.00033331595,0.00042555018,0.0017441523,0.002106566,0.0011748379,0.0014254072,0.00085437484,0.0025886195],"category_scores_gemma":[0.0051747104,0.0003901666,0.0008262312,0.0046116007,0.0005236409,0.00063005724,0.0010479495,0.0010505479,0.00017323397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026071115,0.000041713007,0.9938736,0.000053263895,0.000055471006,0.00005523478,0.0007887923,0.00005146631,0.00005175464,0.000079919395,0.0018870686,0.0030356874],"study_design_scores_gemma":[0.000005336124,0.000015429887,0.99597824,0.00008490996,0.000024398274,0.000077616205,0.0024157164,0.00009497645,0.000012279812,0.000013693424,0.0012684286,0.000009060611],"about_ca_topic_score_codex":0.9769381,"about_ca_topic_score_gemma":0.9889649,"teacher_disagreement_score":0.023061872,"about_ca_system_score_codex":0.017751375,"about_ca_system_score_gemma":0.024555216,"threshold_uncertainty_score":0.1287958},"labels":[],"label_agreement":null},{"id":"W4404578574","doi":"10.1007/s00277-024-06096-x","title":"Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McGill University Health Centre; McGill University; Jewish General Hospital; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Alberta Hospital Edmonton; University of British Columbia; University of Manitoba; Juravinski Cancer Centre; Dalhousie University; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Alberta Hospital; Ottawa Hospital; CancerCare Manitoba; Saskatchewan Cancer Agency; Université Laval","funders":"University of Manitoba","keywords":"Medicine; Internal medicine; Neutropenia; Myelodysplastic syndromes; Prospective cohort study; Cohort; Multivariate analysis; Hematology; Cohort study; Absolute neutrophil count; Chemotherapy","score_opus":0.049579619205047096,"score_gpt":0.3620163353801278,"score_spread":0.3124367161750807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404578574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908173,0.00081737584,0.000111046174,0.0003702524,0.000018220622,0.00006890708,0.005897115,0.000012259059,0.0018875968],"genre_scores_gemma":[0.9953703,0.00074490334,0.00019584688,0.00013710117,0.000016237274,0.000037910355,0.0031341852,0.0000068256627,0.00035665804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803656,0.00016652851,0.00013485414,0.00033281048,0.00063669495,0.0006926761],"domain_scores_gemma":[0.99672544,0.0001671351,0.0009591069,0.00019332419,0.0012795301,0.0006754018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012087056,0.0007230486,0.0007250341,0.003025346,0.0034255437,0.0017095633,0.00209036,0.0009164582,0.0021418342],"category_scores_gemma":[0.004007232,0.00075779686,0.001092217,0.0064016916,0.00078685046,0.000817916,0.0013933397,0.0013191383,0.00026264694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028796367,0.000019025018,0.9985715,0.000009180177,0.000041999603,0.0000642343,0.0001543635,0.000022826449,0.00004176905,0.000043883138,0.00045913385,0.00054312404],"study_design_scores_gemma":[0.000006955828,0.000019086425,0.9984145,0.00002116026,0.000031051968,0.00017347797,0.00067221746,0.00011723786,0.000018875542,0.000019161622,0.00049492565,0.000011343284],"about_ca_topic_score_codex":0.9358082,"about_ca_topic_score_gemma":0.9559526,"teacher_disagreement_score":0.06419182,"about_ca_system_score_codex":0.0130065875,"about_ca_system_score_gemma":0.024302755,"threshold_uncertainty_score":0.12913966},"labels":[],"label_agreement":null},{"id":"W4405793404","doi":"10.1007/s00277-024-06158-0","title":"Investigation of a hemophilia family with one female hemophilia A patient and 12 male hemophilia A patients","year":2024,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Von Willebrand disease; Carrier testing; Factor IX; Haemophilia A; Hematology; Genetic counseling; Genetic testing; Coagulopathy; Internal medicine; Von Willebrand factor; Immunology; Genetics; Haemophilia; Prenatal diagnosis; Pediatrics; Biology; Platelet; Pregnancy","score_opus":0.06843703143780681,"score_gpt":0.3144783161153445,"score_spread":0.24604128467753766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405793404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997131,0.0002231405,0.00017058743,0.00033056998,0.00003370052,0.000023717836,0.00007271785,0.0000110312385,0.002003443],"genre_scores_gemma":[0.9984005,0.000165206,0.00022811758,0.00019000267,0.00010821896,0.000008651091,0.00008068685,0.000011724466,0.00080684345],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994999,0.00008193154,0.000053147363,0.00013574968,0.00008885072,0.00014040213],"domain_scores_gemma":[0.99896526,0.00027138685,0.00014599608,0.000054016182,0.00012724294,0.00043618187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150462,0.0010118956,0.0005456302,0.002186556,0.0030150167,0.0008230802,0.0007112073,0.0015516802,0.0056169913],"category_scores_gemma":[0.0025405684,0.0006107541,0.00058961945,0.0006783408,0.00078771356,0.00073945627,0.0007279828,0.00092751574,0.0006281177],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030729471,0.00044572074,0.33027455,0.000034965156,0.000031040017,0.6588869,0.0017575576,0.00008796454,0.0035564026,0.00014889053,0.00045571494,0.004013021],"study_design_scores_gemma":[0.000031034346,0.0008918121,0.17085655,0.000018922397,0.000051082487,0.8216155,0.0029397218,0.0002741765,0.001662424,0.00013181806,0.0015011868,0.000025786961],"about_ca_topic_score_codex":0.0028411192,"about_ca_topic_score_gemma":0.0017097888,"teacher_disagreement_score":0.0056169913,"about_ca_system_score_codex":0.00053489424,"about_ca_system_score_gemma":0.0005137339,"threshold_uncertainty_score":0.018790722},"labels":[],"label_agreement":null},{"id":"W4406853459","doi":"10.1007/s00277-025-06224-1","title":"Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation – a single center experience","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Tel Aviv University","keywords":"Medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Sex organ; Transplantation; Internal medicine; Surgery","score_opus":0.02966070753217696,"score_gpt":0.3025139312977562,"score_spread":0.27285322376557924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406853459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750334,0.0015052177,0.000115772214,0.00012006302,0.000028982415,0.000021258575,0.000082091115,0.000004475502,0.00061884127],"genre_scores_gemma":[0.99858874,0.00093887566,0.00008082283,0.00010493491,0.00003776324,0.0000065715353,0.000086450644,0.0000027372455,0.00015308923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996897,0.00006652766,0.000039040504,0.00005521157,0.00006813013,0.00008134956],"domain_scores_gemma":[0.9995369,0.000068984635,0.00017349816,0.000029234066,0.000030639,0.00016086314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807554,0.00022697475,0.00032131246,0.0006608728,0.0008261923,0.0006119014,0.00024619413,0.00033013007,0.001915961],"category_scores_gemma":[0.0010455542,0.00024677883,0.0003194386,0.0008195813,0.00033463188,0.0003705948,0.000687213,0.000384826,0.00024232338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092161295,0.00012272099,0.97206116,0.00006531912,0.000035671357,0.014395858,0.0009768408,0.000034953868,0.0005758813,0.00009131781,0.00042150955,0.011126548],"study_design_scores_gemma":[0.000041836272,0.0012839888,0.8392594,0.00019210651,0.000121834426,0.14298202,0.00928986,0.00024285418,0.00074690726,0.00022996066,0.0055705225,0.000038817812],"about_ca_topic_score_codex":0.0014702526,"about_ca_topic_score_gemma":0.0020074674,"teacher_disagreement_score":0.001915961,"about_ca_system_score_codex":0.00041081762,"about_ca_system_score_gemma":0.0005558504,"threshold_uncertainty_score":0.006409526},"labels":[],"label_agreement":null},{"id":"W4408997591","doi":"10.1007/s00277-025-06280-7","title":"Comparative efficacy of venetoclax-based regiments in the management of chronic lymphocytic leukemia: a systematic review and metanalysis","year":2025,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Hematology; Lymphoma; Leukemia","score_opus":0.10868640549403825,"score_gpt":0.44769713419926704,"score_spread":0.3390107287052288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408997591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026144374,0.99553925,0.00038179965,0.0001116319,0.000103750164,0.00045809755,0.0005092009,0.000014920252,0.0002669414],"genre_scores_gemma":[0.06292714,0.93208027,0.0015807333,0.0006244411,0.00016417404,0.001520151,0.0007460037,0.00002258391,0.00033446323],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922971,0.0031124903,0.0027388753,0.0006218537,0.0010008329,0.00022872977],"domain_scores_gemma":[0.97858584,0.016449284,0.0029602007,0.00042354944,0.0014010088,0.00018018248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012071628,0.0019712932,0.016761733,0.007902295,0.0005582468,0.00354129,0.001924667,0.0018293312,0.0040725195],"category_scores_gemma":[0.03174481,0.0010660854,0.028090939,0.0077854665,0.00065295625,0.0019123043,0.0013655,0.0014813514,0.00038031556],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010329941,0.000021068176,0.0011650408,0.7642351,0.2196257,0.0000751559,0.00010039453,0.00023314863,0.00020715421,0.00014770204,0.00042544722,0.012731099],"study_design_scores_gemma":[0.000478697,0.00029255604,0.0025918586,0.1016296,0.89029586,0.00011448228,0.00009155482,0.00015011716,0.00014758011,0.00023558056,0.003940684,0.000031391333],"about_ca_topic_score_codex":0.004941311,"about_ca_topic_score_gemma":0.012715157,"teacher_disagreement_score":0.016761733,"about_ca_system_score_codex":0.0025983069,"about_ca_system_score_gemma":0.004150276,"threshold_uncertainty_score":0.06384164},"labels":[],"label_agreement":null},{"id":"W4409182949","doi":"10.1007/s00277-025-06330-0","title":"A case series of B-Lymphoblastic lymphoma with C-MYC rearrangement in children: diagnostic and therapeutic challenges","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Lymphoma; Gene rearrangement; Hematology; Cancer research; Lymphoblast; Medicine; B cell; Lymphoblastic lymphoma; Internal medicine; Biology; Immunology; Gene; T cell; Cell culture; Genetics","score_opus":0.033397502567156484,"score_gpt":0.3125089815010333,"score_spread":0.2791114789338768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409182949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96511126,0.015967311,0.007215125,0.0028411364,0.00035233784,0.00025491483,0.00048495637,0.00022437963,0.007548662],"genre_scores_gemma":[0.9910703,0.0037269036,0.003294938,0.00059259665,0.00057031546,0.000050369465,0.0001626109,0.000038033122,0.0004941212],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99933416,0.00009996427,0.00012596254,0.00016188184,0.00010816965,0.00016985291],"domain_scores_gemma":[0.997889,0.0007346878,0.00055986975,0.00017659592,0.00013399789,0.0005059503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005261337,0.0013329479,0.0009468876,0.0019339537,0.0018392964,0.0014057932,0.00090813445,0.0025601098,0.0019515491],"category_scores_gemma":[0.0033303257,0.00078168965,0.00063109637,0.0016800177,0.0015344686,0.0018668736,0.0013861419,0.0021343932,0.00072955305],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005107006,0.000042260144,0.062332507,0.000110012435,0.000022840508,0.9286764,0.00044634144,0.0001368683,0.0011378152,0.00042079092,0.0008423784,0.0057806475],"study_design_scores_gemma":[0.000005586469,0.000021131827,0.004902369,0.000017745384,0.000019634444,0.99331844,0.00019317114,0.00006979414,0.0002261764,0.00010714744,0.0011119759,0.0000068409654],"about_ca_topic_score_codex":0.001553764,"about_ca_topic_score_gemma":0.0024796275,"teacher_disagreement_score":0.0025601098,"about_ca_system_score_codex":0.0010595956,"about_ca_system_score_gemma":0.0011130563,"threshold_uncertainty_score":0.0076879263},"labels":[],"label_agreement":null},{"id":"W4409959664","doi":"10.1007/s00277-025-06377-z","title":"What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?","year":2025,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Aplastic anemia; Hemoglobinuria; Medicine; Hematology; Anemia; Internal medicine; Pediatrics; Quality of life (healthcare); Bone marrow","score_opus":0.032783589488283756,"score_gpt":0.3017603778454636,"score_spread":0.26897678835717986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409959664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96785855,0.010423797,0.0015200716,0.006543448,0.00016560861,0.00037607964,0.006525908,0.000038493235,0.006548199],"genre_scores_gemma":[0.9915524,0.0024129164,0.0029818485,0.0008100369,0.000060872062,0.00023400922,0.0015539401,0.0000072958364,0.00038665452],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99921453,0.00027913766,0.00014463915,0.00007974086,0.00013472301,0.00014726604],"domain_scores_gemma":[0.9974216,0.00081403396,0.0008210236,0.000059107213,0.00035514182,0.00052904116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002204453,0.00025293513,0.0006917287,0.00091207953,0.0003750122,0.00080998667,0.000304169,0.00052046345,0.002986189],"category_scores_gemma":[0.0069637466,0.00010605677,0.0011183535,0.00086947216,0.00025943934,0.0012345902,0.00053794996,0.000737242,0.00043454889],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041032975,0.000269511,0.8392954,0.0014375817,0.0004157538,0.000117352756,0.0011570367,0.00041444442,0.0005355063,0.00031638035,0.007221732,0.14840904],"study_design_scores_gemma":[0.000057673362,0.0005286942,0.98758125,0.0005659425,0.00015975142,0.00044893258,0.002153886,0.00071136357,0.0002596761,0.00061127654,0.0068769366,0.000044625638],"about_ca_topic_score_codex":0.0020869232,"about_ca_topic_score_gemma":0.005209121,"teacher_disagreement_score":0.002986189,"about_ca_system_score_codex":0.00071094267,"about_ca_system_score_gemma":0.0007295596,"threshold_uncertainty_score":0.0116583705},"labels":[],"label_agreement":null},{"id":"W4410069148","doi":"10.1007/s00277-025-06386-y","title":"Intrathecal rituximab in pediatric CD20-positive central nervous system limited lymphoproliferative disease: report of two cases and literature review","year":2025,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Rituximab; Hematology; Medicine; Lymphoproliferative disease; Intrathecal; Central nervous system; CD20; Disease; Internal medicine; Lymphoma; Lymphoproliferative disorders; Oncology; Pathology; Surgery","score_opus":0.03727388047417865,"score_gpt":0.37576712239228094,"score_spread":0.33849324191810226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410069148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006508529,0.9985335,0.00008189112,0.00008087911,0.000087853754,0.0000060025977,0.00001473747,0.0000046888745,0.0005395987],"genre_scores_gemma":[0.0044435887,0.9948053,0.00018921954,0.00018372873,0.00015088041,0.000007765698,0.000034472916,0.0000020067826,0.00018310129],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996582,0.00005710304,0.00013537244,0.000059967322,0.00006507107,0.000024274783],"domain_scores_gemma":[0.9994282,0.0003154321,0.00013242845,0.000022446024,0.00007121865,0.000030095394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043076382,0.00072345074,0.001287292,0.0042537367,0.00031704357,0.0007204617,0.00097622524,0.0009807363,0.0016831949],"category_scores_gemma":[0.0010219213,0.0002933748,0.00062611897,0.004327118,0.0005664647,0.001261506,0.0004905204,0.00083776383,0.00073089544],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016922646,0.00010848542,0.0021858166,0.059093803,0.0003858041,0.016549138,0.00037831924,0.00038784358,0.0028562811,0.00094131153,0.01932117,0.89762276],"study_design_scores_gemma":[0.000077243254,0.00039724182,0.013499767,0.033612963,0.0024317517,0.25122967,0.00071968936,0.00033442696,0.0036872388,0.0013092869,0.69260234,0.00009847063],"about_ca_topic_score_codex":0.0012598898,"about_ca_topic_score_gemma":0.0019406241,"teacher_disagreement_score":0.0042537367,"about_ca_system_score_codex":0.0005125832,"about_ca_system_score_gemma":0.00094887713,"threshold_uncertainty_score":0.0056309104},"labels":[],"label_agreement":null},{"id":"W4410838092","doi":"10.1007/s00277-025-06431-w","title":"Impact of secondary-type mutations on the prognosis of AML patients with NPM1 mutation: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Sichuan Province; Department of Science and Technology of Sichuan Province","keywords":"Meta-analysis; NPM1; Hematology; Internal medicine; Medicine; Mutation; Oncology; Genetics; Biology; Gene","score_opus":0.1272697971046132,"score_gpt":0.4394940203620863,"score_spread":0.3122242232574731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410838092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045476784,0.99316424,0.0005376431,0.0002225194,0.00012329457,0.00024395826,0.00089029834,0.000024283814,0.0002459385],"genre_scores_gemma":[0.15913205,0.8345356,0.0018755982,0.0010174541,0.00027443803,0.0012943122,0.0014451356,0.000044289263,0.00038118847],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99179524,0.003404143,0.002694237,0.00092653895,0.00088284665,0.00029704787],"domain_scores_gemma":[0.97790504,0.016889118,0.0027012269,0.0006404721,0.001627406,0.000236782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013074471,0.0024477933,0.017058792,0.0071802363,0.0006058718,0.0031753983,0.0021915617,0.002081037,0.0037011958],"category_scores_gemma":[0.031067925,0.0013507522,0.03318852,0.008456876,0.0007124025,0.0016042137,0.0016069073,0.0013190215,0.00037583537],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001093921,0.000016002412,0.004289469,0.5250824,0.45852405,0.00014399136,0.00010328923,0.00049962226,0.00025122453,0.00015347941,0.00070944545,0.009133047],"study_design_scores_gemma":[0.0002543089,0.000114747076,0.0038420435,0.037667252,0.9556697,0.00010530737,0.000046994122,0.00017726196,0.000104082195,0.00021323065,0.0017787602,0.000026254782],"about_ca_topic_score_codex":0.0062580593,"about_ca_topic_score_gemma":0.014256058,"teacher_disagreement_score":0.017058792,"about_ca_system_score_codex":0.0022673814,"about_ca_system_score_gemma":0.0039154226,"threshold_uncertainty_score":0.06914526},"labels":[],"label_agreement":null},{"id":"W4413688430","doi":"10.1007/s00277-025-06536-2","title":"Rare germline ETV6 variant associated with thrombocytopenia and acute leukemia","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Hospital for Sick Children; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"ETV6; Proband; Germline; Hematology; Myelodysplastic syndromes; Germline mutation; Medicine; Internal medicine; Pancytopenia; Immunology; Biology; Oncology; Mutation; Bone marrow; Genetics; Gene; Chromosomal translocation","score_opus":0.03637632098900727,"score_gpt":0.3535086353302773,"score_spread":0.31713231434127004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413688430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611133,0.0009820821,0.0012511639,0.00011549142,0.000025581809,0.00001753923,0.00030879473,0.000038923583,0.0011490642],"genre_scores_gemma":[0.99878067,0.00021753398,0.00034837486,0.00005611725,0.0000476945,0.0000036308202,0.00025393013,0.000006712504,0.00028522348],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9995902,0.000075774704,0.00006217614,0.00012136104,0.000086858476,0.00006353283],"domain_scores_gemma":[0.9992895,0.00024936613,0.00022043327,0.000051966297,0.00005819083,0.0001306334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015471246,0.0008552,0.0004780657,0.0011352181,0.00053777563,0.0004727404,0.0003959651,0.0011019586,0.0026373172],"category_scores_gemma":[0.0013522699,0.00021899726,0.00038099143,0.0009781288,0.00041331787,0.0002481913,0.00042655415,0.0004960657,0.00031920298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006442662,0.00011058789,0.28875726,0.00017163111,0.0002062825,0.65651643,0.0006818085,0.0005228619,0.035602223,0.00078058435,0.0011711473,0.014834857],"study_design_scores_gemma":[0.000040884217,0.00014555802,0.09398682,0.000049864182,0.0000991314,0.89904696,0.00016987154,0.00073313253,0.0033629287,0.0003535295,0.001992264,0.000018963201],"about_ca_topic_score_codex":0.00094110705,"about_ca_topic_score_gemma":0.0007050232,"teacher_disagreement_score":0.0026373172,"about_ca_system_score_codex":0.00018914665,"about_ca_system_score_gemma":0.00013593001,"threshold_uncertainty_score":0.008822739},"labels":[],"label_agreement":null},{"id":"W4415012625","doi":"10.1007/s00277-025-06594-6","title":"Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA survey","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Università Degli Studi di Modena e Reggio Emila","keywords":"Palliative care; Psychological intervention; Hematologic Neoplasms; Hematologist; Advance care planning; Intensive care unit; Quality (philosophy); MEDLINE","score_opus":0.38920526651762277,"score_gpt":0.457714660730008,"score_spread":0.06850939421238522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415012625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662954,0.00024729656,0.000057189976,0.0013640182,0.000010268522,0.00005013365,0.0004213592,0.0000063665857,0.0012138837],"genre_scores_gemma":[0.99748296,0.00037695369,0.00025720597,0.0009996536,0.000024611756,0.0001241283,0.00048223202,0.0000051542133,0.00024713847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856657,0.00058899046,0.00016230017,0.000101543454,0.00023952374,0.00034115533],"domain_scores_gemma":[0.9911307,0.002266613,0.0036084116,0.00021564828,0.00089025236,0.0018884678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038643875,0.00016333819,0.00030714044,0.00087478274,0.00064936886,0.001022227,0.0004835164,0.0005228454,0.0017360217],"category_scores_gemma":[0.009924961,0.00021850734,0.0005351464,0.0011324806,0.0004890982,0.0008444593,0.0015398961,0.0010291281,0.00032267976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051390998,0.00012290599,0.98846996,0.00007960967,0.000033130404,0.00008145902,0.0036407788,0.00004763127,0.00010760203,0.000045146982,0.0020432982,0.005277171],"study_design_scores_gemma":[0.000011364257,0.00009875166,0.9925028,0.0000643969,0.00001440808,0.00011278235,0.004951869,0.00017194351,0.000036698828,0.000021582955,0.0020048616,0.000008511825],"about_ca_topic_score_codex":0.009268342,"about_ca_topic_score_gemma":0.01229606,"teacher_disagreement_score":0.009268342,"about_ca_system_score_codex":0.0017393304,"about_ca_system_score_gemma":0.0013822293,"threshold_uncertainty_score":0.020437121},"labels":[],"label_agreement":null},{"id":"W4415372345","doi":"10.1007/s00277-025-06631-4","title":"The first Chinese hb m-saskatoon [HBB: c.190 c > t p.His64Tyr] case with low oxygen saturation in 50-year-old women","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; Mutation; Methemoglobinemia; Hematology; Gene; Genotype","score_opus":0.011361279720731251,"score_gpt":0.2886904773793473,"score_spread":0.277329197658616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415372345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993415,0.001799855,0.0006748883,0.0009098481,0.00014317967,0.00004960484,0.000166711,0.00004782162,0.0062739234],"genre_scores_gemma":[0.9974874,0.000641557,0.00022317558,0.0003515204,0.00011605213,0.000008885997,0.00007904993,0.000007191386,0.0010850817],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998877,0.000011066158,0.000010756684,0.000026815636,0.000012816549,0.0000507955],"domain_scores_gemma":[0.99967325,0.00006105117,0.00006167311,0.000023751472,0.00002736099,0.0001528172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119956414,0.0006649167,0.00037066388,0.0011910598,0.0010415333,0.00037004228,0.00042944337,0.0009916924,0.0017369873],"category_scores_gemma":[0.00062405376,0.0003114675,0.00036639706,0.00090968027,0.0006757511,0.00033229907,0.00054576725,0.000545087,0.00034798883],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007687795,0.000037457965,0.06729082,0.000047494395,0.000024340517,0.92168266,0.0004973593,0.00009870723,0.0055555818,0.00021813757,0.00095189974,0.0035186957],"study_design_scores_gemma":[0.00003161,0.00014083397,0.084757835,0.000024278748,0.000050858147,0.9086668,0.00042643907,0.0003223396,0.0013940716,0.00022069621,0.0039334516,0.0000307574],"about_ca_topic_score_codex":0.013302773,"about_ca_topic_score_gemma":0.019519184,"teacher_disagreement_score":0.013302773,"about_ca_system_score_codex":0.00064228324,"about_ca_system_score_gemma":0.0007663399,"threshold_uncertainty_score":0.026450694},"labels":[],"label_agreement":null},{"id":"W4415533018","doi":"10.1007/s00277-025-06661-y","title":"Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Saskatchewan Cancer Agency; University of Calgary; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre","funders":"","keywords":"Hematology; Ruxolitinib; Risk stratification; Disease; Risk factor; Refractory (planetary science); Survival analysis; Hematopoietic stem cell transplantation","score_opus":0.05375767049704309,"score_gpt":0.34237510264134274,"score_spread":0.28861743214429963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415533018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704456,0.0070589455,0.0003842614,0.0005932737,0.000012322847,0.00011997352,0.017341115,0.000025210898,0.0040193093],"genre_scores_gemma":[0.9880712,0.001441061,0.0003907442,0.00024177367,0.000022417089,0.00005776254,0.009544642,0.000009901476,0.0002205472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975076,0.00071346614,0.00027019528,0.00027082654,0.00094340515,0.0002944845],"domain_scores_gemma":[0.99047583,0.0014554835,0.0038000564,0.00064800406,0.002617368,0.0010032402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029360545,0.00037925402,0.00077990216,0.0009904295,0.0008426271,0.0008420332,0.00074319704,0.00037935292,0.0014624993],"category_scores_gemma":[0.005762576,0.00020461965,0.0008216665,0.004504724,0.0005753699,0.00031223992,0.0005294104,0.00041668612,0.00020315366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006453109,0.00019511498,0.9580447,0.00053377036,0.000911499,0.0001682898,0.00038266816,0.0018825924,0.001198999,0.00031594175,0.004382052,0.02553122],"study_design_scores_gemma":[0.00054085307,0.00051642413,0.9931954,0.000068878944,0.00030502197,0.00018031808,0.00013640075,0.000513271,0.00019568506,0.000033696255,0.004278823,0.000035229947],"about_ca_topic_score_codex":0.7329699,"about_ca_topic_score_gemma":0.7803806,"teacher_disagreement_score":0.26703012,"about_ca_system_score_codex":0.009555905,"about_ca_system_score_gemma":0.010687797,"threshold_uncertainty_score":0.5372054},"labels":[],"label_agreement":null},{"id":"W4415603472","doi":"10.1007/s00277-025-06643-0","title":"Efficacy and safety of venetoclax plus azacitidine based regimens in the treatment of relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lanzhou University","keywords":"Venetoclax; Azacitidine; Ven; Neutropenia; Myeloid leukemia; Febrile neutropenia; Chemotherapy; Refractory (planetary science); Adverse effect","score_opus":0.13319423914231435,"score_gpt":0.42072568952026357,"score_spread":0.28753145037794925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415603472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004081021,0.99456763,0.00041540814,0.00014954679,0.00011705085,0.00015669275,0.00029968703,0.000018051358,0.00019479223],"genre_scores_gemma":[0.1361918,0.8588604,0.0020957272,0.0007566116,0.0002702878,0.0007278976,0.0007013922,0.000027628415,0.00036826526],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943499,0.0028436356,0.0014526981,0.0005715145,0.00060705375,0.00017529009],"domain_scores_gemma":[0.9924199,0.0055211964,0.0011717384,0.00021884775,0.000539104,0.00012919273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008966744,0.0027178389,0.01738604,0.005602795,0.00050182536,0.0030675642,0.0017706462,0.0020967657,0.0028548478],"category_scores_gemma":[0.01708258,0.0013829377,0.0428335,0.005862245,0.0005158704,0.0014905431,0.0011685437,0.0018341804,0.00024862826],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021275543,0.000029064135,0.0015907346,0.25569177,0.7278488,0.00008542343,0.000051975887,0.000735766,0.00024286436,0.00011998284,0.0003950478,0.011080881],"study_design_scores_gemma":[0.0003875629,0.0001440078,0.001513375,0.011402302,0.985121,0.000049605656,0.00002089288,0.00019501208,0.000075790434,0.00013365968,0.0009417887,0.000014941824],"about_ca_topic_score_codex":0.0067619197,"about_ca_topic_score_gemma":0.01378777,"teacher_disagreement_score":0.01738604,"about_ca_system_score_codex":0.0023012015,"about_ca_system_score_gemma":0.0026255085,"threshold_uncertainty_score":0.047421217},"labels":[],"label_agreement":null},{"id":"W4416122738","doi":"10.1007/s00277-025-06723-1","title":"From pharmacokinetic-guided FVIII prophylaxis to low-dose Emicizumab prophylaxis: a pilot study revealed a flush of hope","year":2025,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; McMaster University","keywords":"Regimen; Breakthrough bleeding; Hematology; Retrospective cohort study; Hemarthrosis; Coagulation","score_opus":0.08272565726646962,"score_gpt":0.4121387801383494,"score_spread":0.3294131228718798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416122738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987134,0.0008190334,0.00009500513,0.00007364042,0.0000095265295,0.000022399445,0.000019939356,0.000002987846,0.00024416947],"genre_scores_gemma":[0.9992754,0.00038371852,0.00012308398,0.00006846494,0.000018691553,0.00001049004,0.000034711138,9.3404117e-7,0.00008442754],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996612,0.00017966823,0.000027739788,0.00005274942,0.000030851912,0.000047695412],"domain_scores_gemma":[0.9992557,0.0003782255,0.000080604994,0.00009308713,0.00005677694,0.00013543697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011145661,0.00015491736,0.00034010952,0.00009869635,0.00013363698,0.00036511302,0.00017815336,0.00018393622,0.0013256763],"category_scores_gemma":[0.0011856164,0.00006357849,0.000339679,0.00012690114,0.00038540867,0.00026203363,0.00011563396,0.0006360554,0.00012124994],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08035343,0.033729862,0.2835369,0.0010758507,0.0012854787,0.0024767215,0.001405039,0.00078146654,0.05280306,0.0012872919,0.0019746015,0.5392902],"study_design_scores_gemma":[0.009277596,0.57134974,0.39281017,0.00017823026,0.00089526555,0.0041720583,0.00069003453,0.0015737639,0.010787837,0.00041046747,0.0078249825,0.00002978458],"about_ca_topic_score_codex":0.00043909682,"about_ca_topic_score_gemma":0.00063970516,"teacher_disagreement_score":0.0013256763,"about_ca_system_score_codex":0.00021820003,"about_ca_system_score_gemma":0.00034201652,"threshold_uncertainty_score":0.0058944225},"labels":[],"label_agreement":null},{"id":"W763774166","doi":"10.1007/s00277-015-2443-7","title":"A rare case of acute leukemia of ambiguous lineage overexpressing C-MYC with monosomy 7 and Philadelphia chromosome","year":2015,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Electricity Association; Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hematology; Monosomy; Lineage (genetic); Internal medicine; Cancer research; Chromosome 7 (human); Chromosome; Medicine; Oncology; Genetics; Biology; Karyotype; Pathology; Gene","score_opus":0.06190959098888071,"score_gpt":0.3484919326592154,"score_spread":0.2865823416703347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W763774166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8426148,0.009772764,0.0060942452,0.06796955,0.005500958,0.00040317993,0.0005415239,0.00055595173,0.066547096],"genre_scores_gemma":[0.9669612,0.0023054613,0.0030624622,0.011181496,0.01117849,0.00008238658,0.00020781708,0.00006700767,0.0049537565],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99888414,0.00019456519,0.00010857828,0.00022163914,0.00017481073,0.00041626557],"domain_scores_gemma":[0.9971896,0.001227239,0.000447972,0.0002416705,0.00017014316,0.00072351506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058075914,0.0022613304,0.001537956,0.002034421,0.0033025919,0.002477358,0.0019395319,0.011742597,0.0031681587],"category_scores_gemma":[0.0082102055,0.0012265466,0.0015652664,0.0015860754,0.0021625473,0.0032526874,0.002635256,0.0061845174,0.0011003761],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002931607,0.000012308233,0.0012411583,0.000012132489,0.000002731853,0.9972319,0.00004299139,0.00003056461,0.00014968807,0.0003023569,0.000608833,0.00033606807],"study_design_scores_gemma":[0.000020740823,0.000028446137,0.0012323898,0.000009856565,0.000010199527,0.9966493,0.00007323168,0.0002888549,0.00012561203,0.00056454324,0.0009914918,0.0000053781773],"about_ca_topic_score_codex":0.0013131815,"about_ca_topic_score_gemma":0.001790604,"teacher_disagreement_score":0.011742597,"about_ca_system_score_codex":0.002144162,"about_ca_system_score_gemma":0.0009427485,"threshold_uncertainty_score":0.015557051},"labels":[],"label_agreement":null}]}